var title_f41_58_42912="Cholinergic urticaria";
var content_f41_58_42912=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F53590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F53590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cholinergic urticaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small urticarial papules on red skin (axon reflex erythema) occurring on the neck within 30 minutes of vigorous exercise.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick, TB, Johnson, RA, Wolff, K, et al. (Eds). Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, McGraw-Hill, New York, 1997. Copyright &copy; 1997 McGraw Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42912=[""].join("\n");
var outline_f41_58_42912=null;
var title_f41_58_42913="Late lye esophageal stricture";
var content_f41_58_42913=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80689&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophageal stricture due to lye ingestion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 451px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiographic appearance of lye stricture 25 years after ingestion in a patient with dysphagia. Panel A: Barium esophagram reveals a smooth proximal esophageal body stricture. Panel B: Barium tablet radiogram demonstrates stagnation of a barium tablet (measuring 13 mm in diameter) proximal to the lye stricture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George Triadafilopoulos, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42913=[""].join("\n");
var outline_f41_58_42913=null;
var title_f41_58_42914="CT cystogram bladder rupture extraperitoneal";
var content_f41_58_42914=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT cystogram of extraperitoneal bladder rupture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This CT cystogram shows an extraperitoneal bladder rupture. Contrast is seen directly adjacent to the bladder (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael S Runyon, MD, FAAEM.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42914=[""].join("\n");
var outline_f41_58_42914=null;
var title_f41_58_42915="Chronic rhinosinusitis";
var content_f41_58_42915=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Chronic rhinosinusitis (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/58/42915/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42915/contributors\" id=\"au1390\">",
"       Daniel L Hamilos, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/58/42915/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42915/contributors\" id=\"se952\">",
"       Jonathan Corren, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/58/42915/contributors\">",
"       Deputy Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42915/contributors\" id=\"de128\">",
"       Anna M Feldweg, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42915/contributors\" id=\"de2799\">",
"       Constanza Villalba, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/58/42915?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      CHRONIC RHINOSINUSITIS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The sinuses are hollow air pockets in the bones of the face and head that probably exist to cushion the brain during trauma (",
"     <a class=\"graphic graphic_figure graphicRef75045 \" href=\"mobipreview.htm?9/62/10210\">",
"      figure 1",
"     </a>",
"     ). The sinuses are lined with a thin layer of tissue that normally makes a small amount of mucus to keep the sinuses healthy and lubricated and flush away germs.",
"    </p>",
"    <p>",
"     Rhinosinusitis occurs when the lining of the sinuses gets infected or irritated, become swollen, and create extra mucus. The swollen lining may also interfere with drainage of mucus.",
"    </p>",
"    <p>",
"     Chronic rhinosinusitis refers to a condition that lasts at least 12 weeks despite being treated and causes at least TWO of the following symptoms:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Nasal congestion",
"      </li>",
"      <li>",
"       Mucus discharge from the nose or that drips down the back of the throat",
"      </li>",
"      <li>",
"       Facial pain, pressure, or \"fullness\"",
"      </li>",
"      <li>",
"       A decreased sense of smell",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Chronic rhinosinusitis is different from the more common form of rhinosinusitis (called acute rhinosinusitis), which is a temporary infection of the sinuses that often occurs following colds. Chronic rhinosinusitis is a more persistent problem that requires a specific treatment approach. It is sometimes overlooked by both patients and healthcare providers because the symptoms are more low-grade and chronic.",
"    </p>",
"    <p>",
"     If you have been treated for rhinosinusitis with antibiotics multiple times within a single year, or if you have two or more of the symptoms listed above much of the year, talk to your healthcare provider about whether you might have chronic rhinosinusitis.",
"    </p>",
"    <p>",
"     An article that discusses acute rhinosinusitis is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/13/37073?source=see_link\">",
"      \"Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CHRONIC RHINOSINUSITIS CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     Unlike acute rhinosinusitis, which is usually caused by infection, chronic rhinosinusitis often has more complicated and elusive causes. Infections can certainly contribute to or worsen chronic rhinosinusitis, but people with the chronic condition usually have longstanding inflammation that cannot be explained by infection alone. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"      \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Healthcare provides divide chronic rhinosinusitis into three different categories, depending upon the features that are present.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Chronic rhinosinusitis without polyps &mdash; Chronic rhinosinusitis without polyps is the most common type of rhinosinusitis. In this form rhinosinusitis, the swelling and irritation of the sinus lining may be caused by different factors, such as allergies to things in the air, irritation from things in the air, and infections (",
"       <a class=\"graphic graphic_figure graphicRef52698 \" href=\"mobipreview.htm?25/22/25955\">",
"        figure 2",
"       </a>",
"       ). The factors are different in different people.",
"      </li>",
"      <li>",
"       Chronic rhinosinusitis with polyps &mdash; Some people with chronic rhinosinusitis have abnormal growths inside their nose or sinuses called nasal polyps. The polyps can become large and numerous enough to clog the sinuses, causing symptoms (",
"       <a class=\"graphic graphic_figure graphicRef64506 \" href=\"mobipreview.htm?0/29/467\">",
"        figure 3",
"       </a>",
"       ). Scientists do not fully understand why some people form nasal polyps. Treatment involves medications to shrink the polyps or surgery to remove them. Some people need both.",
"      </li>",
"      <li>",
"       Chronic rhinosinusitis with fungal allergy &mdash; Some people with chronic rhinosinusitis develop a strong allergic response to fungi (plural of fungus) inside their sinuses. It is normal for air to contain small amounts of fungi (airborne spores), and most people can breathe in air containing fungi without problems. However, in some people, the allergy to fungi causes the sinus lining to make thick, dense mucus that fills the sinuses. To diagnose this type of chronic rhinosinusitis, a healthcare provider must find thick mucus in the sinuses, see fungi in the mucus under the microscope, and show (with allergy testing) that you are allergic to fungi.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CHRONIC RHINOSINUSITIS RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Several factors can increase your risk of chronic rhinosinusitis or worsen your symptoms once you have the disorder. These include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Allergies &mdash; Allergies are much more common among people with chronic rhinosinusitis than they are among people in the general population. This is especially true of allergies that are present year-round, such as dust mites, animal dander, molds, and cockroaches. What's more, allergies that are poorly controlled can worsen the symptoms of chronic rhinosinusitis. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/8/41092?source=see_link\">",
"        \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Exposure to tobacco smoke or airborne irritants &mdash; Exposure to cigarette smoke or certain environmental toxins, such as formaldehyde, can increase the risk of chronic rhinosinusitis.",
"      </li>",
"      <li>",
"       Immune system disorders &mdash; People who have certain immune system problems are at increased risk of chronic rhinosinusitis. Most people with immune problems also have recurrent problems with other infections, such as ear and chest infections.",
"      </li>",
"      <li>",
"       Viral infections &mdash; Some people seem to develop chronic rhinosinusitis after having repeated viral infections (such as the common cold), although it is not clear that the infections actually cause the chronic rhinosinusitis.",
"      </li>",
"      <li>",
"       Deviated septum &mdash; The piece of cartilage that runs down the midline of the nose and separates the nostrils, called the septum, is not entirely straight in many people -- a condition called a deviated septum. This may be present from birth, or develop later in life as the result of injury to the nose. A deviated septum may cause one nostril to be blocked, but it usually does not cause chronic rhinosinusitis.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      CHRONIC RHINOSINUSITIS SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     As noted above, the symptoms of chronic rhinosinusitis must include two or more of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Nasal congestion",
"      </li>",
"      <li>",
"       Mucous discharge from the nose or that drips into the back of the throat",
"      </li>",
"      <li>",
"       Facial pain, pressure, or \"fullness\"",
"      </li>",
"      <li>",
"       A decreased sense of smell (which is especially common among people who have polyps)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Many people with chronic rhinosinusitis also experience fatigue, although this symptom is not used to diagnose chronic rhinosinusitis because there are many other causes of fatigue, unrelated to sinus conditions. Still, fatigue is a prominent feature of chronic rhinosinusitis, and it can be the most difficult symptom for some people to manage.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      CHRONIC RHINOSINUSITIS DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Chronic rhinosinusitis is likely if a person has had two or more of the symptoms listed above, for a period of at least 3 months. In addition, there should be evidence of sinus disease that can be seen on a sinus CT scan or with a procedure called sinus endoscopy.",
"    </p>",
"    <p>",
"     A sinus CT scan is a procedure that takes about 15 minutes and involves a series of x-rays of the head and face. The x-rays give a detailed picture of the sinus linings and any mucus or polyps within the sinus spaces.",
"    </p>",
"    <p>",
"     Sinus endoscopy is an office procedure in which a physician uses a thin tube attached to a camera to see inside the sinuses (",
"     <a class=\"graphic graphic_figure graphicRef87501 \" href=\"mobipreview.htm?36/37/37471\">",
"      figure 4",
"     </a>",
"     )Endoscopy also allows the physician to take a sample of mucus from inside the sinuses to examine under the microscope. Samples of mucus from the nose (which are easier to obtain) are not representative of what is found in the sinuses.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      CONDITIONS RELATED TO CHRONIC RHINOSINUSITIS",
"     </span>",
"    </p>",
"    <p>",
"     The linings of the nose and sinuses are similar to the linings of the lungs. About one in five people with chronic rhinosinusitis also has asthma. The people most likely to have asthma are those who have chronic rhinosinusitis and nasal polyps.",
"    </p>",
"    <p>",
"     Some patients with chronic rhinosinusitis, nasal polyps, and asthma also have a condition called aspirin intolerance. The symptoms of aspirin intolerance consist of a noticeable worsening in nasal or chest symptoms in the first few hours after taking aspirin, ibuprofen, naproxen sodium, or other nonsteroidal antiinflammatory drugs (NSAIDs).",
"    </p>",
"    <p>",
"     Worsening of symptoms may involve sudden nasal congestion, pain and pressure in the sinuses, wheezing, chest tightness, and cough. These reactions can be severe and even life-threatening. In contrast, acetaminophen (Tylenol&reg;) usually does not aggravate sinus and asthma symptoms. If you think you may have aspirin intolerance, you should avoid aspirin and other similar medications and talk to your healthcare provider. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=see_link\">",
"      \"Aspirin exacerbated respiratory disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      CHRONIC RHINOSINUSITIS TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Chronic rhinosinusitis cannot be cured in most cases, but proper treatment can significantly reduce its symptoms and improve quality of life. Treatment can also reduce the need for repeated rounds of antibiotics",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     repeat surgery.",
"    </p>",
"    <p>",
"     Unfortunately, people with chronic rhinosinusitis usually need lifelong treatment to keep the symptoms in check. Several treatment options are available for people with chronic rhinosinusitis, but not all treatments are appropriate for all people. Different combinations of these treatments will be recommended depending upon the type of chronic rhinosinusitis you have, the severity of your symptoms, and if other conditions are also at play (such as allergies or asthma).",
"    </p>",
"    <p>",
"     Healthcare providers usually recommend starting with aggressive treatment to get symptoms and inflammation under control, and then changing to a less aggressive approach over time. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/4/30794?source=see_link\">",
"      \"Management of chronic rhinosinusitis\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Potential treatments for chronic rhinosinusitis include:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Life style modifications",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with chronic rhinosinusitis who smoke cigarettes should stop. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/13/19670?source=see_link\">",
"      \"Patient information: Quitting smoking (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     If you have allergies as a contributing factor to chronic rhinosinusitis, you may be able to change things in your home or work conditions to reduce your exposure to the specific allergens that bother them. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/40/5764?source=see_link\">",
"      \"Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Daily nasal washing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people with chronic rhinosinusitis find that washing their nasal passages daily with saline (salt water) helps reduce symptoms. Washing the nose before applying medications also clears away mucus and reduces its interference with medications. The table provides instructions on how to make your own saline and perform nasal washes (",
"     <a class=\"graphic graphic_table graphicRef71059 \" href=\"mobipreview.htm?42/33/43548\">",
"      table 1",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Glucocorticoid nasal sprays, washes, and drops",
"     </span>",
"     &nbsp;&mdash;&nbsp;Because all forms of chronic rhinosinusitis involve some degree of inflammation (ie, irritation and swelling), most people with the condition need medications to reduce inflammation.",
"    </p>",
"    <p>",
"     Glucocorticoids (commonly called steroids) are very effective anti-inflammatory drugs. They also decrease mucus production and help shrink any polyps that may be present. Using glucocorticoids in form of nasal sprays or drops has the advantage of putting the medicine right where it is needed, and also of not treating the rest of the body, where the drug is not needed.",
"    </p>",
"    <p>",
"     Your healthcare provider will probably ask you to try a glucocorticoid spray initially, as sprays are easy to use. Sprays do not reach deep into the sinus cavities, but they reduce swelling in the nasal passages and open up the areas through which the sinuses drain. Examples of steroid sprays include triamcinolone acetonide (Nasacort&reg;), budesonide (Rhinocort Aqua&reg;), fluticasone (FlonaseR, Veramyst&reg;) and mometasone (NasonexR).",
"    </p>",
"    <p>",
"     If the sprays do not seem to be working well enough, your provider may suggest switching to nasal drops, or adding a nasal glucocorticoid solution to the saline nasal wash. Nasal drops or washes help get the glucocorticoid solution higher up into the sinuses.",
"    </p>",
"    <p>",
"     If drops are prescribed, then you must put them into the nose while lying in specific positions. This allows the liquid to move into the different sinuses (",
"     <a class=\"graphic graphic_figure graphicRef60094 \" href=\"mobipreview.htm?35/55/36726\">",
"      figure 5",
"     </a>",
"     ). In the US, steroids do not come in nasal drops, but a medication called budesonide (Pulmicort&reg; Respules) can be dissolved in saline and used as a nasal wash. Your healthcare provider will give you specific instructions on how to use these medications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Glucocorticoid pills",
"     </span>",
"     &nbsp;&mdash;&nbsp;In some cases, your healthcare provider will recommend taking glucocorticoids (steroids) by mouth (orally). The most commonly used oral glucocorticoid is prednisone.",
"    </p>",
"    <p>",
"     Glucocorticoids taken orally get into the circulation and deliver higher doses of drug compared to nasal sprays, rinses, or drops. This can result in better treatment of the inflammation and more dramatic improvement in symptoms. However, glucocorticoids taken by mouth suppress normal immune responses throughout the body and can cause side effects, so healthcare providers use them only when necessary.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Antibiotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Although chronic rhinosinusitis is often caused by inflammation rather than infection, sinus infections can develop and aggravate symptoms. As a result, some people need to take antibiotics. It's not unusual to need long courses of antibiotics, lasting several weeks, to fully treat a sinus infection in a person with chronic rhinosinusitis. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link\">",
"      \"Microbiology and antibiotic management of chronic rhinosinusitis\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Leukotriene modifiers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Healthcare providers occasionally prescribe a group of medications called leukotriene modifiers to people with chronic rhinosinusitis. These medications include montelukast (Singulair&reg;), zafirlukast (Accolate&reg;), and zileuton (Zyflo&reg;). These treatments work by reducing inflammation in a different way than glucocorticoids. These medications are not used for all types of chronic rhinosinusitis, and they appear to be most helpful for people with chronic rhinosinusitis and nasal polyps who also have asthma.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Although healthcare providers usually attempt to get the symptoms of chronic rhinosinusitis under control with medication first, some people need surgery to reopen the sinus passages and remove trapped mucus or polyps (",
"     <a class=\"graphic graphic_figure graphicRef87501 \" href=\"mobipreview.htm?36/37/37471\">",
"      figure 4",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Situations in which surgery is helpful include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Some people with chronic rhinosinusitis develop a severe fungal allergy causing a buildup of thick, dense mucus in the sinuses that is difficult to remove in any other way except surgery. The surgery also allows for collection of samples of mucus, which are needed to confirm the diagnosis (&ldquo;allergic fungal rhinosinusitis&rdquo;).",
"      </li>",
"      <li>",
"       People with nasal polyps that do not sufficiently shrink with steroid treatment may need surgery to remove remaining polyps.",
"      </li>",
"      <li>",
"       People with severe deviation of the septum may benefit from having the septum straightened so the sinuses on both sides can drain more freely.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     As discussed above, surgery can be very useful in the treatment of chronic rhinosinusitis, although by itself, it is rarely enough to control symptoms long-term. The factors that caused the sinus linings to become irritated and swollen and produce extra mucus in the first place must be addressed. In addition, because it is often impossible to eliminate these factors completely, most people require medications to control inflammation over time.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      SUMMARY",
"     </span>",
"    </p>",
"    <p>",
"     Chronic rhinosinusitis cannot be cured in most cases, although treatment can significantly reduce symptoms and improve quality of life. The best approach to treatment involves identifying the factors that contribute to chronic rhinosinusitis in each specific person and correcting these factors to the degree possible. Most people are treated primarily with medications, although many also need surgery. Even after surgery, medications to control inflammation are usually needed indefinitely.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27016963\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27016970\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/53/17234?source=see_link\">",
"      Patient information: Sinusitis in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/12/11457?source=see_link\">",
"      Patient information: Deviated septum (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/18/29985?source=see_link\">",
"      Patient information: Nasal polyps (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/37/14930?source=see_link\">",
"      Patient information: Chronic sinusitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/18/16674?source=see_link\">",
"      Patient information: Rinsing out your nose with salt water (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27016984\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/13/37073?source=see_link\">",
"      Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/8/41092?source=see_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/13/19670?source=see_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/40/5764?source=see_link\">",
"      Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27017021\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/4/30794?source=see_link\">",
"      Management of chronic rhinosinusitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26537?source=see_link\">",
"      Microbiology and antibiotic management of chronic rhinosinusitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11674?source=see_link\">",
"      Orbital cellulitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23145?source=see_link\">",
"      Septic dural sinus thrombosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=see_link\">",
"      Aspirin exacerbated respiratory disease",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Institute of Allergy and Infectious Diseases (NIAID)",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.niaid.nih.gov/topics/sinusitis/Pages/index.aspx\">",
"        file://www.niaid.nih.gov/topics/sinusitis/Pages/index.aspx",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Allergy, Asthma, and Immunology Online",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.acaai.org/public/advice/sinus.htm\">",
"        www.acaai.org/public/advice/sinus.htm",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Academy of Allergy, Asthma, and Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.aaaai.org/home.aspx\">",
"        file://www.aaaai.org/home.aspx",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?41/58/42915/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/58/42915?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42915/abstract/1\">",
"      Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42915/abstract/2\">",
"      Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008; 38:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42915/abstract/3\">",
"      Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007; :CD006394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42915/abstract/4\">",
"      Hamilos DL. Approach to the evaluation and medical management of chronic rhinosinusitis. Clin Allergy Immunol 2007; 20:299.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f41_58_42915=[""].join("\n");
var outline_f41_58_42915=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           CHRONIC RHINOSINUSITIS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CHRONIC RHINOSINUSITIS CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CHRONIC RHINOSINUSITIS RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           CHRONIC RHINOSINUSITIS SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           CHRONIC RHINOSINUSITIS DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           CONDITIONS RELATED TO CHRONIC RHINOSINUSITIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           CHRONIC RHINOSINUSITIS TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           SUMMARY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/62/10210\" title=\"figure 1\">",
"           Facial sinus PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/22/25955\" title=\"figure 2\">",
"           Blocked sinus passage 1 PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/29/467\" title=\"figure 3\">",
"           Blocked sinus passage 2 PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/37/37471\" title=\"figure 4\">",
"           Endoscopic sinus surgery PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/55/36726\" title=\"figure 5\">",
"           Medication positions PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/33/43548\" title=\"table 1\">",
"           Nasal irrigation instruct",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f41_58_42916="Extrinsic compression CXR";
var content_f41_58_42916=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large thymus leading to tracheal compression with tracheomalacia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 532px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest PA and oblique expiratory film show marked tracheal narrowing with expiratory collapse.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42916=[""].join("\n");
var outline_f41_58_42916=null;
var title_f41_58_42917="Spondylolisthesis imaging";
var content_f41_58_42917=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic radiographic signs of spondylolisthesis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 512px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIAAZ4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6kubiG1gaa6mjhhXG55GCqMnHJPvVEeINFP8AzF9O/wDAlP8AGuf+MQB+HOrgjP8Aqf8A0clfMpSMHhFHfoKAPrhvEmhrndrOmDHrdJ/jUZ8VeHhnOvaSMf8AT5H/AI18h3UcThtqKRj+7XPz2uWOUHPPSgD7hj8Q6LLjy9Y058/3blD/AFqUa1pZ6alZH/tun+NfH2gwqkUZKjO30rpIFVtuNgyRyRgCgD6e/tfTf+ghZ/8Af9f8acNU08/dvrQ/SZf8a+adrI5AAYg8lTkH6VoW0wiiywxx3FAH0MdV04db+0H/AG2X/GozrelA4Op2IPvcJ/jXgDXi4/hz6kcVDJ9llH7yFPUsOCaAPoM69o6/e1XTwPe5T/Gm/wDCQ6LnH9sad/4Ep/jXzjNY2h3hGePj+JQRWZcWOz5hKh56AUAfTz+J9AT7+uaWv1u4x/Woz4t8ODr4g0gfW9j/APiq+TtWihaB98UbcfewM1xN7DGJQqxqM84x0oA+5v8AhL/DX/Qw6P8A+BsX/wAVSjxd4bPTxBpB/wC32P8A+Kr4YtrRGYZjXH0rYhsYRHkIh/AUAfaC+K/DrHC6/pJPteR/41IvibQW+7remH6Xcf8AjXxSLaLJKoi4B5wKt2dvGSWKjHsKAPs0+ItFC7jrGnBfU3KY/nVeTxf4aiOJPEOjofRr2If+zV8nAwqhXarA9RgVxniawjB8xI1AJ6YoA+4f+E08Lf8AQy6J/wCB8X/xVH/Ca+Fv+hl0T/wPi/8Aiq/PZoo+6L/3zUbRR/3F/KgD9DP+E28K/wDQzaH/AOB8X/xVH/CbeFf+hm0P/wAD4v8A4qvzwMKf3F/Kjyo/7i/lQB+h/wDwm3hX/oZtD/8AA+L/AOKo/wCE28K/9DNof/gfF/8AFV+d/kx/3F/KlEUf9xfyoA/R1de0htL/ALSXVbA6du2/ahcJ5Wc4xvzjOeOvWqv/AAl/hr/oYdH/APA2L/4qvnXTkX/hkJV2jH248Y/6fK8cWCMgfIv5UAfdv/CXeG/+hh0f/wADYv8A4qnL4s8OMcLr+kH6Xsf/AMVXwmsEf9xf++as2qIkoIjXr6CgD7n/AOEl0LAP9taZg9P9Kj5/WnL4i0Rvu6xpx+l0n+NfGCQxzzbkC8HoR0rWtLWNEJCAnqDjmgD68Gu6SemqWB/7eE/xpV1vSmOF1OxJ9BcJ/jXybECV27Bz045rV0m3dZo9hUfNtJxnPtQB9RNqdgn3r61X6yqP61C2uaSv3tUsB9bhP8a8zubSMWsO6IbioByBkmuL8QaJHuaRVAY8kFaAPfR4i0Q9NY07/wACk/xp667pDfd1WwP0uE/xr5cSxt4+TCoI68UsaIZm2KmcdhjHvQB9TJq2nP8Acv7RvpMp/rUiX9nJ9y7t2+kgP9a+c9OdowgiBB7444rqdF1AIrAr1PJoA9ka+tFOGuoAfeQUpvbUDJuYMevmCvGbzUwbospBA+U+/wBK0ra7Wa1fGPUHNAHqf260xn7VBj/roKX7bakZ+0w49fMFeQwzBN25lPr7Vq2B+Vw3K7eDmgD0Y6jZA4N5bA+8q/40n9pWPX7ba/8Af1f8a8qmAMjcL+X6VXZUGUCqOKAPXf7TsMZ+22uP+uq/40xtY0xPvajZj6zqP615CsQfAKjJ/KuZ1Rd15MoAyPUd6APoL+29K/6Cdj/4EJ/jSjWtLJwNSsif+u6f4185CJBEwZBzntS28SKpIQFT0OOlAH0fFqmnzSLHFfWsjscKqzKST7DNXK8G8FR7fFWlrgDE4OMexr3mgDjPjEcfDjVz6eV/6OSvlqWXuxFfUnxl/wCSbax9If8A0clfImpzsG+Q4+ooAtyXBXODmn2zNKV3xkY7jvWdYhwA8pJzzzW9aoWwV6k4oA27O1URx7ODsHX1q8qAAKMg59arzSmJQRjgdB9Kg+2EkHgHg8UAaaKwc7Sc/nUzM207iMk4yKqW8wkXIzhRzjtUjSZXj/8AUKAJVYHJJIbrUbOC/wApPHJ5qCVjgKo7ZqF5JN/U8Dg4oAna4BHGOh6f/XqrO0spfy13HHSmxqxXBBPHHGRVq1UiVVdRyejnigBtzpTNpf70FXlGfcelc9ceGS5DyA54xz1rrtS1Iu/loFZQNuB0FS6fIvmKzqHCjg9AKAOPj8OTrzIpVB04qwbEiPEcRJH+zXd21w17NiUARk8DHQetN1hPskTCLBb7oPtQB5lcWUkZYtjOabCRDENwOc9Peunu4hcKxwAycnHpWBfRrEPvYHpmgCs04xlieewqnrIWWz+baSASD6U2WdVYFWIA5rn9U1Rnkby8gYxk0AZU+Mmq2DnA60M5Y8nNNoAVsgkHqO1FJ3ooAU0naig9DQB9EaZg/six56fbucf9flePqfSvX9LP/GIaf9fx/wDSyvHlI6UATpip0YADae9VFqRSQeDzQBtWLhQrMenUetdJp7LcA7cbx1GK5WEnyx6Vq6LM0N1E4POeRQB0kMGGYFRtI4yOR9K3fDtg0uoRKilV4Pvmp7ew+1W8cqd+QPrXWeH9O+z7S0Sq3c9aANG4wfJQtgjj/Gua1ldzEeYcE9+9dLqki26SHB3jpx0rjtUkMzDLEjkgD09KAOd1K2YKdgJycZzUFjCQjFyR26da1Lh/LVQ+ec8VAQNwEK4OMkHJoAktZGZ5EjRvlGM+oq7bTmBWZunTGeabY27x7iBw+B3q1LpchifAVc8ZoAzLm5aS4BTdtHAYjvW5osgiaMAEjGM1zb27wSYLknIHA4963tKlUlNxHXaM8ZoA1IraR7uRArbCeDxyM10B2w2xViu48EY6Cqa6hbBA6eW8i8Yz0NMku0kUbyAW5yo60AZz3Wc4wB/s1DHP65cevelu9kcbFCDk/lWS19GA+c8HGTxQBtRS7hISDtUEj8K5SOQyM8uRy3vWvZajG6yRbs5QgLXKRXioWCkgg4INAGtNIRDubp0wO9MSQBeAQPQVTEolwQMAdh2qzaoCvIznpxQB03gfnxRphyMmcZP4GveK+f8AwRIT4u0rdjP2gd/Y19AUAcd8X13fDrVx6+V/6OSvla6sYmkPmr0r6q+Lhx8PdVJ6Dyv/AEclfNLeTcdeD6E96AMn7Oq8BeK09KtyZVKgbVGefWp1t1yBwOcCt3T7JEhJKrubB+YUAYl8JCSu0kDGaqxwvuzyMjPrxXUTRQqSCTu78UyO0idsZA6DGMUAV9Mi65HUY6cVamiZcBenuOKvQ2wRWUAgA5yOtOaMjsMds0AZZgAJOeD396jeAkjAJzkHHpWqsf8AdBwB6U0rtVsAfiMfjQBiyQlQfnIz2HA/OmWtu7zF8DC85z0q87I+0t8zc4q9b+Tb2EszhckgAZoAw5FaSYuTtB4OKsw/ukIGeCc5PapG1HT1co2FY/eOa07S90tQu7bK2OhNAFjQoC6b3Rjt9Dwat3ieedrL1btUaamFXeAscSjARRkmov7SluCTbAKvXcetAGLrEK6b5r3Gf3mMAenvXAanqEKyOS2QD9a6jxokjqWaSTdnkZ4ry7UZGMjKcgCgBLy+3AhPw9qxpXLE81PICaqsMGgBtFBpKAClpKKACiig9DQB9Dad/wAmgr/1/H/0srx1a9j045/ZCQ9/tx/9LK8cHSgB6/WnqT2JqNTUkfUUAX03CNOeatQu6sCD3qug+UdsVagTJAyRQB6v4Mu/O09Y5AN64I/+tXQ6xqEmm2aSI+GzkLn361zHhGJ4vJ3LnAHHtV7XrlrnUXRyrRqRtGOAKAOjF0L4dSWwPvdKyLyMoWCnOB0FaejRiG0kuWHDdARXN6lq7x3LkgEE4PvQBDMgZQ5BVhx1qxaxBnRsEjb29aIIluY95AwTxk1etoeSAp2rgDtmgDUsbNSPnyx68jFW7kRkEA854H4UWcT7FCqQCM5zT7m0fy2O4DjqTQByOrhPm4Py85xWE0k8hAQlVHvmu2fR2kIDTIc+1H9iRRthiMnPWgDlNMDIzE9hjHQ11VluW2A684B6mmw6UkfIGTnvV1kwgXAwOlAGReH5DyfyxWHeQtIm2MjI6jpXR3MLlnJPbrVWCDJI2gn1I5NAHPWdnJDMrE/LngVXv7M213JxxIdw+hrsTbqyKGBG78jWfr9oxtYpAAdhwfWgDAs0JUgnAq9Emwc5PoRVa1XaxJwQeOKuLg4B5oA1/BYz4t0j1+0D8eDX0BXz94OAXxjo4X7v2gd/Y19A0Ach8WwD8PNXB6Yi/wDRqV8ryPsc9ge9fVHxcYL8PdWJAIxF1/66pXypIrGY/XofWgC/bSj5dxwM4+nvXaRQztbo8QDxsBtZTmuCJ2phc5HU0trq2oWLFLS4kRM529RQB2BsLiRw8kbrg9+KuW9nIjAEc9c+9YVp4u1JIx5jb+mcita18Xqz4mtgScc4FAG+tmxQdMkAinPYuSRtIHpg8e9OtvEWnS7N2UJHQ5FXo9Y02YACQD6Nn+dAGPLblSTjgcdaoXSHlQRn6V1ZuNOm6SgHOOeKpX2mCZN1qyufTvQBxNywDKu7IHbArM1ed/sqqXwFy2K3NQg8tyJEIYHHOa57WkxAXHGUwKAOTYv5jNuIYnOc1fsNTZCqy8k8bh/WqZG41G6YOMHHt1oA9A0y7DwbDgnHB9q2bNljfKYH9a4nQpi2zfnjiuus2CupwQDxjFAHPeL7rFxKmeGHGa8vvyWkbPbjPrXpPiyFjcMWAAK5/GvN79cOfXNAGfIcVBIDjPYnHWpn7+tQPQAwim0ppKACiiigAoPSlpD0NAH0Rp3/ACaDH/1+n/0srxwV7Hpv/JoUf/X6f/SyvHOwoAcKkiOGFR05DhhQBoxnccVq6HA1zeouCqKdzH0FZ9hAWKlgee1dXpsAt4unzN19qAO/0TH2Ka5j6xDbjHc03SrWHz5EkyzM25lPb8ay7fUFsNCkXLZcjp1FczdeJJowyqTgfN9T70Aeuao4i0+KKMNyMjb2FcxLpck8hbDcnuK8g1jxBqF1Ikj3Lgr0CueP1rV8P+LdSEgimvJCOmWOcUAeu2lgYUGCMD0HNXo4YUkEk7qi46EdK8/bV9Q3Em7kx3wcZFEt1cSI7G4d89TnrQB6Wmo2oddj7hnj0qa+v4/IK5GR05xXmEF1MWREuWG3jj1rX1F3BRklYMcd+9AHXNExRZAwXPJyaBPCT88ijHvUM6yLBAVYY2A549K4/X5rmKQSwyuMHnmgDuR5LsMTxZH+1Vn7OrfMrL9Qc15RDrd6MKZzk+wq1Drl5nl1zjqBjigD0mWyJTHOPY4qpHZFJi2wFe3HQ1y8PiuYQgFG4PVXPP51bsvFmXH7l2J4+YigDpGtzu4wfUZ6VFqdmGt2UkDI7/zrPbxHM+9ktIUx6sTVG91G5u4yGcKncKMUAYqD5mBwVBqQcHjJ9DipUgJbdu6nGKe0eW9xxgH3oA0vBoJ8W6PgYxcD8Rg179XhHg+Ir4t0vrxOOv0Ne70Acd8Xxn4dauP+uX/o5K+Y3t28/lSc+gr6m+Jiq/gjUlcZU+Vx/wBtUrwGeyiY8YB9qAOdW1jRTkZz61DLbqpGAM+tdPFpMlw2yJGY44IFRXmh3VtkSROce1AHOrEN3+IqxFEWl4zzVpLGZj8sbn/gJrQh0+SOMM0T7j14PFAFV8IOc5I/CqzM3QN9avTwyE/ck25/u1Xe1lI/1b/98mgCEXs0bfez7U+PXJ4XVkkdG9QTTfsFwScQv7cU1dGmPEskcbDpkmgDTXxfO4Au44J17llwx/GsvXdTgvIdttbmPPBy1NfQbjl45oJP9kMQazrqNoSUbqKAMtlwfp60+K2eYFlAKg8Vct7T7Q4O049B3rqbLTUS2GFCnPPFAGTo1hLCFLgds10sa8AnGQKZBbjdyenQ9KttGSuM4xznp+FAGTqtmLm3fyyCy9K8h1TK3UiuMMDg5r3AxddhzuHevN/G2mBLoyrgHqaAOEkqtJ1q7cjB54qk556dPWgCM0lOPWkoASjNFLQAdetIehpevekPQ0AfRGmf8mhJ/wBfp/8ASyvHQOBXsWncfsgR/wDX6f8A0srxxT8ooAeFJqaEAOMDJqNOnFTR4DfSgDpdGWKWaMPgFe2OtdbFGgx82QTgYFcVp2Nu7HIxit1Z5RGR5h46CgCxr91/oghjONrZOP5VysEbzyMMdc9RW5NgxYYsw6n60lhablfylyzDAB70AcLcAk47ZotX2yAjqK2bjRZUnPnMmST8q5NQvp0kTjC59AKAOu0S7iuLECUkOOORVp3ycJu2g9c9K5jTGnhcjY2DXe+G7IzkFoGbPIO3jFAGPbwS/a0AUksfvDjity/inRLbeCAZgvA7V1ul6ZH52TbqNp9Oa3Luwgc2y+Xght2M8UANjjIsYyVLYjHQe1c/d6YZ4T5iHkZw1d7cW/8AopRABx61mLZt5vIAyMA0AeS3GhTwTMzFNvX2NRNp1zHHnymbvlTmvWr7wyt5FkvtYdCD1rJ/sL7O5VpGBA/u8UAeXeU+CCCp9TxWhYwlIx5h+X2rv5NLU/eeNsf3kqJ/DsEwHCqeuUOKAObgYEbgcr7ip41H3Qecc4NbI8LhD8t4q9vmGf5VTm0i5hLFZEl9cNg/kaAIEXGAoBHrT8Bf4dvbg8mog+HK7QpB5yOn4VO20sCSBnjPYUAbfhdF/wCEo0xlIz5w469jXs9eJeFJT/wlOmJ1/fAfzr22gDmPiX/yJOo/9sv/AEaleF5IxkAkjBr3X4lAN4K1EHofKz/39WvDmwFJ3YzxjNAG9p8qwwoY4yh960xqkobBO7gjpWLZyKsCMWA7c1OGSQcMD/u0AapvBwxwCT3A5prXqledu7OeRxVAEbtvHPTtmhxuP060AWDeDP3IyOmCtRSzW7cyQRsc9gRVNyFB/PiopZMDJPJPrigCaV4ACEtlx39ay7iKGQEhNnPPcfSrbNvwoGSf0qvLEDja4G7p6GgCtbWAmjmdSDhSVx61zGpafO8kZSJiuPmOK9N0OzRLKeSQocgDJHFDx20eNu0tnIYjigDhNL0hgRJKpVF5APf3rWlUldqrnvW/PAgB+ZSmOo559KrbAr7lVcDpxQBnpbmMBivBHPJoYqDjByBz9a1ZpHubdy6gODgnpWJcOImbzCFHTmgBCwUsTgYHQ+led+PdTjQiJNrOentXR67qkEMTndk469K8f1S8e8u5ZZGLZPGT0FAFeVy2WbmqxweRT3IIxUQoATFBzSk8UmaADNJRS9qAEoPSig96APojT/8Ak0CP/r9P/pZXjangV7Lp4z+yDH73p/8ASyvHFU7RQA5DmrkCZG7rVIIR0rS0yIyEqzIqDneT0oAuWUuGAHHbiugswSu7qOuCaw7eBGlCwvuAPJro7O2ESguc57dBQA8wiUAYA5/E10vhvRFedfNLBmHyIO3vVKwt0dgY1/eYz24rr/D6pCwxjew5YnpQBi634Qka6HkkcnO4g4ArldR0OW2nMbowYHg4617rCqNBnAIA64rj/EhjdmOBv7HHNAHmEelzLINhNdr4Xjnt4x5j7fQZrOLL5h65PoK0NPc7QSwJ6YNAHf6QwYK0pPqCa1JZVEsG4feFcvpl6AQjn7o5561avb8SzxLGSQowaAOw3h0wKrgfNlhyKpWc5a2Vy3bIqRblc/40ATvPtPJHJ9aZMFnXsT0rJu7hhK2Cc7sACnwXLZGCMn160AFzCinJTHHX3qAqpTkA1cvW3wF16GshGYjlSSeOTQA2ZQGZlYgepHFVwJTkuQQD2q4sGGJIAOeeelQXuIw5yQiDdx0oAwNTjL3QcMCxGSccUR27NGAeOw9M1HB+9uGcknvjOa00H3VC7gec+tAE/hOMr4r04FcETDOevQ17ZXknh6IjxFprkEZmA5+hr1ugDl/icxTwPqbDqBHj/v4tfPSagpl2N95jivoP4pKW8B6oFBJIj6f9dFr5kkt8Sq4Y5XFAHRwSN5aAKMHPOeuDWxpYby2LA4Pr29azrKNHsoi+R8vYY71r25CRqnC454oAvAoMsRxjGOhqKaUnkYx6elMdwTxnp+tVnbOQzDDHHSgBJZjkkAEAdj2qB5CWJGefX0pdpc8AnPYdfrUpgYENnPHXGaAIB8oIGdwPA69fpRGY2ZWI+YHn39qvwWbdSPl+nU1o2OmIeicj2oAguJvJ09AFYbuox3/wrNSSVEdjgvuxtz2ro9Ws2EKIqDaevP8AniqEWnSMqjavXBGKAIbaQi32FTuJ5x+taIgUwguCuOeKv29jFGqFz7Yq3KsYQqvzf3RigDm5JobWzuJGK7SPlB7mvOfE15M6EbuvOBXd+JLWScAYIXPRa4fxHZm3mCqWyw44zQB55q9/I0bRseR1z61y7qa6PWbfbcOWyOegrElC54oApMp71Hjmrb4NQuAKAIaKcaaaACkpe1AOOlACUHvRQcY5zQB9Fabz+yHH/wBfp/8ASyvHx0FewaacfshR/wDX6f8A0srxxTQBNHyeatKwClRj5vSqi8Gp7bmQCgDe0thEvbj1ro7NhdwDBBfnPr9a5dcCNQBjj06Vp6HK63qLGcfhQB1Gn5Eac7TnnPet3SpmW6AIAIwQaiazLFHSMk8PhRW1pekt5gmCnDDK8ZP40AdbEwFmw5Y4615/r11GzyB8A5JGDXV6hqK2cAt0ALAfMc9DXnGpSE3UrOvA4G0dRQA1ldiHyOeeverdtlMBidvU96zjNJuxhQSOR/dq0k75C8HJ5AOaANyK4GEzznjpV228yaQ8kADoayrRwxA3BlPb/P0robKMSRYI5zwe4oA0Te+XbRIx2k8AdKhi1HbO7lgPftVG6ttz7SxxnOcUtrbrKSxJUEjPvQBp3bAASjLB8H6GoVnLsMqQR0yMVcigWSJoXZs54JGOnNRR6cS3sc4x3+tAFuItLA4J4xwT/hVNzsnGBwvOCa044WhgkLgcjgDoP/r1h3MgVyRkr3PegCfzXkAY9CM4NU9WcfZSGwA5C09WZlUqpANZ2vtiK3X1JOMdKAKifLu2kDPHBxVi0ctIOg7Cs1WPcFVHarenqzT5BwuOlAHX6EMazpvQnzxyPoa9SryrRJAuu6XGQcmcHHpwa9VoA5r4jjPgzUR6+X/6MWvn68sQ0o5OMdMdK+gviL/yJuoY/wCmf/oxa8ORDNdBSCQSM9ef880AW47dYLZFAJwBzU0SDJIAzgAAHrVtICSM8fWrkFnlc8HnIwKAM6ONmG05Prg0f2e0h3EkA9CRW8towG3bxn0qyliSMEEdMigDDSzRedpLdMDrVuKyY8bAMHPIrajsVUkkH2qX7OF6Hr6jmgDOitgo5IHtSzTNbLldvfqKty4UALncPbisq+3MCN3fnNAHM+K9VvzcQhJtsWDwvGRn1rHtNYfzRvMm8cDLkjNX/FUTYiZGVSMg8VzoilZ8AIRn6UAdhZ6g7HCTHPfNaSXFxgcBh161x+kLNJOUELsR1xzXaWYPkLnhiOc0AQS6jsiCzIOD+VYHigQ3NssqACRRiunvbVXiOV5bP1rm7+xZd0W4bWGMf1oA8w1OyRiwAHv+NclqFrtc4GD6V6BrNnLaSlW3beTuPQ1zV2iyBjKMEdj3oA5BwVPNRMc1qXUKg/KRWdKnJoArmk70pByaSgAoopKACjtS5pD0NAH0TYHH7IEX/X6f/S0142rDA+leyWPH7IEX/X7/AO3teMgUAThwat2WGfg9PWqKDHFXLMYOcc0AawIOBxitnw20R1WMO4C9+9c+qg46578dq6fwfp5nv2l2koo7UAe1aZHaG1hKkMccHGBWjJPFbW8kimMtjaoI6muf0uGVYFAz5fB/CszXbtp7lkgLKIT+R9aAJ7tWkWQkAllJBx3rmbtEWQIxDSdwO1dNHcomkfaLoYGMH1zXH3EyTTvKoySeDnIAoAZIVM2SuFJ/M1dtkLy5yoAORk5NVFB83B4Knr1rQ09f35IGeBjA5FAGlZWxLFm+bJ47Yrp7JBHH8x25x9aybFdp57nODWnAQ28ZAHpQA26eMM+SMknvVY3KK4G4KNuciodVYRvkd+OBWReRyJJtfoRgHsaAN5dbhTYcksDzjkVpWviCCYAmFg2OpriWTCBst064PNTWh2MctwenpQB2U2piY7SWyDxtHH1ql50bg4xnOCGrJt5Sm3aRxzj2qSaTAUggrnOPegCxJfxqV3E5zwFHUVieKb1vLtpRgLkirjMkm0E9eeRWNrq79MkB+YoQ4+nSgDPS/YoSRu/xq5a6pJGo8pQGzyetYUXEWOnvWhaxtgAEZPUUAdd4TvZp/F+kFySGuAPwwa94r5/8Ehv+Et0jcB/x8D+Rr6AoA534hp5ng/UFHfy//Ri15LYWy/aEJwCf4scCvYPG0Yl8MXiHoTH/AOjFrzeOBQhJA2YwPloA07bRSTuUhs+tX49M2Y3kH9KxYbiSJNschTqeucCnG/m3cS5B5OT2oA3/ALIgxnHHvUg8terA/QVy0mp3AJ+b5RVWfUrlhxIR79hQB2BnhGc8/hQZ4GyN3I9TXGfbpzwzjGeTmj7dJgEgAE9cc0AdZKtu+T5gH0xWRc2JyxSRGHY56VgT3MjowPB9cmsm7kkKnLMxJ5GelAEnieLEWCQSDnjH6VjaTbiVyx+YKcAepqSUDZ0NaOl2gEMe3OZG6daANe0hENuNoAJ6kcVZhcnK9weMjNK9u33fuquMHFEMZjd89O/tQBKJ9qlZB09+KzrmVHyGGfRuuK0XZGjwfvHkZrNu4QgJPy5PWgDC1iONwY5EVkI4J6j8a8617TiGYxpGy9eDg12/id5II0ABII9K881nUPmIViD6UAclfMVnZQCAOxqoWDDmtO9CyZcjr0rKkIU5A4oAjkTPI61CRjrUjSnsOKiY5NACUUUtACUZxzTj6009KAPomw/5NBiJ73pP/k6a8bQcV7NYD/jEGH/r8P8A6WmvHUX5RQAoq5aglRVVFy4HvW3ZQfuwNvfH1oAl0+0kupljVfqe1eveBtMjRI4SFI/iccZPeuG0e1Csu0Yxzj1969B0MtaBeg9PegDb8TzC1iVLddkagcgVyZmDJKzNvB4C4zyev4VsXupCdGDrvccAf571zl8yxQMyHYxx8v40AW9TdEihgH3QNxHY5/lWUYscqAPT/wCvWLf6vJJqMnkszAfKPTj2rd06VpigmjK5/SgB0cZ8xTuCnqcda07WF14DE5PXHI+tKNOmEx+VsDvjitKz0uZmYk8nsTjFAE9rg884+npWrbIShYgZx0FVY9PliwDgDGODWta2jqnTqAOtAHP30RnvLdEOCT3NXNQsgbd1X76nIOOtXhp7nUFkbBCDA9q1JLXKnatAHnjRADuG6dDxU0cHYcEHnH8629e08xEThMZ4bnFUbaNpAflA/WgCoiADnr0z60MBsXHXH5datm0lGcg54zgYpJreTLAKNuOKAKCpuCAnLflUdzbh4ZIiRkqVWtEW7BzgAcdP6U2WFyCe+eTnFAHn0sJyFx8wOOuMVq6fCwRDu5xn/wCtVrVLMJqL7gQGwwGKvWEPA4xj07UAaHg1T/wlOlZzn7Qp6Y7Gvea8Z8J2yDxHpzheVmBzj2NezUAY/i8Z8O3Y/wBzt/tivNnYqMHHA7V6R4wOPDl2f9z/ANDWvLpZFIyCfrQA+WQdFYZ6561A8oUjjrwarSyYc4xgHPApnzSPgcd+aAJZD8+cHB6/jSEFR0z7Dt+FW7W1lcMqIcFd2T0qeHSp3yzDHbgdaAMwsVIUDPYmm9zwDk9q6GPRI85mk2/Q1ft7KxtTmNN79ckZoA5eDS5ZlDyERR9iwyT9BT5tJt/lwHmOOucfpXRXMUkpO1CF6c0ttYAMCx5HpQBxsuiS3BVbWF1Jblm6YrpdM0cW0fJwFG0V0cirBAAuKy3n8zjlf6UAVLm3AUjHbr1qg0Z37lGe3StxlDg7jnjg1RvitvbMZARjqaAMu4OxjgisbUbvyw285J6Co9Q1faSE49Gz0FcreXdxeSMiMcgnLdqAMjxPezyTMpkPPb0rjb6ByMhWNdtLpE3mhmUkEZOOaVNHZUyUzkcGgDzVYnDlSMKevpUdzYAAlSfxr0uXQkEbSMoBrm9WgSInAyR6UAcHPD5ZPpUFbl4sbE7RWRMu09sUAQ0tFAzzQAUHkUUH7tAH0Xp3/JoVv/19n/0tNePoMAfSvYdM/wCTQ4Cf+fs/+lpryBOoB4FAFm3j2kOeueBWzZEIw3fNn8x71kIeV9K1bZSDggmgDttEKkqVO5QMfL/nrXRpdKvQAfXmuAs2KYCkqR3B7elbFrKXblmxxnJzQBq3d00jbYgCTWJqrSRbnG4hVLc9K07ddrAknGeB7VHqIE0vlqvyYO40AcBHdyowfDK2c8GtXT9buI+GeVhnox4qlfQmCaSJhyrY471Gm1DQB6HpHipZ4vInicuOhV8HFatvqcTtmR5kzyNwyP0rzC2fbIHXsc8V22lSC5RW2gptySaAOrtJ7dx8tyfXkMM/nWzZXSqCEucg9w3SuViRlUAqOvpnFa2nRneMZUcA0AbVrcvNeELPuBcjhjxip9TvHiikYODjphqzdAiDzzOACUc8joan1mMrBjbnv9KAOb1PWZ3t2iDuA44IboaxtJ1e883bLIfl4IODWxNapv3eWAfU1z+t6dIZWntsNx8yjsaAOoXXywAYKAO/er0Ws27FVfcrYz1HFed2wYsBIMHPercSbXLMOoxQB6B/adjt+aWHd+BP6VRutdtIVPlwmU9hXN2+3JO05xxTguCOBn17UASSzPfXP2iRkXHACjhR6Vq2cRCjgc96p2sYBHGT3wDxW1bKdm45G3jJ/rQBseF4ANasm4OJQevtXqdeZ+GyV1ezGeDIO1emUAYXjlgnha9J6fJ/6GteRPLvJAJFetePRnwnff8AbP8A9GLXk6AhkdFHBoAu2ejyzjfKyoDzjua1LXT4LfAJ8wnqW6VXE2Y0w5GeM0olbPJJ+tAGn56Rkbeg7Ypv2jPUucjjnFZwkyxwcn/Cnh+RgmgC+rgEAZHfnrTlky2feqSyAHByRnHSl81TkZA+tAF+OU5wRke9W45OgUH8ayY5AxHzAH8zVq3c+aACTwcjFAF2/YC2+bFZSEYG0kg960bxS8OOF9zWQ97aWitmaPeO2elAGpGqIgZyPp0rH8QXERgILAD+71rOu9aRpBiTzcHAUcCs6dPOLNNIcknHHT6UAc7qAa4LmNML2J4qLS7cxOdwJB6gDrWlLsjjkluTsgjRnd9pIRQMk4HUAc8elXrbyRbxXNu8U9vKu6OWIhkkH94MOCKAGwWokAVkCkDjJpk1kGJ+Xgddp71PPNOFyoAWq7ahLHlZcDGM+lAFYWCMjRnhvU8muP8AE3hyZizxkliM59a6W/vmX5wwXB6ism61y5JaMbW7gkUAeUanp89vISwxz2rHmQ4JIr0DxJI8kfmKowevy9PauOuyjZOADQBjNSVLMoB4qKgBaD0pKCaAPozTD/xiHB/1+H/0sNePZORXsOlDd+yJCB/z+H/0sNeUQWjSHIOBQBJbupxngitO2lKuFNU47AcA4Ppmuj0zSojbiSZ1LHgIoyfqfagAtNzOCccfoa6C0QhQzDIxnHqfaobTTYweRhOxB610lnbpHEDsB3UAUPKcNnkDA2564pWtGUqWUkn+Vdnpmiq9o0twuHYDb6iqSIDdYkz8vU0AeZ+KdLmjvYpVQhJV6YrO+xugHye3zCvc9Tt7WexUGJCRyGxkiuVu7KIPjYCelAHAWlm+/k98/Sup0ItbN5b8qTkEjpVuayjKFtrFs9F60+3slGCJOM9+1AHQ2citET5Y+XnA71qaeuImlCZXBIyP0rl4vMjmwjZAOciun0+VpI0HQHkgUAXdHg8qN3C4zU+oQmePIYj1Iq6iqqKox75qcRhgBgHNAHM/2V5iHcV2njr1qGTQJUjLQEZPVfWunuMIOMA1QNw0fDYJ96AOQl0nZJjbg5IK44qBtHUkgqVB6kV3o8q4wTg571XutPT78eSp7UAcVHorCTIlBXqBjFPexeI7tm4Agcc10a2eHOFYHrj/AAoa2AU4HOMGgDCg27QFBwTjb71rWy7sgADPYHgVUuoRBKCD16DFPikVAS5/CgDX0A412xBwf3wHH416hXkvhyRn8QWGRx5w6fQ161QBheOcDwte7hkfJx/wNa8kd+vDDtXrPjw48KX3/AP/AEYteQu2QORn+dAFmyn58s4J7YGcVbRjkAgkHtisaKQpLkZwDWtGScgkY6jsaAJxjaOf1pxfoQRk+tQREfdLHj9acrFl4OaAJgSdpywAPelEnzYPr161Xy4+UtnHIqZDvXkkbsE5oAsRZLBs9u/FWBdx24YrgkfxVS3le3X0qpdRySbVQMdp/A//AF6AJdfvbq8sJVt3Ma7TgqSDx/WuItY5JFYsST3JOcmu+tYT5WGQhOpz0/WsS8toIp8w8gHnjj6UAZVnC5cHGQDxg1e2OGCsDknAyetaOn2xZeRx3GK0Bp5ZRx9PrQBhIhtvnXO4EcYrxrxJJqnw68SSPoUjR6Rf5uY7VwXhOPvxsOxU9CMEKV5r3yXTnYjDDA7kVN9ijEYDwxS7Qw/eIG4ZdrDB7EcH1HBoA5zR5RqWlWd7E0EiTxrIWgcvGCeoUkA8HI5AIxg1FfWpYH5Qcdia5m/srz4YX0uqaVDJd+Dbp915Yq257Fj/AMtEz/D9fo38LV3Md9aXlvBPbOJIJ0WWKRVI3qRkHDYPTsRQBxN2CpbcNvYf4VzuqFkkEiAZHciu6120jYM0LKp7jvXE36P8ygFz6igDF1iQG3lDHhlyPwrgLqT5jj1rqfEMrJCEO4HJFclL1zQBCTzzSUpooASg9DRQx+X6UAfSGhDd+yRbj/p8P/pYa8/tLbCjODt5r0Pw5z+yZbY/5/D/AOlhrhbWP90O5A60AQqQJMAY9Peug0CNZpNmfnP3e1VLTTXkceYQDnhQOa63SfDjLE126tHGv3W6ZNAFiG0YnaRxnOe2P61t6dbRyyxpIzELjGBwOaxoY5VJIkbOeSBzzW9a3S2cSIm6SRyAfzoA6O5uVs7DcSMn5RWBFPE8gwvU9V6VW8UXTCUQdlAL/U1StpJVQPt+7n23UAauqX6IGEfy4GecflWG1wzzhlHBHA9frSGU3Ik81yuex5p9tZyZUF0Hux6UAWghZcY5NXLTSpGBYDk8VLB5FrHJNI0aKiZaR2Coo9STwPxNeWa78ZtUTWLjS/DOnaber5vk21wjSTmYnoVUbckk9MH8RzQB6pd6ctvGsigbudwqO0ufLbg9ecVleHrbxHbaPJdeMNSE+oz/AHbKCONIrbPYlRl2/EgdsnmrCbmYBAWJ/WgDsLK6W4VQ2Mjj6VsWxz061yWktsmO8gjHH1FbdtOUJLMCKALdz1OOD71TdhhsjgenerbyxuNwbNV5I1l+7j6CgCKOdF+YgKD7VctphKjKRk1mCKSNsbM9+au2ieXMC3OexoAbMCWycj2qnNPHCDk5PpTtXuSsvlJyc/gKxZyY4Xkd8hfm/wAKAKerag8t0EjITHXFNTO3LHdnpkVll2ZzJnljzk4rRhk3FcEgdfWgDofCceddsnZsnzRj8q9ZryrwqrHWbFiTjzB/WvVaAOe+IH/Io3//AGz/APRi144c7uVyAPzNex/EAZ8I3/X/AJZ9P+ui148vCkA5GKAI3G04I9PatWE+ZAj4HBwayjyTge1XtPfdEynt60AWsBvlJzzyPQ1L8oGxc475NNUDoBgH0qZEHpk+9AAsYJUADb6Y4zWjZWRk+aQ7F/LNR2qfNuK8VPdT+UGwSDjgY6CgCSWW1s1G1EJPr3qh/bmDhUUDtgVmXDu3LHk857VnPICQFOGxjigDXv8AVHuv3atjnNUoIhIWPQA85qG3TdIAOW/lWxbW2SAuQo9aALOmW5Y7ScHsM109vGsaBe30qnpln5CAnO4+taSYyaAIZrWOXJZcH24rLvYVh6Dg9Ca1p5do4PNZ11IHUhiCe9AHL6lchfMAwUIKvu/iB4PXt2rBurvDFuWYjqx5xW1rcRRt65eHk8HkfUVy90VZizEsMd/1oAstdJLGyjaGx061yl8VVzKpAIbDDNaAnWOUH5lUH0xVW/jAnEqAGKQZbtQBxvidbe6QMy4J7gdK5GbS28kyxtlM+lei6xpiyQExjIPOPeuMdZICyPkA9u1AHMSxspOR+VR1qX0Pltkcqe/pWawGeKAG0PjaMDGP1oobpQB9JeGlZ/2TbYJw32w/+lhrk9KsrjKNMFVBz1+8a7LwgCf2VbXHX7Yx/wDJs1zmnxF2QO54HIA7D3oA63whpf2u8VpQSAcsSOgrd1u6N1KY0QLEMqu0DgDuKr+GG2BkA2ZHf6d60/7KZmGCQc9PagDlxDLv2/KM8Ak810ekaZHa5u71gNi5wf51tQadZ2sZmuVUkDILc4rhPF2orqCtGv7u3U5AB6n3oAlutRsrm6kMmXYntSXd4J9kcA2RAc5HJrkbYGBg8Mg69G4rat7qKZMqSGXrj1oAt8IAAQSB29affz3cOm3D6fFbTX4QmGOdtqM/YMR0/T3I61nz3GyJm3bh1wR2rKS8eeQYQOuOeelACW3g698QyJP471mTUdp3rpVkTHbRt2yRjJx1wAf9o16PofhvSLPUIL+002ztJraA28bRRhfLQkkhcdCSTlupHGcVy+l3TFgBnePvDPate/1hYIFgQnMjcjuaANbW1GwuCNgGcdefpSaLaZiaYjAY7U57dzXIX2oyz3a20DZfIQnGdxzXp2nwAW6L/wA8wF+pHegDHvkaC4iKj72SeM8g1Xd5GD4bIA6CtTW4if3ignYcnjtWNC/ykLk7uxFAE8MzbD87ceoq7HOyMCTz0GfSqIRWQHOM8bSOtWFUFQW4PYUAX0vFaP5xlsYz61PbMqgkFjjJ5PSsePIKgk4PvwTVlWaJsHJPTNAEd22+dyOWznpzWPr0vl28UR/5anPB7VusheXJwQeMVzfiqPN6i8bY1z3oAooisrOowPQ9h0q3ZgyMqqO/B5NQRqREUPORwc9a1NKiIAwMtQB03hqPZqllg8bxjt616TXnvh+Jl1S0whCiT8q9CoA57x+M+Er8f9c//Ri15AIxtAPPfivY/HI3eFb4f7n/AKGteS42564x36GgCs6jacg++PrU2mkiVlJ4xjBoKYHy8Y68c062Ux3CHpjr70AaioB9BnpVmGNpSFQfjipraCF1D+agUjOcippbq1t0YI6hvr+poAZI8drH+9YZPQVkX1224uORUGo3ytIdgZj3OayriaSTOcKMg4FAD7i6O75yD+FVlfcQozk56k0wxkynOCf9qtXRrLzpUDHPPGRQBp6PYBYhI6kM3ABrorCz2kZxnsKlt4AFC44HFXEAVeOpoAkAAWkZtq8dTzTSfSq9w5AJ6c0ARTSHPsfwrPmY5HOB+dTSMTyenTkVQuH+bbkZxkCgDN1DJZtv3Tk+1c3fqmcsvJNdDeEgAM2RnoOMfWsPUVXaWUdR9MmgDmLxWTf84K9QBVN590ZQ84HBHY1evEY54yMdT0zWYyM3yqAc9c8CgCCG8Uo0cgHzcc9qw9XgUPlyCh5DetTatCYX8yI5PfbmscXpDbJslTwaAIJ7VWBAAZW6Vz17aPCx9O1dHK218oSVPPJqvdos8RyMjtz0oA5diWPJ9qQ9CBU9zHsYmq7Hg0AfT3gcBv2WbMMSAbxsn/t7NZ+iW6sUO1vQZ4PvWj4FUP8AstWQPe7f/wBKzVLRbqParLywxmgDs9KtkULvLDjJHr+NalxqcVihLuPYHmsGPUFt7VmVArD7ueg965K/unuZHed3LE8dh70AWfGPiG4u4HWKRljLYGOOK86vrq5R1zNLg88mt69ZpSBgYHvWNqEf7sgjJXnNAElhqm5ws3OO9b9hcAyrJFnbjBAPWuHRCM4z1re0VLmW5SOJ9oz8xPQCgDvpLL7Ta5wMscjtxUVposYYlsg8du/rWpbXUcpVFVsoMBe7CtS0G/IA79fSgCroWhf6QzMOSNvrkVcv/DkWWuH3bkUhPTJ6V0Omw+Wm44yOOKsXMe4opUkZz70Ach4b8LJHcC4nXleefWu1jjEMQVO1OSMLGqADFNlGWAA4+lABNGJYzkAbvauVmtWgnlBJ4Jx9K6xDxjqe9ZusW3mZdTg4waAMVBuUqvQDHFW4mwV+YYwBkjnimWkDgL8ob6f/AF6nMDK2ORx1xQBG8i+Wu0A49qaZd20q4dQMjjoalMBEbDqxyR/SpbSyWNssAd3UAYxQAiN8q56gZrndZWWbV5BGC+QK7X7KrKSR+VVJoo4p0bA3EAc+1AGBpGhTSnfdkD0ArqLSxggACgcd6iWTBq1CxagDW0xFW7gwMfMK6euY0sf6VB/vCunoAxfGfPhq8/4B/wChrXl3lDnnAPAwK9T8XjPh27Bx/B1/31rzXYCAOM/nQBVMQwcHjuKiePnOOnHHfParihT0GR796Qxg5K8dMDGeKAK4Axyc46gDtRLH94MB05OM1YK7WwfXnj9aa6EjqOvT1oAz3jAPYcDr1qCSI8E5467RWkyjauep5xUbRZLbuR7UAUUty8qrjGep65rqtCtvLYnsnSs2wtj5i4GTj0ro7dfs8IBA3Y5oAvJ2qXngVXt2DYIP6VbYfL05NAEJ71TnYMc8nB6VeI4OfyqhcLkHPcUAUZnITgVn3DljhT09auXAyQDms673AggdeDg0AULj5kO05GO1ZV8NyKNwC+tbM4ABUsVP0rKuQu3JBxzgdaAOflg84k8AZ57Vj6kyo2yJdp6e59zXTTOkMTbVJx/OsSSJZJjJM+3jpj+VAGBGgZ/nUbR1JPasjV7NZQ7xIqsD0HQiujvSqxlY+nbistmIIUnA9T3NAHHnfb8YOM9CKeZY2TOcNWrqQAcMIwy+uelYl0in5k+XrxQBSu1VyTkGsyVSpIrRf26+lVplDg9jQB9K+BgT+yzZhc5+1v0/6+zXL2TyMeOBnnjFdj8OcJ+zJY7gCBdSZH/b21ZLiCWMAIi5PVev4mgBI5GMZ3uWP5/lVeVUkiJZzvGMIB29c54/KppQUUGOMsM4yT0qONHlkyV6jnjrQBmmBmYNsIbp9ap6vZHyHwu08V6BpugmYbmX5R69DU2ueGZfsM0qKhzyKAPJbezOcYx3JrpdIthbhXZAwb07VZTRGt0H2jOTzgD+VTfLaxFGX5cHBPOKANVQnkbo3yw5yO1amlXY4BYBz6dveuXsP365QKcntk10Gk6PMsiuzsgY9DQB19tcMsAIO4Z5xUn9ogzBVXIA70WVusaYZiwxjp0pq2YEzvlgOvSgC/BdIzY6Ukjc5Vjyc1TghXnIJz35q4sYGAAcelACrIVOc5pk0jFOgBNTCLcegoMJIO4cGgDJkSdGBjY49O1EcxMioytuORkd60jCxbjJGOhpyW/7xSRk0ANggJwSM46VcSAKd2OnanxrtPQUOQucZPNAEUvQ1n3fID5xtParsr8HpwO9VWBZWGetAFa3bexwDwfwq9FzjIzVS2TYxBGDVyMcj3oA19LA+1Q/71dNXMaY3+lw+7iunoAyvFK79CuV/wBz/wBDFeeNEcYbA+nSvStcXfpc6/7v/oQriZbQc8D64oAxfLO7j07HjFPRDnd6dPSrbwYb5s4poXbwDkds0AV2iB5Azn1qBkKk8n+daJTjcMjPP41BKAQeMMT0oAp7ATxjoM5FIsQJBx0/SppQAu7jGPWqUs7l9qr0JOFHNAGppQxKCep7ZrSuX/iK5HpWNZ3DDBI6evWr0kylfmFAGnZsSBkYBq/u3dO1ZFnPhAdrEVZFyvfcPSgC8w4Pc1TmUEcCp45wRgnIokVHBweaAMa4jwSRgHpjvWfLFjj1rduLcsQAcj6VQnjCcqD9SOlAGDffLlVUcZ5FZciYBzkY5HvW7cwbiSMhcc55FZV2hHC4C+9AGBdRnncoI9M1kXajqeSOAMc1v3aKFzyDnkEism4jLtjPy+/T6UAc9dJhHbBwTxWPOTjcTk+w6VvXPUq4HHTHpWRcIRyo47DpQBl3PMTAjlx09K5i5BSQhj9K6SZdwcFiM9BWDer1B/A0AZ7tuPuKikOR6GnP1NRv0oA+mvBGf+GX7LHX7W//AKVtWFEPLQDbkHuTjFb3gf8A5NfsCc/8fTdP+vtqzLC2N6yRRnLN1I7fX2oAbbgvIQoO0kEV12iaNHdTKxVlQf5xU2k6MkChmRpJegbt+VdRplkytvk3cdew/KgC/bWUUcAWONRxxxzVLVk2wrEOhOSK1VcKhc8IBXH67qG5pJULccZz6elAGdqVmqxMwcDGTg84ri9RAJK9QOM44q/qmrTCIrGCQw6+tYJnaXIKkAnrn3oAt2jvbuhU/KCM4Nd7Y3WQD0PYHrXnltAZMZJ4PHNdloShWUHkgcZagDrre8BQBkJz+lW0midME4P8qzYApRiOmasQIMDzBtFAFpAnBXkfWrKAYzVJdqgAHgHpUyMSp7fSgCwTxSg9Oc1ArFgfT3qTzMED0oAmUKScU/yx3IJ9qrrIMnAFPEzZ5AJoAkZSuc8ioZCMkDpVmKTccHGfaqt6jggjGP1oArTjjHAB65NQrIvTcD9KjmBZwzc44pmAuPU0ATxkbsDr1q1GMYJ5xVWEeuDVqJTng+9AGjpvF7Bg/wAYrqa5bTv+P6Dn+OupoAr6gN1nIPp/MVz01uD0610V9/x6v+H86yWXigDFmt+OapSQ8n09K6CWLINU57fPQUAYuw7sEDHpTdgJGAMj2q/LDg9PwqPAz0oAxtRTYhAHLd6xSHVgUbJPUY4rq54A+4EZrn7uHEu4HaOgBGaAEt53XaMfpVzzk8zaQeMe34VURCQG+fpnHr+FDHYpPygetAGpBqCH7y4OOcmpPtkTbQSRg1yd3fiJ8Ak49uvvUguhKoOTz3z3oA6+KcH7jhh3zUryFkBHWuXtbncoGfm6c1sWUrtANxIPoTQBMZ3V9yu+dpG0nj6/WoJL5icSfzps3LDjOao3DDPGSO+KAJbi681ezKcZ9qoSqsjgAldoPJpk7Mjll69xmqct46ZPOen09qAIrmHO7aFPPesq5gKx5B+hzj/9VXhfrvCSrtXH3h1HvT7+13x7kO4MOGHIIoA5O6iDE8bmz1rH1BGJOeMcDHSumlgaJieMgd6xbqEsrAjn2NAHL3UfsMA4Pv71kXkIGRtIrpL2LjB7dfase8TqeOV60AczMnJ7+9VX4HNaNyoUtjFUZxlD60AfTfgOJ5/2YtOji+8bp/8A0ratPwnZx6aN7ASO4+Yn09KqfDFtv7NemH/p5k9/+Xpqt6aDJsbcASO3P6UAdvYeVKQVUj+daLYA2jhfX1NYtm4tbXeCN5GB6CmNcsxJD7getAC+I9TSGAwg8kdQe9cVfmSWzIjHXgmtbVCZGIdvp3FUBugjJdQQW7gUAYKaMrhmZ28zb+Rqg2jv5is3zKCAwI613drtRGbYCWGcmqsxBR8AA5ySPSgDn0EVvvBQk5woA4P0qza6mWufLCbcY+bqR/SmXyMXEgHmbR+lVGtWYeYSy7eRxjHNAHYW2oFWCg7h+VaU96scSPIGIPQDkmuU06STz0VwQQMljyDXUWdoZx5jfMeo9BQA6O+83GFCjrmtGylSdiBkY61UW3WR8Rg8HnitGKERKAvH0oAmaMJ8o6Uhzn1FPX5l2t26Gm7cHHQ0ARDJY9RU4ALZ6UAccVIic9aAJIgN+B+tJcrwwqaJMHcelRTvgkDvQBmumQeKrbDnnnnGB3q+454FRNHnnGDQAyJce2OKtJw39KiTqalj7dqANDTR/pkJH96unrm9MBFzDn+9XSUAQX3/AB6v+H864u+8U2lrqdxYJZ6rd3FuEMv2OwlnVNwyuWVSM4rtL/8A49H/AA/nXn1rrVv4dvviDrN7/wAe9jBBcOO7bYWOB7noPrQBMfFaf9AXxH/4KLj/AOJrT0jULXWtLgv7IubedSU8xCjcHBBU8g5B4ryT9mnxrq194k1LRvEurX2o3Go2iarbm7WVRA+4iWFPMH3RuQjb8vBxXo/w5H/FGWH1l/8ARr0Aa80PX1qnJFtOACBWuy561Xkiz2oAymTnms+5iEvLgK3Q98VtSxHNU5oTk4/AUAYzW5VV29Tz06VkXpZYmGDu6DGK6iaImMZOTWBqcJTcSD15A5NAHLXBJY8kAdAO9V7e4ZG2EZ7kE/0q/cQgktwcng4qq8TgkKcADGaAL8FwfMRs55zgdq6u3ZXhVhnJrlNMs/McsAdo4yDj8q34m2LhDlSOATigC7IFIxkE1Qmj7j6mpfN3fxEGmNIc4yAD0oAyryZIsZHPYY6VkXNwG5298k45q9rUyKxY8D1ziuK1TVNkgRCCemA3B/KgDfeSKZcKCDU1tNJCCASVx0PNcWuoylstzg5IBxWvZaukiAOQrg4GaAOoPl3UZVsBiMcdRXM6jZSISCMbe/Xj1q2uqvC+RtPP+eauy3kN/ASTx7Hlf/rUAcbdwLGGLnPcbRXPX6OHbH15FdfqSqgkXgvziuZv4hg8jpg80AcheA/TJrOlPUVsXybs545rLkG3hevrQB9SfC1f+McNOBH/AC8SnB/6+npLbUEgvms4LLU7y4ihSeRbOzkn2K5cLnaCBkxvjPpR8NX8v9m7T2znE8n/AKVNU3w6uZRd/ECZHZJYtFtCjocFSDekEH1oARte1kTyJF4b8QLDgYJ0uU5+ox9Kj03xE19bvIqvGwkeJlliMbI6OyOrKeQQykfhXGfBnxLraeLvAT6prGtyW2rQXEUyXGsjUFu5dmUJhLboAOTu55AHAya0oXMeqa4+eP7a1Lj0/wBMmoA1NWuHaNnVsEH86piWaZFjjLEtg4NJukmlAYHJOQBWxYaayRkn75HPsPSgCwjMbPZHIdy9QRnNZ9691FGwIAOMVr29s8XzEcDsKtTWy3dr+8Ug+uKAOXsLl5ov3ihcHnPetS1jGw5z/exnrVq20VlQ7evUAirdjYzcxlD14PoKAGQaeLiRHKBWx6Yz9a6iytwsCpgcenFFtZAIMjp3rRRAi9OlAFERCNjtHXqaVf8A69STcudopqqT+VACHgjFSL8/+9TSuRnFSIh3A4oATYM4ANWIouM04AEBuBxR5nOACBQA5iMYH6VUcEuf8atHBHJPWmFcnjmgCm6dKaBz9autHnt170wRAdulAFNk5yOKlhHINSOo5GDzSRoepoAv6fzdQ/71dFXPWHF1Fk/xV0NAFe//AOPST8P5151qGkar/autmLTNA1XStUWDzLfU5HxmNcYKeWysM4P4V6XLGssZRxlT1qv9hg/un8zQBwjt4jkvrS9fw54Sa8tEMdvObmQyQqwwVRvIyoI4IFXfCGm3Gj+HLOxvHia4jDFzESUyzFuCQDjn0q1feLvBWnyyRXviXRYJYztaN9QjDg5xjbuzmqMfj7wdMGNpe3V2qjJa0sbmcdSOqRnuDQBuGo2HHes1fF+iOy+Tp3iSUMMqy6FfbTxnqYgKpjxpbSOog8IeMpQc/MdMaMD/AL7ZaANiVMjvVOWPg4/lWD4X+JWleLftf/CMeGtd1MWkhinMUtooRh6lrgZB5wRkHBwTg1rXWqawy4tPAOslsH/j41CzjXPblZnP6UARTLhflHes+5hEqkEd+SB+lXJpfE6xs7eBopCSAEi1xN2PU7kUDt0Jqss/iEuPP+Hl3sPUw61bsw/AlR+tAHO3Viy8YIA9e9Rx2zM+1xxnuP6V2UnmMMSeAvEZA6kXdkf/AG5zVYXFhFCJJvBfiyFd2D+6SVgPXbHKxI+gJ9qAMi0t9oYAkEn6Us9qd4x0BzjNbw1PwZEQ13Jf6eAMk39rc2oHTqZEUdx3re0zS/DusWoudLuor62JI822uvNXPplSRQB54YWVjhiecnNQSyskbHjHqRXqZ8J6UesUv/f1uahfwVozghop8Hrid/8AGgD508T6iwLgFgOc8Vwd1qYRmJPU4xivpHxt4Z+HWhSWq+Ixdwtd7vKCyTvu24z93OPvDr61x8mi/BOXJaa+/wC+7v8AwoA8RGrKXwTtbOeuatxaluOd2T6ivXm8MfBEHLNqGf8Arpd05NE+CUQ3LLqAHT794c/pQB5zYaqHXZI2Rmri3jW0m6Jvl7g9GFeijS/g3EOG1AAjJObvp78VYuYfhBDH++bUAijqFuz/AEoA84uJkuYhIjE55Ht7VjXcH3i2B3PPavWrC6+DDkpbXd3kHkN9qGPzFW7mH4RuheeS829Mn7V/h70AfPOo7XVlUYAP3sVz055ODX0bOnwNnyslze/IcEA3gwfyqlLp3wEA+ea/GefvXv8AhQB0nwwi+0fs36cgxk3EuM/9fTVS8PXWq+GtW1i5sbDTb631G2gglivJ2THltMTwEYEETYwfStnQ/iB8KNB8LQ6Bp+o3KaXEzOkbW9y7ZZy5+YrnqTTZfiH8JpMhtRueT2trkf8AstAGVY+JD4buPtmk+APB1hdYK+bZnynx3G5YBx+NclZX12893JcpEkl1eXN26RsWVDLM8m0EgE434zjtXaz+MPg9dAJJqF6R6CK6H/stLHrXwfGDHdXregEd0f0xQBX0e3EuHwCMZxW+2+MN5YyByTipLLxH8N4osW818EIBGbe56HuPl6VoJ4j8CeWpWa9CEcHyLgcf980AZlvOzbQ/3hx0rQi5UAjrz0p7+JfAcYDNPeLk4H+jz5J/75obxj4DiiLNd3Yjx977PPj/ANBoAsxttC/liroA3A4x61kN45+HqgA6hKTjOBDMTx/wGoLj4nfDmzGZtUuFwcf8e0/X/vmgDrYxwMGpGIU4BzXHW3xe+HEpxFq0+Rxg2s4/9lqaT4pfD9WHmalcA+9rP/8AE0AdG4+cntUbkZ4rCX4k/D9kDDU5yDzj7PP/AC200fEr4fNnGoznHOfs0/8A8TQB0EYI+9+FTKK5s/E74foT/wATKb8Lab/4mlb4p+AYlDNqFwBnGfsk/H/jtAHUrxj0oKjGa5eH4p+ApxmPUbgj1+yzj/2WpH+JngSP7+ozLzgZtpuT/wB80Ab8jEkhTz7Cnx7x1xXNn4peAlyf7SmwOSfss3/xNJ/wtbwDkr/acxI/6dZ//iaAOnbcR6UgHHNcvJ8VfAIOG1Kf8LWf/wCJpv8AwtTwBznUrgdOtrP/APE0AdQ49DUYPzZH5VzifFTwA4DDUbjB7/ZZx/7LULfFb4eI+H1O4U+9rP8A/E0AdtY/8fMXH8Vb9eb6J8UfA2paxZafpuozSXtzKIoUNtMoZj0GSuBXpFABRRRQBRsNI07TmdrDT7S1ZyWYwQKhYkkknA9SfzNXqKKACuJ+Ndz9k+Eni6UHaTpk8ef95Sv/ALNXbV5x+0VOtv8ABbxU7gkG2WPj1aRFH6kUAZfiTTofhze+HPF2nWyWulW1tFpGuQRA7VtTgRT4B5MT4BOGYo7DoK9aRg6hkIZSMgg5BFRXdtBeWk1rdxRz20yNFLFIoZXVhgqQeoIJBFeZeGL24+Guq2vhPxBO8nhu5k8rQdUlfIj6lbKZj0YAERk8MowMEYAB6nRRRQAUYoooADXBfDiCC48T+PNYgQxrc6sLQLjAP2aFI2b6l/MH4Cu9NcZ8I5DP4MFy4AkudQ1Cd8erXkx/+tQB2dFFFAHh37S4fzfDZj2hsXOCxxj/AFVeMrFciHe6xFCOGU85+lewftOBTceFw4JX/Sen/bKvH7bCbQDhWwdzcj3oAejW8SgRlmbHzAjOKsK8bpJ8iRsx6YyB+HrUJVBK5RdwPO0nGaI4nZCywk4OBxwKALDCZI8A+cjgfOOg/D2NTW02ZPLu0V4lBBD8Z/GqyC7ndY7UhSOMHgEe+alhEiod7gybjwBnP+f60AYOtaR9ju2njURIfu5Aweg9arNqN8S0SDfHtAOOQOK6zW7K6l0/zYrfaigY9/U4Nc/o2rfZZ5FnhEiBeM4zxQBjXsEokYgeWSTntUDTyYCyLkjrxzWtqGqLf3RjjjVAV2hgOT9alFn9ntjLIiNgZUdeaAOeli8xwAAuRzV0aRJOii3Rg3ckcZre0fT0vcebDlWz93Ofeut0fQxAiojOpbgofXpQByvh/wAGyPIrzlWOMFBznPH9a9B0XwxYxXCCRFzGchCOR7CtXTbGO3KpBGYwhbczE+nv/niraXMNm0kjbpJHH8Iz+vpQBIthp2FWONUkA+8BnkVdgs3iiMjKpjUcAL+VY39rpfSr9ng2ADdljjPPTHatCW/DQAzzxBsbdit/n2oAkkhSSYySQq8TD046f/rqtqmlQ3VuUjVYV6nHGfwpbbUWczp5sZMeBz0z2/SqRnxdt5c7SuwJKIfu4+vT60AYt14RhSdTEQp2YYjkZzx/k1i674ZjIm3MrKpzksMZxyP89q7GLWHlsy6xCNo/lIZeuOoH4YqhdBbmdHhDlcZcHkDPTPrzQB5RPoq2su62JbbnketPDsCGvOuOQa7e/tPNlPkRpCvJZm6D5RwK5zUbI7gHJLEgLxw2aAMtJ9iP8mQxwCRkD6VIkcssXmq44A+QelJqFnLFP5bKADgg9unWozC5bclwVwCSRxQBZJePywqE55A9BTpZDLFHGAWYc8/yqtcRshzFKxwMDLfjSxo4dX27V2gHHX8PWgC1DC6v5ZJHOQwPAFC2jbZZmLyMSBHnGO+Tg0jyTSuYvO2oBxgAZyOpNEjGNUVZirDrjnHJ4oAr8K7AjBzyMU7yY5P3hdQd2QAOamkfCBZEJJGCcYz6Y796qm2MjZDDZjGAcUARyxDzDl1PIwd1DISwyvQev9KmSGGIMYz82PvNyMZ5psIUKTESXJJzQBXmdiqiJWDKeG96iKLtbzQhJ/GpnunA2HLEd1HrVIrhyZ1bI6Y64oA6H4dSqvxS8J4Qf8f8agrxgc19t18QfDPYPih4UMZO37fGMH8a+36ACiiigAooooAK8w/aYBb4JeJEHVxbIPqbmID+den15r+0ZE8/wg1iGJS0ss9kiKO5N3DgUAelVyvxM1HwpYeEbuPx9LapoV3i3kS4DMJCeQFCjduG3cCvI25GMZrqhXmPxfZNH8ReAvFd1k6fpWqNb3ZOAkMdzEYRM7HhVRtvJ/vUAZnh7xheeEdJtbzVL6XxN4AnTdZeI7cGae1TnCXaAbmAwVMoGQVw4BPHq+mahZ6pYQ3umXUF3ZzLujngkDo46ZDDg15freh6n8M9T1DxN4Oia88N3D/aNX8PoozHx89xa8gB8DJjPDYPI+XbZt/AWl6lbQ+Jvhrrl74Yl1KJbpWsVD2lwHUYeS1f5CdvptIJJPNAHqNFeatqHxN8PPuvtL0bxXp64XfprtZXgA+85jkLRscfwqwya6XwX410fxfDP/ZrzQX1sQt3p15EYbq1bAOJIzyOvUZB5wTg0AdKa4v4PKU8BWqMCrLd3qsD1BF3MCDXaVxvw3Z4P+Em0uXYHsNauSqg9I5yLlTj6TkfhQB2VFFFAHhn7TIQyeGw77WIuccf9c68cggixubc6gBh7n0r2L9poxCfwwZtxx9pwAM/8868ajfzNyxMXGeG60ASiQHBnj8rqOB2x6fXvT08xFRvNbGAPmzwPTjtUcAeSRzOdhboffFPSOOGMEzPM5Hc4GfegCzI8vmKYUVEGCWBxzUEUUb3YDt5nPpnH+eKSOFrhmeRgpUHgH/ORTjeSIZPkSOQDCsOCB60Aa7XbqGhDFW2kEMhG0Y4yK5PxTbNBAGMkZJO7K9T71vR3NwFzM481+gY5+XGBg+ntXO+MryaVVjuAsa4yqLz+v4UAc3DKd4bG45zwK7LStL+3W0TzO0TcHcwO3Gev6is3w1p0N5FvkTbhvvPkACvQ9OSNbYW5midNu4DGTzzn/69AD9FsxBMqRbCFxsbGce1bQmCuJpYf3iZXzMkcj2/rWM1w9lFBH9m3ITtEgORjIwQe/HWk1PVrYTAAOGHUjkkf4d6ANZria5izcXKRRBSWZRg5HP4f/WrNu9dtYWSP7UJgB8r89+fSueN4EDljtifOzI3Z7f5xUKLbxzhdispHAxnt0oA6KTW43tGjW2ZSQuZUx82N3YDv75/CsaGV5ZP3TM+5umeeegH+NUpHhiicQPncSCGGPTj9aSGZhtaPCyZHOTwc9P1oA1rW8voZfLCGRGXJz0GB0/XNWrXWjFcZ8srMx5y2NvbgfjWFPeX3mhWym0g+aBnH+f60+7vFuZFCAtKSC2BgHH9cUAdAniMKzRmFXlb5VK9z7+9S37SxqJ4pPLaXHyhhliR/EOMdB+Vcutw8pREtQoOcDGAx+tPaKf7RukLE7sjLfe+n+e1AG3dMhtw0iMLlwACMbQT2/n2qjf208ckIAULtIOR+v6frUk+rNEvlsF3hfl7Dkdyep61UvL+QXIaeFijqOR8xY5z+VAFK+gnuIW8wq8aZ7YH1z3rnfsj+YSsuxc9X6V1bySzQkRghG42BsY9896xbqJnjKT4YqSc9jyc0AVACrBd+SciprQMS+csM4z6H1rLKRKdoLbyep7Cta2MyQP5gTywDlumaAJTDG85dBsUHAyc9s9KItqSh1QMAer/AJ1VkaErhI2kBPBPRfpTmJ8g7QcgYJI4yKAJQ6OdzylUJz8x/l61EQokX7PvJzjDDPHPBpx+zrkOrM5IAOOnqaf/AKuMMrBU5AHqaAIvJlPAXcWHCZ/Hmgg7SWKofp0H/wCuomkO/qwOcZppb5s7sYAAB70AMYQtCzqXaUHAyMDPtVZ4yFCmRQ2SSB2qR3JY7GG0AAnHvTRFCxALFWIxu6ZoA2/hm4/4Wf4VGP8Al/j/AK19uV8UfDHy4fid4XCsp3X6DA57HmvtegAooooAo6nq+naUIzqeoWlmJM7PtEyx7sdcbiM9RVE+LvDgBJ8QaRgck/bYv/iqn13w5ofiDyP7e0bTdT8jd5X221Sby92M7dwOM4GcegrK/wCFceCP+hN8N/8Agrg/+JoAnk8deEooFml8UaEkLfdkbUIQp+h3Vweu+IrX4neJNC0PwdLLe6VpmqRahq2pxofsoWA7ltwxAEjO+w/KSABnnnHar8OfBCsCvg7w4D2I0yD/AOJrpreGK2gjht40ihjUKkaKFVQOgAHQUASVS1nS7LW9Ku9M1W3S5sbqMxTRP0ZT1HHI+o5HUVdooA8n06Xx74Fg/sKDw+/jHSYF2afqCX0VvcLH0SK4V8AsvTzF4IAJGcgdL8HfDV74Q+GmhaHqsiyX1rC3m7TkKzOz7Ae+3dtz7V2dGaACuQ8c+BbLxNJDqNrPJpPiazX/AEHWLUATQnnCsOkkZyQY24IZhxnNdfXJ+NvH2g+EEWLULrz9VmwttpdoPNu7lznaqRLzyRjJwM96AG/DLxRceKNBuTqdvHbazpl5LpmoxxEmL7RFjc0ZPJRgVYZ6bsc4ya9/jw/8TbO+O1LHxDbiwmOAALuHc8JJz/HGZl+qIO4pnwh0DU9F0DUbvxAkcGr63qU+r3NrGwZbZpdoEQYddqouT655PWj4vanoNt4Qv7TWtZtNNvHiM1iXlxMLiMhoniQHezK4U4UHPTvQB3NFZ/h27u7/AEDTLvUrU2d9cWsUs9sc5hkZAWTn0JI/CtCgDwn9p2TZP4YycA/acnGf+eVeMLJMkJ8pcAnDBRjPvXs/7Tsgjm8MhgCGFyOR/wBcq8ZinBUgbgMYByMH60ASNmZTvDBmOct0pRAjOIY5MsvJB9PSoQxmTO8qw/hJ61NHPIh2JGHm28enNAErwmGUq6NAMHLjnNOt5rZipVGeXtzt/wA/yqsv2po33SrycEHqKmgkEMUnmiM4xyGxigCS8u5Em8y4HGckY7Z965e9WTUtW8vI2k4X2H0FbEuqAswjXJ3Z+ZsjHoM1Q0KLz755TEXCsOhx9BQB2+k6elnpkaK0NwrfeXBz/wDWqSaW3dYkitzGCCGYHt/nH5VTjth5pVZgqkdieTjPH4jrSTyCG3EjKSN3PI5x/wDrFAE08c9iGAljMuQUUkkbfUfjisqWeWX55kKzq2QMY46flUt5ei6QMYBGzHhgeevX8D2qo86eaqNucsNpPb86AGm6VQVcqFJBJfnr1pY44/KMvm5QkAHPGMfoOf0qvMyee6jKyfdK+3SpUtZljYMxMJBfaOM+/wClACS7TuR8KzEjdn0ptzGqCPk7DjhTTYltoMrtZgefU81YkCoV2/Ki9Ax6EUAJ9od9qu5YEZVWFPe8dEyyJkgE/Lz9KjVomuHlZgGxwo6AdaiuCZZC0x4zkYPb6UATuFMDujgOvJAzwc1G9yCjcsD0zkVCykAzBd0ZOAemaltoY5AzSELnIGTnHGf6UAGBI6gPJPI45Y9/cVckuI0WNdsvmKSuQB/KmARB0w2T0ypGc1YR2I+XLSqM5A688ZoAatuzws7y5G/LrnAA98dOaXU4YbYoC6Oudu4dP/r561qadArRSz6hFIUA+UKvB+o79Kj1HSLWa13yTYcHdtDHgHp/WgDiNYaI3Kvbxt8vBPTmpkmzBGpB2sOVDcCrGrWsVtApglMjseQRxVJbi6Kl1RUBBXPTnvQBOlzErfMwGDwO/SppG82ING7IgJJBxgdMd/rVSSRXIAChwB1XFEIJlIDjav40ATxtGuGkfc5FRu6r96EnP+1+NP3ZC+UoJPYjg80EXnmkukYTr6GgCSO4jWIHaAcYXdzz6VXllLY3Rbl9QetRDYxOSqkdicnP0pbm6uGXYEUKecDtQBFLGUUlQMcYGc4qpJHHtJ8zc3oTVhZmAO0kevGaa3l+UWVfm6HPSgDX+FsTj4qeFizZH9oIQB24NfclfEfwsER+KPhf5/m+3IRjp0NfblABXM6tp3it9WmudG8QabBZsihLO90szBGA5IkSZG5984rpqMj1FAHn80fxSST9zdeCpk9WtruIj8narNrN8R43QXNj4RnUA7jHeXMRJ9gYmx29a7fIooA4+bU/HMKpjwvoU7HO7ytckAH/AH1bCqkPiTxw2fO8BRp8pI263C2T2H3BVjXfih4K0HxCmh6t4isrbUmIDRsWKxk9BI4BWM+zEcYPQiuxikSWJJInV43AZXU5DA9CD6UAcgviHxUZAp8FShSu4sdUgwD/AHevX9Kwda+JHiDR7jT7O58B3h1HUpGgsbVdTtmaaRULHOGJVABlnxhQRnqK9PzXzb+23p5bwp4a1VSVe1vpLYEcEebHu/8AaVAGxPpfxJ1ucXfim08SLIHJSx0DWbbT7WNcD5SwcyyHjOWYdeBinP8ADUX9zH9r8A3NwQq5uNS8Y3O4eoxGW5yT04rhvgL4t8XaX8NP7dt7m2v/AAvoFwbS80WO3H2gQH97JdJJ1LqZM7D8pVW6EZr6qsbu3v7K3vLKZJ7W4jWWKVDlXRgCrA9wQQaAPCbj4HW0jn7L4U8O2Su37wya7qVyWUnngeXz+ddZ4d+GN3oKRnRbzw/ok+Nsk+l6GPPYHqplmlkJH1Feo5ozQBxV54B/tCQPqXinxVcf3ki1D7Kjj0Kwqgx9K0PC/gXwx4WbzNC0SztbnnNzs8yds9d0rZc/ia6WigAooooA8I/adiSW58Lh2CnF0F5/65V4lHE0QCRATEj6jkdx617d+08qGbwyXYKB9p69/wDVV4sqKqttXgZGRnHt1oAfHdQqvlujIAc5H+elSPcxLKWtiVjHBLcnFRIrrbyM8ayc4BIyTTbdoQCflDnopGe9AD5hOCDEWkfIP19yKiSeHzFaeBhJk7uuGz7VJLczhnUOgX7u7uPpTUaW35dfOGenU0AVNQmmZm8mFNoyB8o5rR0L7RBYDdbAFiWU5xnFVb66hZ9k0RiOT0J5rZtG8uGJEYmIEZ3HrmgB8l3AZBFOm0HlWXJ49vr/AEqCUx8i3kDxZ5BA6+lOaa3gb5QNzZIGODUUcs8iNHBGjPj5lIxx/hzQBO0m63MsksO7sCMde4rLdRI4Ak8ts9fU9M1LtjuHEbxgso5I6cf0qOSHaAkbAkOOd3TPSgBrRIjiadycDA5wTjinPPbFx5k5RCOg9+oqGe2UIDOqsRxwc98Usi2jRmR4mMgOAoH+fegC1sszjbK+8ZKBhgZqO5lkVityyO46Ac0yK3F2FaEAMRk56j61LcQNariYB5GGTjtQA03aOwLxfKOCccD6UkhA27RkA/mM09buVkzIi7eikjFLGxViohDdPnzg49aAB1ZVO9xhTnaemfpTIraRWP7pmHXrwB/9fip2BVirRlix4z7k1q2Gj3c6q0G2IrgmNyAcH1oAopY3AZN0atHj+E9PrVu2jijmZIAXc/8ALRhnbj/61dwmi/Z7ZjLZvKoUByOdozgH3GSK19P8JhZBfeWBIe23gZ9vSgDj7OxZApa4OyUDG7oMdsVrjRLZ9OcTouz7wZSVIHtitPUNMuHv3t4I4librgYOO9Wm0mO10S5jnOJNjFeentQB4T4hkAWby3ACH5cHgcc1z1hdyyMVZztHU963vElmn2+VRtQOSduc4HvWRLZwwRKVbcT1waALSsQQyA5Axj1q2pHk+ZLEFz6H07YqhER96NGdx03dqtm4dl2mPy8nvk0AJ5q8MmAo7Ae//wBeobmfywBFLIfYmpJ7pLVE3LG3Xnrz9KhW8tpWzsCH+ZoAeB+6Gf8AWDncx/IikjjaORXdWc9So4FTOsbqWV0Zs5HPNRy/aMBkkXk4IC/1oAWJMgkovOeBVfcpBWb5R9KY6SZYsxb8eKe6RsiM0iM30OaAN74WtAfih4W8tSP9PQAn8a+3a+JvhdGV+J3hZ5NrH7cgGPo3NfbNADJ4/Nhkj3um9Su5DhlyOoPY15P4u8KxeFtFj1GXVPiJrEMcoW5NlrMrTRRkH975asu4A7QQoyASecGvW6KAPNPCPh3wx4k01NT0Pxd4l1exf5dyeIrvCNgHDBXVlYAj5WwRnkVgfEvw9ZQ3Wl+G/Dlxrc3ijWGKxXE2t3039n2y/wCtumUzY+XOFUkBnIHOCD13ib4dpea2+veFdYvPDGvyLsnuLKNHiuxngzwsNsjDLYY4PPJOBi/4K8FQ+HLy91S+1G81rxBfKqXGpXu3fsXpFGigLHGCSdo7nknAwAYth8FfA1pp/wBkfSZrlXwZ5J7yZmuX7vIA4DMTyeMegFefePPhXpfgqR9ftNPuda8HRKP7Q0N7iYvaRfxTWzBxwv3ijZGA3I4K/RFBAIweRQB5tonws+G97p0F9pWh2VzZ3UayxTCWSRXUjgglj2/+vXnX7Tfw58O6P8KLnUdC0i3sp7S6gdpIgclSxTHJ6ZcfkK6+R5fg7rU8jxu/w41GfzB5SEjQ53PzDaOlu7HIxwrHGBn5rv7SbR3PwJ8SyRSoYnigdXByrDz4yMHvnt9aAPBP2RdD8O+J5vFWkeItPgvJWit54Q5YMEVnD4III5ZPrmvUfD/w98MaD8Rb/wAJa1YSPZaijX+gzG7nTMY/11rkOATGcMoAJ2NknivM/wBiyxu4/iJrVw8LpAmklWLqRy8sZT8wjH8K+i/ibZWPiWGHR9N1vT7HxpYyLqWko9wvmpMgJBMedxjZdytwRgk4OKAFt/hD4EgQqnh22YE5zJJI5/NmJqVfhR4GVw3/AAjVg3ThlZgcexOKvfDvxja+MtBW6jT7LqVuxg1HT5D+9s7hSQ8bDr1BwSBkenIHU0Acc/ww8Du6sfCmjArnGLVQOeuQBz+NRP8ACnwK4UDwvpibQQDHFsPXPVcGu2ooA8qsvDVh4b+K2gWHg8TWMH2K6u9VthcyvE8J2pDlGYqGMhYgjBwj16rXDfC1TqcGreLJiWl166aS33KVK2URMduuCehUGT6ymu5oA8F/ajCGTwxvbB/0nA9f9VXjEfmIyqkbZHUdB9K9n/ahjWSbwwWzuUXJXH/bKvFUlf5jHLyDyD1+maAJnjuHkOSYUPO0dMU2NEDSIVZyOd3oMc/zoZ5JWXdJkEAEY96qXcslqzCJd6cjcOaALebR4lTG9s87zj+VTPLGIf8ARpDkgBk/rWXpVxaysyzuqsx4OOhqxIY4GcAxgkZyvXFACXR3fNJEWKgEHP5Vr6TIt9bILhljTIAHI49KwbmWa4tj9nIVR69W56Umi3hhuispC9Bj6UAdfHZR23ltOgKp056g0jWsM1ysdsduGwzvxgcfpW7Dpj6nYRzxRHgbWBHP160kOlH7QVkjZCFCgA9R69Oue9AHNX1iLUziT7x+6eRjP+NVbDR3kjdnhmA7SA5HvXeR+GxJHM0gZnKjGCTk/T1NX4vDQe2WDMsbEHcQPv57UAeX22mZvHBuv3Y+VCR27GmpKiM0bKJOcZTrn0r0W0+Htxh5ZZ1MQ7kGqb+DIYJXlX92BtzjJx70AcRLIuw5Vo+oyBgk+lTWsEahZnchuQQ+eD2rqF0vz42IiV0JwCQQc46ipYfCUVy/llJEbbjDHgHtzQByQVpN6RrvO7cFQZx6itC302dsFlAUp8wHIHGcV2sPhX7FEGUpJLjHTHJ4q/ZaN9nhImTaC2CAc8UAYWl+GJiN/VgQfLPJUdefxzXUaRpTxqDcRPJLIeMDp7V0Wg2uyYPvXZxkda7OAwRrhQoPrQBzmhaRceYRewqIRyo9a3Lm2xCyqPlHQD+lXRMhHyEH6U2JlkLcg4oA5X7NtSRgcADqR0ryLxp43U6s+nW5BSMhS/TLDr+Gf5V6P461l9P1n7EAwhkXc7gEbRivN9Q0XTNVvDd28LRM2QSVOMk9ee+c0Aea+K7e5tpI3m2hCPlZRww7YNYs99G1ssQwSucEDGc+vrX0L418GPf+CY1t4Ed4F3L8vzEAdBj1r52FssV0yuhR1ONpFAEunXm19pkK8j2Fas86GIkHLsTyOgFYtz0AAAIPaoo5UUHMh6dKAJLgCWYqSx5qUJHHnK5/E4FSo9q0Wdp809gar/Z3wWQMSfWgCWG48s7kGD0+tTwOHk3FmHqOxNUDGyoTIMEcDHalSQg/LG2Aec0AaJljVMnB7AHP51HJOJGxHHk/pVWKVSRlBuB59qdLdJjbHhMUAdV8KwzfFHwv94KL5Dz34NfbtfDfwpui/wAVPCyk/wDL8g5+hr7koAKKKKACiiigAoqnrOnQ6vpF7p1y0qQXcLwO0TlHCspBKsOh56151D/wsvwfF9lhtLDxxpkWI7aV7sWWoBexlLgxyYHy7gQzdTyTQB6ZdW8N3bTW91FHNbzIY5IpFDK6kYKkHggg4INeSan8NvDHgyxm1fUtf12LwjpTC/GiTX26yR0bcihT8zDftKxknL465xWk3jL4jsQsXwrZSf4pvEFqFX3+UE0lt4J8Q+K9YtNR+Jl7YSWVjMJ7TQtMDG2Eg+7JO7gNKwz93AXj0JBALvwg0m/Npqvi3X4Gt9b8TzJdyWx4Nrbqu23gPTJVOScA5YgjIrhtD8CaZr+r/EbSb9EsvGVvrTanZ6vGpaeCOXElrIjnnapDKUU4+Ujg4Ne91wvxC8L6lc6lYeKvCLwxeKNMRohHKdseoWzHL20jdhkblJ4VueM5AByWhadbeOL+7muTc+EfihowWC/udPIHm8fJIUPyz274UgMMjG3I4J31134heHVVNd8M2niO1XduvtCuBHNtH3S1tLjLHqQjkDmq3h6y8Q+IviZY+J9W8ON4Zi07TZbGUS3Uc8t60jKwT5MjykKswYkEluB1x6jQB5qnxe02DzH1zwz4y0S2j+9c3+jSeUP+BR76veJ/GGlax8J/EWt+GNUhvYhp86xTW0nKSmMhQRwVbLLwcGu8r56+POmW+ieLLW40eL7KfEFhdtqiwjasotGiuVlKjALjDqWPOGxQB7xomnRaRo1hpttnyLOCO3jycnaihR+gq7QKKAPBv2oG23Hhc5/5+uPX/VV4mJmLq5Tb2ODz6dK9W/a+leOXwjsZhn7XnH/bGvA4tRnGPnPHTdzQB0ctyN+0Ab+oH9Kz5ncMCVGDz04FQR3BnH79ge4buKFeNlO6Vgc8DrxQA+a2YssiMgU9QvrTrp2wvzIec/e5NEJtThZZSpzySP6VBCtu8xLDKLycfXH9aANC3uorf76HZ14PWqs95A98sqQ7VzxjjBqSV9PdEC5RgeT3NSWtn9pn8uEqwbOBwaAO98L6vOxiit5/3bgZUt3rrH1nY6xvNDM4PzcZ7cDivOk05tL0hJr1RbtgFGJ5YVJ4Nltv7YT7dMSkjY4bp9aAPb/D6/2pAGii2gDbtJ5FdK+lPFCzxYZ8dDXl2oHV9M1K3m8LW899BIqrtQFgPf8A+vXtNiZXsYDcRmOVkBdCeQfSgDnbjTr2XQ5YrYiK5ZTtJ5wa5Xwb4Y177TcnxG26JP8AVeje9eolPlwBSbiowRQBxlxo6bdqKcZ6YwBVS7xa2p86AnB7Dp/nNdZfW8ryq0cmB6VTu7Bzv3ksG60AcfOlixAF00ToQzoTgkfT8avwRWkjHyZDMWH4YrXXTNOgV2kVXlkGOeamt59Fs40FxLbREDu2MUARadHsRFTHPYVvW0D+WVcAKelcve+PfBmjyMH1S2Z1zuWLLkflXJav+0H4btJdlhYX12AeXOI1x7d6APW4rREBHY1NFEkedgAz1rI8IeJ9L8XaDFq2izeZA52OjfficdUYdj/OtS4uI4MebIqA85NAEN5plleOXubaORyMbiOaq3fhzS7q1+zyWyiPoNnBH0ritb+JUdlrMmnWjQyylsKW6A+lY/iX4m+INGmt4U0y3uGl5yp7d+lAHrVlYw2dqlvGCYlGPn5z9a8r+KPwhh8RSPqHh9o7TUCCWQ8LIfr2rTtfifuWOO+017WV1zuc8VJbfFCxLRI8YcucAq3XnHSgD5W8U+GPEHhi4EWuafcW2ThZGU7H+jdDWMI2ZN2M+lfdVn4h0HxAjWMstpPv4NtcBWDe2DXCeO/gdoeuxyT6BJ/Y96QSFUFoHPuOo/D8qAPl3T7hEVlZAfrWmJWkiDCQbc9FOM1L4y+H/ifwdI51nTJBaggC8hHmQt6fMOn0OK561jjmH/HxsPoaANhpyCC5B4xxRLewyMEPHGDWbJCYs4YtUDDc2SHz64oA0Jpk27I1Unu3pULmBEG7O7PSqDbh04pirI7DccCgDrvhZOsnxa8IiMbV/tGPj86+9K+C/hJbuPit4SJxgagh/nX3pQAUUUUAFFFFABRRRQAUUUUAFFFcL4z8X6imtL4X8E2cGoeJXjE08lwxW106I/dkmI5LMfuxjkjJ4GMgHbzSxwxPLM6xxopZnY4CgdST2FcHqfxh8CWN4LNdfgvrsj5YdOjkvCfbMSsM/U1m2nws0fVrzzfHes3fi/WImEjR3U5itoD22WqEKqkYyG3Z6969F0vTLDSLNbTSrG1sbVfuw20SxIPoqgCgDgj8UZ7qTyNG8B+NLy5dcxGfTvskJP8AtSysAo98GmaV4O1fxPqV/rvxAS3tp7iwl0yy0q0l81LGCUfvGaQ8PM3CkqAAF7549MooA5b4Z6nNqfg2wF8T/aVkDYXyswZluIT5b5x6ldw9mB711NcTC/8Awj/xOnhkylh4kgE0RLHaL2BdrrjGAXhEZHPPkNXbGgD5y/a7i8ybwkdwGBdnnv8A6mvn5rTK/vDsI9q+kP2qIo5ZvCyykAYusf8AkKvDPsQ2BVYMcdM0AYsNjG8oAkY571sx6NFsBjl3N0JJ4HrT/sssDZlVVAIAyMf57UkwRFJW4VR1I9KAC+0iNoFw6bx2HU1gXVt9kYiXgjpV7+044HLMxLDoO1b3gTwNrnxC1EtZRfZ9NRgJr6UYRR6L/ebHYfpQBx9pHcXU6R20TO5OFAXJzXufwk+Gt+8zX2vWzQBcGJG4JPvXsPg7wLoXhDT0isLaOSZR893MoLuf6D2rQ1LXbCwiZnniyvbcKAMjxB4C0nXtOFrfK3A4KHaQax9D+D3hvS7tLiXz7or/AMs5GwhPritXUPHulabFG88ysZPuqpzXA6z49uNZ1Zbe1mkt4H5AzjIoA9rt44LSNYbZI4o1GAqYqOa4dbuOJI9ysCWb0rxlPF0VjexrBO8z/dZVbdtP1r0Hwx4jS8VvO6dmPpQB013dxWNpNdXkixW8KF5HbooHU14drXx1WTUJo9Fs1e2jJCSSH7/vjtXt2pWNtrei3mn3Jza3sDQuy9QrDGR7jr+FfFGueF7/AMLeI7vRtRZGlgfaGU8SL2YexGDQB6VffGDxJcq/lLYx46YU5/nWZJ8V/E+8LJcxuR12oBmuFnsHCboicD7wznFVJ4ZPlwFVh6GgDpbrxZr13dyTyXk258j5HIA4rDvLy+u5Q80z/VmJxTbaZzGYncYyPl/+vUobyUw5IJ7d+aACx0tJXEl1P97qByajubO2VniCjb0B9DTwRy+7LDsetW7d5LmeCztrczXdwypGq8nJOBigD279l/SbrStJ11pmDWt1LE8YHZlBB/Qj8q9kvIopkKyxh8jAzWZ4N0MeHfDtnYNtNwkY85lHVu9a8yGRMK20+tAHiXjDw7plvqzXnkNJcM+cIcAcetefeK9WmuYilmskU0b44PT3r6B8S+GRJYXLJM29xy68MPpXkb+ENL06TfqN5cgucAEcH296APMb681N4QLm6maQHacnP51XhmeN4meVR6kHOOa73xRpFtb6lKbW1d7Zlwrk5yfUdh/9euN1Xw3PbNtfCMxyOw96AK2prLBcCbTdRZz97cuQVPpXoXw+8e+LtPEfm3yXlkgOY7hs5Gex61xml6fZvbPbOWe4ALB1HGR2qraW1ys3kwpNJk8KvOfw70AfV3g/4gaN4rWSxk2QXZG17WfBSUY5256j2NeffFf4F2upRzat4JRbPUVBZ9PXiOY/7H91vbofauG8P+BvEmsTJJ9knslU581wVx6Ed6+hfAsl5b6XHp2p30d3ewLy2fm29s0AfERlmsruS01CGWG4iYo8cilWVh2I7VbSXzNodl219FftJ+DLfVdKGt21tHHqFsMyygYaRPQ+pHHJr5cDOvHPFAGrOkUbffVsj0qFmhU8nj2qiXY9+ablgNxOfagDvPhO8J+KPhMIDn+0E6nvg191V8CfCJ8/FjwiCOuox8/ga++6AK2pXE1rYzT21nNezIuVt4WRXkPoC7KoP1IFcRdfEie0m8u68C+NVYHBMWnxzqPfMcrA/hXoFGKAOLtviLpsiBrjSPFVp13edoF58v1KxkfrWNonxo8NXkF4uqxatpF9Z5e6tLnTbhngizlZXKxkKjLhsnGM/jXptcn4x+H3hzxhe211rti008MZgLRTPCZoiQ3lSFCC6bgGCngH6nIB5Jq/xE0fx5rTw6z4kn8NeC4GAS32TW9zrCnpK0u0eXbnoFB3MNxbblQEuND+GGlRi++GXi7SPDfiWH5oJzqjPBPjnyp1kcgxt3PUHB5xg/QkEEVvBHBbxpFDGoRI0G1UUDAAA4AA7U8gEEEZB7UAeeeCfi54V8QeHYL3UdZ0nSdQBaK6s7m/iUxSqcMFJbDoeqsOCCO+QN//AIT7wf8A9DXoH/gxh/8Aiq5Hxlax+DviNpfiiKFf7G11o9H1uPaCiyH5ba4IxgYJ8tmJxtZeM16GNF0pT8um2I+kCf4UAZR8e+EAjv8A8JToRVFLHbfxMcD2DV8NWHxI8XX3xMvtS0DXZ9KuddvwG3yjyVDNsjDhsrhFIAJ6AV9TftM3GneHPg9rD2tpa293fNHYwvHAgJLtlxnHH7tZOa+Z/wBmDQYtf+MGlx3VrFdWdpDNczxyoHQqEKqSDwfndKAPcfG+i+DvAXh3QvEvgy+059Z8P3kM91PFdLJdajbu2y4V/m+dm37uegBC46V7zba9o90pa11WwmUYyY7hGxnp0Nc54o0nwBoekyS+I9P8O6dY3H+jGSeCKEOWBG0NgHOM9OcAntXAfB/RPC8U154M13RNAv8AU9OQXNhqLWUD/wBqae7HypwwX5iPuMeeQOScmgD1668SaHaHF1rOmwnbuxJdRrx68npWNP8AErwfHMsMOvWl7Ox2iLT9145P+7CGP6Vfg8FeFrckweGtEiJxkpYRL06dFrdijSGNY4kVI1GAqjAH4UAeZ+L7/VPHGhz6ZoXhPVYpTIHttT1QrYJaTp80c6g5mJVgDgRjPIPBNekWC3KWNut9JHJdiNRM8SlUZ8DcVB6DOcCp6KAPnH9r2doZvCO0Z3fa/wD2jXhNnPcSIEWTAHOe5r279sjPn+Dv+3v/ANo14VpF15RGSvHqM5oA1o5JRuSbdIpH5fjVSW5mlYWVjbtLPK21I4lLMx7AAd6imv57y6SCHLTSuERVHJJ4Ar6t+FHw60/wVpsd1LGs+vToGmuHGTFnnYnp7nqaAPO/hj8BmLwar48Ylsh49KjP5eaw/wDQR+J7V674t8V6Z4M0yO3htkeVV2w2VsAoQdsgdBVb4ga9qVnpc1t4fhMmoSDaJP7gPUj3r5+u/CninzHurq1vJ3fJMhyxJ+vWgDSvPHvibXdbaaa8a3t1yVt4/lVR7etUbF/tMjG/m3Lkl+ck1Rt/DmuSTq/2S7QDksYyP6V2+heHWtdMmkS2e7nGN3mLgn2oA5DW7+Lyo1tpFxGeAy8kVhyXEs9+J3uQF6fLxgegrd1ZpZZGQ6MyMSQpUZya6Pw74YsbLRft+sadI5fgKRnHvgdKAMPwzod5cvHdae4mhZgHb+7z3/CvcNN08wwQRQhW+X5ivc1g+C9Njj0DdDbzQW0zFtrrjA/wr0DRraP7BGkS7QgADetAGjp8PkWkUYGNo6V5V8efCdrfWL69Em2+gjCuwP3lBHX3FeoarqlppFoZr6UIo6Dua+eviX8RH1Sa7sEGy0c7cZwT/nigDyWG5aIl92cds1I80Ui7lyHNMje1ZSq7sjqT3pzSw+WI1UBgevSgCABQ5O4pj+L1pGEjYKksq9zT/M2j5wCPTFIqRt8zSsqnnbigB0ptyg8vep69etepfst2SX/jTVb6eDzPsNqDFIwyEkZgoI98bq8oYsqHEanPr3r6Y/Zn0hdP8A3N6ybZtQumYt6og2j9S1AHrZ60VCJd0hAHA71Ju9DQAy6QyW8iKAWIOK4rXvCz67pywXTmFkYMCg54Pr9KveI/HFl4fvUivbW4khYH97CN2CO2KyNQ+Jnhy6t0S2uyrvjh1KlfrQBl+K/DcMehLAm5hCNysvriuf1/wv8A2joEZs4SLjhvnH3h9PrzXb6PqKXqNG6l7MAMHbvXnfjn4v21pqbadoVmDHAdrzydGI4+UD+dAG74Q+GCpAlzcyRu4zvUdPzqnrniXwR4CuHNtaLd61HkbE52n3J6VR/4XXHbeF5Y7ayBvnQjk/KD6+tfPt3dS3l3LPcEtLIxYsTk5NAHfeKvi94r1+d0troadasNoithg49261yFjreradqIvIL64S6znzBIcms9IWOCGxVgwrtBZzmgDp9W8eeIdatZLfUdSmkhcDKtjFcddQNndHkjqas7lWTaOnqelPa2MjP5JLYHPNAGSYmycfrQEcD7taZs32jI2k8fMaf/AGbPgErx7c0AbHwijx8VvCJOc/2jHx+dffNfCnwosXT4qeFHw+F1BMkj2NfddABRRRQBgeJIvFEk0B8NXmi28QU+aNQtJZmJzwVKSJgY7Gsa70Px7cB9vjTSbbdjHkaAfl+m+4b9a7iigDh7Pwt4tDq178QLxwDytvpdpGCP+BI/P+cVZk8IapMFMvjrxNuHGY1so8/gLeuvooA868SfC7/hI9GutL1jxh4nu7K4Xa8UklttJHKkhYQTg4PXqBXJ/DTS38QG90rxJ4q8W2/izSG+z6hZLqzRo2PuzxBVUmNwQQT64PYn3GuU8aeAtE8Wy293fJc2er2y7bbVLCYwXduOeFkHUctwwI5PHNAHzF+2BJb6TqGgeHLK+1afbC19cLeahNcockpGQHYgMNsvPXDVT/ZO8L6Rq9x4r1jxEZEsNMtY1aQXMkCqrb2csyMuQBHkg8d69N8efs4aVrDPq17421lbtV/0i91Yx3AKKMDn5NuB3JNcZ8MtKivP2dfGeieHLhb7Xru8aYQRny5bq3iePIRc7irIjjp1fFBcac5Jyirpf1+p2/gj4X+HvHGuS+JbvQJ7Lwn5OzSbWe6n8283feu3y+5FIwEXPIO4jkZyda+H2l+GPiTa6S2u6z4c0qaPz/DF/FckwWN02RPbEvnPmYV9pZQ3K5JNe+eB9d0nxJ4V07U/DpA0yWICKMKEMW35TGVH3SpG0j244q7r2i6b4g0qbTdbsYL6xmGHhnQMp9CPQjsRyO1BB5XqGv8Axb8HYOoeH9M8ZabGADc6WzW90w6bniOQW74RSPerHh34/wDgzUrg2mqPf6FqKNskttRtmVlb6rnH44/CoZLTV/g9cibTRfa18PHY+bZYae50cf34ycs8A7qeVHPPJPXxt4E+KGmK6jRPEVuE4yqSSQhh6H54z+RoA6fS9TsNWthcaXe215Af+WkEquv5g1cryGX4B+GrXUPt/hjU/EPh28RcRtYX7bV+ocMSPVc4NVPDnjHxlo2s3Hh/xNNp2p3tjqFrbPI8Jtpbu1uZAkVzGVJUlfm3JtGNp+agDlf2xELS+EcDgC7/APaNfOqg9ADn2r6U/a5iEjeFcnBAu8f+Qa+dIVKvndwPWgDuPghZWv8Awn+nT6jtVImLrv6bscfrX0/4u8Y6N4dtfOv76Pe+SscfzM34CvjaG/kgOIWbd7U+aa7uXBkd33D+I0Aez6h8e7SK5Is9FeZAf9ZK4U5+mKq/8NCX4ACaDBgdjIf8K8iktgItzkA1F5bCDeSQucEigD3HRv2hYzdhdX0IRwk8vDLkr74I5r2bw/rGleJNJ+3aTLFNBJkHbwQff0r4ZdQenStPRtd1TQn87S7+a2OeQjYB+o70AfU9houoSareL5K+RuykjdieorZg8P3McbK8ysH6jHSvMfAPxuhfTfsuvW+LsD5Zk4Dn3Haut074kadb2ctxf3BJBOFxnPpigD0OC2SGySFsbEUA56V5/wCPvirpXhW3e001UvtUwQsYOFQ+rev0rgvFfxuvru2a20e2jt2c4Dn5jj6etaHwx+GMmqt/b/i9BJJKwkiiPVu+W/woAzPDv/CZ/ELWbN9St5rfSWk3S3AXam3vj34xXql/8KfB99YvbvppSRhxcCRvMB9c11zSR2VuiIm2FBtVUHSksr2G73CMkOvVT1oA+NfFGkSeFPEd9pNywZ4XIVyMbl7H8RWMZIpG3Mcn2r6c+PnglvEnhk6ppdv5mr6eC5VR800WPmHuR1H5V8q2tyhQuufM9KALTEsxyny9qAIyV6s1R/aGb5XzxyacrhfYe9AEt2HdIxDGduQCR/WvtLwhpUOheDNLsrZw0ENsp39mJG5j+ZNfGSNJKHQSZ78cVs6Z4w12wSK1j1O78tPlSIuSoHpigD6qu/EukaPZyT3V0Aq/Mwzk5ry3U/i1qWrXLro1otvYqeWflyK5bTvAPijxXfQ+fL9mjdAWlnJ6fTqa9Z8K/Ciy0WzMV1eG8kcYdjHgflQBzFh4f1fxWy3VtfOLd+SZOinPYVW1r4KXYRrm21BJJ+pRVxmvbdPs7fTLaO1tIwkajgCrYBzmgD5ytte1bwrpMtjq9rJ520ogZegxgH3rxXWpJJLyWaVDG0jbgpGOvPA9K+w/iF4ftfEwFqkqx38S7wQMkA+1eW6V4mstCun8JfECGzv9FEmyOS7hEgtGP1HEee45Xr04AB8/rM3PzEVGZMN09uK9++Knwq026smuPhxpltNqNo4e/s7S/LssTJuQrCSeWyCMMMj7obPHgM6yRTSQzRPFNExSSORSrIw6gg8gj0NAEkbnGe1WeqjnIPaqsWDx0NTJGc45zQA1/vjafr7V0uk28V1bosSL5npzXNmMhuR3rpPDt7LYuojMXJ7jJoA05rAGNUkXB/u45NbGlW1nChEwaNTxhlzj0NarSTXFgt1FD57IcnanPTkfTmsrUtZnmlKNYNCuACGz17fjQB0ng+30eL4jeHI7N3aYXobPrhTX1NXyj8ONPurn4heH7uO0ZYEugxYcADB5r6uoAKKKKAOU8SeO9I8Ma5a6f4hF1p1tcoPJ1S4jxZNISf3RlzhHwpbDADA610Gl6nY6rai50u9try3JwJbeVZEP4qSKlvLW3vbSW1vYIri2lUpJFKgdHU9QVPBHsa4HVvgp8OtVuBNc+FLCNwMYtS9sv/fMbKP0oA2vEnxE8IeGiy634i021lXrCZw8o/4AuW/SuWf4v/bwW8K+CvFutwN80V4tj9ntpk/vJJIQTz22iux8NeCPDHhghtA0HTbGUKE86G3USEehf7x/E10VAHOeA/FUHi3RGu0t5LK9t5ntb2xmYGS0nQ4ZGxwfUHuCDgdBvXNxDaxGW5mjhiBCl5GCjJIAGT6kgD3NfIn7V+ozeE/iPbz+F9V1bTNV1O2W6v3tb14lkCjyosKuOQI35OfvdqzPG2leONN8IeGp77WbzVdCv7aG/WO9d3WO4liDOGlxktncQDkAFsd6aV2dmBwv1usqV7fn8l1Pq7xv4asfGPhqaznSOVmjaS0kLttSUqQj/KeQM57ivilv7R+HXiaRAzTRabc8SIN6xSRyenBaPcM/hXs3wD+LN/carY+E9aUMeIoQykyRqFCoq7VwycZ3HoM5PSvU/iN8L9G8Xx3V35TQ6xIhInDnEhEZVEcHI2Z25wM8e5q0+XRns4Wt/ZtR0K0vdfwtapX0d0+j+0t0131Xl3gLxDqBvbnWvAUltdX96Vm1jw1dTJCl7MQQ11aSdFkbbllxjnnOFr1LQfi54V1C6+wapcy+HdYUDfp+txm0lXPTBb5Wz2wxJ9K848DfBzxZ4Bu/7c0C60K71EM6tpl6j+SIzjLQzAZjkOCB8pGG5Pauq1nx9pslkbT4seAtR0y3j+eSW5sl1OwT0PnRhhn/AICMVErX0PHx/sPbv2G33q/l5dj11WDKGUgqRkEd68h+KWh6boHi7wH4h0DT7ax1q68RQ2NzPaxBGuIJkk80SBcb+FByckVi6ZpHw02xz+BviRceG0/1i2tlrqiIk93gnLflgVNba14S0bWLLXvHHxVtPE95ppkFjFAIAsDSDaX8m2DM77eATkDJwB1COI9z7V4zpK2XjD9pHUtVsmaW18LaYmnTOD8jXjSSHA9ditID3DZ9s68mv+J/HzG08J2V74d0BzifXdQh8u4lT0tYG5BYYxK+AATgEgVc+CWjadpvhu+utIjhWxvb6U2xjyS0ER8mNmY8sW8tpCe5kJoA8/8A2r2jD+FhJ1Iusf8AkKvnsxKrE4yDz16V9DftWOVm8Kr5RkDfas4HT/VV88Txsj72QrnsaAFiDmcAMAO3StDZ5rgyAnge1ZERctuZcAnjFaEE7RMGDFj0A/pQA+/ePywAGVu4qu7KtuAAW9j2q2LpGJJhLEDoRkZqK9lLRgeVsyOiigDNkkGzHl4z3qo7AdB+FWpVYjv+VU5x5QLMePUmgBwn2KeQuO54xXfaVaazZeCLjU9V00xaWxEdtLd/u2nkPCpEh+ZzjJzjaApOeK7n4I+FbTQtMi13xtp2m2s2oXEUWjvfFjMS3TETZVc4BVsbsZJwME4nj/xrH4q8bx3iiSfRdJYrao3SZs/PKRn+IgAf7IHqaAO2+CvwwhSGPxB4jts3DkPa27dFHZmHr6V7awCKAuAo7CuA+HHxR0rxfdNpmz7FqKL+7jdhiUDsp9favQJUzn0oAp6jGbm22xybXBBFcPrGpvpWsWbFpFn80KAq5357flXb3kqWsW8qWPoOtUrC5s9SvFk+zgSR93HNAG7BLkK6/LkA/SvlX9oLwDF4W8QrrWlR+XpGpMWaNR8sM3VlHoD1A+o7V9UNjBIxkVWv7Kz1nTZ7DVbWK5tJhtkhkGQff2Poe1AHwgpTAKPuY9qtho1j3upBxjHvXrnjv4B6lZXsl34LcXlkx3LayOBLH7Anhh+tea3Pgjxmt+ljJ4f1L7QxwAISR+fSgDIs47nUtUtbDTInlvLiRYokUckk4FfW3gH4W6H4TtIZruBNQ1gIDLczfMqN3CDoAPXrWJ8EPhQ/gx5NZ15optblTZFGnzC1U/e57senHQfWvTLu/tBIbd5lMjDlQc4+tADLEeeTO0fljJC/T1qxc3McK4Ljd6d6qrcxzIY4pFULxVWYxJMssrJJxgY5oAuC4MkgKlT61ehlSQfKwJHXFcvquq2OnWxa4lSMk8Ada5uz8S28F8xW8UB/urmgDF+K+pat4P8AiBp3iC1G7TpwsU65yCB1B9OOlcV8fW03VYdN1rTo+blCJHUdSMYBH410vxB8XaZrUNzptwzPMoHlnZkA5ryFtbvBpkulTiOS33l1Vhkg+ooA5XTtR1LRdTg1LSr65s7+EARzxOQwUcBT6rgAbTkY4xXfa78QtF8a+GbpfGmhH/hLILfbY6vp2I/OcYwJl9M8ngjGduw4ripRmOTKLjsaxyfnxjFAEqnGMmrbEEB1kOe4qsx/dgbelTxbRGCF+tAAxJAbnB71d0y5CygbkUjoXFU9y54GB9KiJVX3LnP0oA+ivh/eItg0MUsLscFk203V/B+ravd7o9kdqCPmwOfevGvDXjW70WUyRIsp4yHrf174v+IdS077Fb+VZRnq8IIYj60AeraNc6X4W8X+GdItrrz9QurxIpFBztGD19K+hK+BvhRJJJ8XPCTSOzs2oxksxye9ffNABRRRQAUUUUAFFFV9SvYNO066vrt9ltbRPNK391VBJP5CgD4F+Ot9L4v+O+swWhdib1NLgU84ZNsRA9i4Y/jX3PrnhvTtX8MnRLq3ElkI0RI9xTGzG35hyOmOO2a+E/gXZy+K/jroEt25MjX7ajK+M5aMNNz9WUD8a/QegqE5QkpRdmj4b8beE9d8H+LNJgkiddQjuUME1s/3kkYxhlIOVBfAGcHpxzX2poNzf3elQT6tYDT71gfMthMsuw5/vDg+tYvxO8Of8JT4B1/SI4w11dWjCDnb++X54ufQSBTVvwD4gTxV4L0XXIymb61jlkCHISTHzr/wFgw/CqlLmPQzDMpY6znFJ9/OyX42Xfbc36KKKk80wdU8GeF9WuTcar4b0W+uD1lubGKRj+LKTU+jeGNB0Ny+i6JpenOeC1paRwk/98gVr0UAYXjvVzoPgzW9URwktraSyREjP7zadg/Fio/Gp/CmkjQvDGkaSrK32C0it9yDAYogUn8SCawfivNCNA02znTct/rOnWuMcYN1Gx/RDXaUAfPX7V8/lXXhKMPsL/aj9ceTXz9fEEZWfex9e1e1/tnsUn8GMpwR9s/9o18+27iVQerdKALsUrRoMLuJ4zWhFKCVcL07EVRiKFQPm3D0qQb85XCge/JoA0HulZG3MyA+g/SoLy4UxKY2JPapAxWPBKnPYjNNdFwHZl+lAGY0jBgGyc9q73wDdeDdAsbrxL4k3alrNnIEsNGEeEdyMrKWIIIBzyeExnDErXDzJukB/i9RTdQjTYgGcgc/WgDc1jxTqfjHXp9S1y5Vp5AVjiGRFAn9xAc4HqepPJJqu80sFtJbrtAY/nWBYHy7xO5zWzqed6sX+bGcYoA1fA1og1qG5kuvs0kTBkYHBDA9a+wNG1M3VhFJKwZyo+YH73HWvim0lVpEd2ZdvvXq/wAOvHVtbxfYLt5GGco7N0oA9yv57gs8ioGA6KOc1lq8l3IXEUkew87RgmsI+NrCyRnEm/B6A5ra8PeNbDVWYWu0N3U9aAOpspElgAAkXj+KoJFEE/mRyyZHY8rV+1mjmQMjKcjtUsiBxg4oAq2OordMUMckbD+8ODWgGYjAJx7Gsy/kFtaNjGTwDXl/iXxPqWlNc2du+0mLzFkVunPpQB6frjmS2a0jkaOSYY3DsK5zQ/Di6a3EhmlbJLvya888HeOr3UjbRXrSSyhthcf1r1eG7AiR87qAJbjSoXG5mKAckA9a5jxP4o0zQ4jDgSy4wFByfxp/jfxvp2j2Ukc0oWcrwg5JzXzZ4kvor2Uz28szSSMWLM2aAOv8Q+JL3Ub4zMNsGTtX2rD1Ce6abMKAYIOS2TXKI0xYMZpGU8cGpJZ5kJ8qVwAc4JoA0tfvikMchIW4zgkDFcubh7m43yN82etTTma4I87JA9KIbRA7M+R3APegBlywEDAMfoe9ZYILdBW3MIcBSuT3xWXdRqrgoPloAhLbm61Zt1OzPJFU327/AJe9XIw3l8qcUASSMc4UAVDKCQcMDT35HyofxprKQuXUgmgCkGZWx2q2XJQYIqvKoJzn8KReFIzxQB1vwhO/4seE+eBqMf8AI19818CfBmCaf4teFPJjZxHfo7lRnCgHJNffdABXnPje80+31m5S08bapoGqiJfMhhjW6h5Hys0UkbhTgfwlc9816NXmHibXbnwyvxM1qxhWa6sbS3miRgSu4QnBIHYdT7CgDnPt2otBIH+MeoedjMTLoECqrf7S+V8w9sitjS9X+J8NhFqFlH4W8Y6OVHkvbSSafd3Q6biHzEpz1Ge1a/w50bWI7bRtc1HxrqOqm/tFluLWdIfs8jOgYGEKoKBc+pyK2fhb/wAiJpn/AG1/9GvQBa8D+KrPxfoY1Gyjmt3SaS2ubS4AWa1nRsPHIoJ2sODj0IPeuW/aL19PD/we8RSmRVmvIfsESnq5l+RgPcIXP/ATTtf8D3Nzrl74g8D+L5vDt/feX9u2QRXltcFAVVzG/wB18YXII+6OM5J8U+MunX3iSzg0PU/iZF4m1eOVnstE0bR0eSSYLjMhjkwmATy3QbiAeRQBl/sTaObnxpr2rkApZWK24yOjSvkH8omH419jV5Z+zx8NpPhz4MaLUth1vUHFxebG3CPAwkQI4O0E5I7s2CRg16nQAV5t8M3Ph3xb4p8EzkLFBOdY0pcKoNncMSyIo6LHN5i8/wB4dq9Jrz/4p6XqMEuk+L/DdtJc6xoTsZbSL717ZPgTQgZG5sBXUHPzJwCTQB6BRWJ4S8U6L4u0sah4ev4ry23bH25Dxt/ddTgq3sQK26ACiiigDi/ijbefp+gSdrfX9Ok5HHNwqf8As/54rtK5z4h6Xeax4O1K10ltupKqXFpyBmeJ1ljBJ4ALoo/GtHw5rFtr+iWeqWO/yLlN21xh42BwyMOzKwKkdiCKAPnT9tL/AFvg3/t8/wDaNfPFjZ306mWzs7udVbaWihZxn0yBX0R+2l/rfBv/AG+f+0ayvAWt6n4f/Zm1a/0O8eyvhrqRLOiqxUO0CtgMCOhPagDyi3sr7ySZbC+THPzWsgx+lMTBVHXaVblT6ivqyz1TXvD/AMRbnwfqWvSeIbG80aa/SS4hjS4s2U7cMYwAyNnjIznGPf5J0wm5sICH4RFUjPTigC8zFui5bPFSRxmUbpDj1qsiHruyPbpUwfKhTkcUAKF2qdinjvVe5kyuMc1MScDbk+tOJSbG5ACO44oAyIo5XnG3gitxbcyBXlbvgE8fpWa7CGVio5PSrtvKWRRLIeOi460AJdQgxjaQCOOO9SQILMpLlsjkVdkYLH+6O5sD7wwfeq0zxyqC2Rt65PU0ATadqbu0hkVnrTs9WvLWRprVRGB0welYi7bcjyhkk5ORVrzlaVQ6gcc80AdlpHxb1rSLny2SKYd9+Rj2FeseGfiFBrMcL3VyILhjgxlu/tXzFra7LhWUYXFLaX0kQG12Rl5GDigD7UaI6hbMzMWUjoK4zWdJt7h2EigSqCoz71518J/iu1lf22l66xa3mcItwzfc+vtXpXxOeLTPKu7cFnn+TI6YNAHAeAdGjbxDJFd3SExOdscfGTXovjTV/wDhGNHkkk27yMRAn7xry/4UDd8TY4c5EgZgAeMjmtX9qGVor3RYd5EbRu+0HvkCgDyTWtWn1e9luLx2dnJx7e1UWESQEtkEdMdqSIgRlYhuJ6mob8kQNkY46CgCu958m2PpVSa7ZhgEg5qukpIO1eelPiQ+aAV60AWrR7l2wNxB4q87IqgKGLY5GaYXKhFT5QO4NNcjPzZJFAAjknsMe1QTAuTkjHXNP2l8lTjHPNNRUJO9jjtQBnOhL9Rgc1aRvlHGSO5pZioAIAwKSL51xjigBQ0vGB8g4pGbKkMMt60MMLyxB9BTUcoODmgCvITjkVc0LSrjXNWtNOsoy008gQcdMnqary8nnqa9m8M6p4f+F/gyLWLsRah4pvlLWtmrcxKejP8A3R39T0oA9D0Ky8KfCzXPC2i20JufEeszxxFx1CHO6Q+i56Adfwr3avgv4e61qPiL45eGNU1m5a5vZ9TjLO3QDnCqOwHYV96UAFcNeWutWXifX5oNAi1bTtTjhXDXUcYIWMqysrA5BzXc0UAeTeGvCcfhnVF1DQ/h39mulVkjP9t71jVvvBEYlUB/2QKuatoXiWP4NjQtNtEOq3CmC6jjuUR0geRjKI3YbTIUJVScAFs54wfTaKAPn9vCnwgtnj/4STwVfeHpYm8sf2jBcLCSPWaNmhYe5evUvAyeBrCE2/glvDyI4UONNkiLSYBxuKnLHrycmuuxWNqnhXw9q8wm1XQtKvpgMb7mzjkb82BNAGzRXGD4YeEI5TJbaR9kfjm0uZrfp7RuKuL4H0hWZkn11S3Xbrt8B+A87igDp6K5r/hCtL5/0rxBz/1H7/8A+PU1vA+ksMNc+IGHXnX78/8AtagDpVjRXdlVQzkFiByeMc+tOrlx4G0gAD7Rr2BnH/E+vuM/9tqgm+HPhm4cNd2t7dEY4utSuZgcdMh5CD+NAG7qmvaRpP8AyFNVsLL1+03CR/8AoRFYbfEXw07FdPvLjVGGcf2XZzXgP/AokZf1rT0vwl4c0mRZNL0HSrSRekkNpGjf99AZrbAxQByC+JPEF+yDR/CN3HG4P7/VrmO1Qeh2L5kn4FRUngTwxc6A+sXuoXkc19q9yLu4gtVaO1hfaAfKQknJxlmJyx5wOldXRQB8x/ton974N/7fP/aNcD8PviT4e0X4e3fhPxR4auNYs7i9N2wScRqeE2jqDkFM9a+u/FXg3w94sNqfEek22oG13eT5wJ2bsbsYPfaPyrB/4U98P/8AoVdO/wC+T/jQB4ZoPxo8FeGrS/j8O+BbixlvEKSzC4V3fggbnbLEDPTNeA2skluibGKsAAcd6+8f+FP/AA//AOhV07/vk/40v/Cn/h//ANCrp3/fJ/xoA+LbK9juEUAYk7p61IwZ5G52Hpivs5fhB4AVgV8LacCOhCn/ABqyPhd4JHTw1p3/AHx/9egD4rJjzhS52jkYxk00zqFYiPkcYNfa6/DDwSpJHhrTsnr+7ob4X+CWUKfDWnED/pnQB8PMPOuBuyo9B2rUkEfHlBSVHOa+y1+FngdW3L4Z04H/AK5//Xp3/CsPBWCP+Ea07H/XOgD41eEtiUsp46jt60RxxgFn6dRX2WPhj4KA48N6fg/7FO/4Vn4MIA/4RzTuP+mdAHxgpPmb9nGDinSIoCNtLDHevsz/AIVl4LHTw3p//fuk/wCFY+Csg/8ACN6fx/0z/wDr0AfFOsBpUjfYwwOc1kmTJr7sf4Y+CpBh/Denkf8AXOq5+EvgMnnwvp3/AHwf8aAPh0K2A6A5XmvqrwPc23jb4TwmUCe9tE8qUdWDKOD+IxXdp8KvAyfd8M6cP+AH/Gtnw94Q0Dw4k6aHpVvZJMcyLECA31oA+avhi7Wfxa00xqwjkZoWz7g1e/aowvizQcsTutGyvb75r6DtPBfhyz1FL+10e0ivEYusqphg3rTvEXg3w94jngm13SLW+lgUrG0q5KgnOB+NAHww+Y4j5P3e59KoSTsyGMnJPrX3C/wr8Dv97wzpx/4Af8aZ/wAKn8CZz/wjGnZ/3D/jQB8KMhR8jIrUs2Vk3OAR0z3r7WPwm8CHr4X07/vg/wCNOT4UeBU+74Y04f8AAD/jQB8TqUDZyQKUSKC28HnpX2z/AMKs8D/9Czp3/fv/AOvSH4V+Bicnwzp3/fv/AOvQB8SFozn7wJ7UuxCNx5PpX20fhX4GJ58M6d/3wf8AGj/hVXgb/oWNO/74P+NAHw4VyWGCM1FECj/e+Wvuf/hVXgb/AKFjTv8Avg/400/CbwHkn/hF9Oyf9g/40AfD7MuPnwKjKrjcCMV9y/8ACp/AmAD4X07j/YP+NNPwk8BFSD4W07H+4f8AGgD4SluTvBTGR3xVaRzI5kkLM7HknkmvvL/hT3w//wChV03/AL5P+NH/AAp74f8A/Qq6d/3yf8aAPjn4Pc/Fvwh/2EY/5Gv0Dri9M+FvgjStTtdQ07w3Y297bOJIZUBBRh0I5rtKAP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Lateral lumbar spine. Note the pars defects (arrow) and anterior displacement of the L5 vertebra. B) Oblique lumbar spine. Observe the clearly visible lucent collar (arrow). C) Stepladder sign. On an oblique film, the alignment of the facet joints changes abruptly at the level of slippage. D) Axial CT L5. Note that the pars defects are readily identified (arrows). Observe the asymmetry of the defects, which is usually present in spondylolysis and may explain why some pars defects are hard to demonstrate on symmetrically positioned 45&deg; oblique lumbar radiographs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yochum TR, Rowe LJ. Yochum And Rowe's Essentials of Skeletal Radiology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy;2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42917=[""].join("\n");
var outline_f41_58_42917=null;
var title_f41_58_42918="Scalp laceration through the galea";
var content_f41_58_42918=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F87633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F87633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Scalp laceration through the galea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 386px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) This patient has a scalp laceration that extends through the galea aponeurosis (white arrows).",
"    <br/>",
"    (B) Computed tomography of the head shows an associated skull fracture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Edward Dickinson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42918=[""].join("\n");
var outline_f41_58_42918=null;
var title_f41_58_42919="Assessment of fetal lung maturity";
var content_f41_58_42919=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessment of fetal lung maturity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Jonathan Gillen-Goldstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Andrew P MacKenzie, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Edmund F Funai, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42919/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/58/42919/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pulmonary system is among the last of the fetal organ systems to mature, both functionally and structurally. Race may affect the timing of fetal lung maturation: fetal lung maturity appears to be achieved earlier in gestation in blacks and South Asians [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because the immature pulmonary system may not oxygenate the neonate adequately, preterm birth can lead to significant neonatal morbidity or mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Therefore, fetal pulmonary maturity is sometimes assessed before iatrogenic preterm delivery and can be a factor in determining the timing of delivery in these cases. Several laboratory tests are available for this purpose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/4\">",
"     4",
"    </a>",
"    ]. All involve testing amniotic fluid, which is an indirect assessment of the likelihood of lung maturity; direct studies of fetal pulmonary function are not possible.",
"   </p>",
"   <p>",
"    This topic will discuss tests for assessment of fetal lung maturity. Clinical manifestations, diagnosis, treatment, sequelae, and prevention of neonatal pulmonary immaturity are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19656?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/34/43561?source=see_link\">",
"     \"Prevention and treatment of respiratory distress syndrome in preterm infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/55/31610?source=see_link\">",
"     \"Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     WHEN IS FETAL PULMONARY MATURITY TESTING PERFORMED?",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96072826\">",
"    <span class=\"h2\">",
"     Term",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elective term cesarean delivery should be scheduled for &ge;39 weeks of gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/5\">",
"     5",
"    </a>",
"    ]. Fetal pulmonary maturity can be inferred if:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Review of the patient's prenatal record confirms a gestational age of &ge;39 weeks of gestation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34553?source=see_link\">",
"       \"Prenatal assessment of gestational age\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      Tests on amniotic fluid suggest a low risk of neonatal respiratory distress. Testing is only indicated in women of uncertain gestational age. Testing to confirm pulmonary maturity in order to proceed with an elective delivery before 39 weeks should generally be avoided. Even when fetal lung maturity testing results are mature before 39 weeks of gestation, neonates delivered before 39 weeks are at higher risk of adverse outcome than those delivered at 39 to 40 weeks of gestation without fetal lung maturity testing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96073487\">",
"    <span class=\"h2\">",
"     Preterm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal pulmonary maturity is sometimes evaluated before semi-elective but medically indicated preterm birth when this information significantly impacts assessment of the balance between the maternal-fetal risks of continuing the pregnancy and the maternal-fetal risks of preterm birth.",
"   </p>",
"   <p>",
"    Assessment of fetal lung maturity should",
"    <strong>",
"     not",
"    </strong>",
"    be performed if delaying delivery because of pulmonary immaturity will place the mother or fetus at significant risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/7\">",
"     7",
"    </a>",
"    ]. Additionally, fetal lung maturity is generally not indicated prior to 32 weeks of gestation, given the high prevalence of fetal pulmonary immaturity and the lower predictive value of a mature test result at this gestational age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     FETAL MATURITY TESTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two types of tests are used to determine pulmonary maturity: (1) biochemical tests measure the concentration of particular components of pulmonary surfactant, and (2) biophysical tests evaluate the surface-active effects of these phospholipids.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     surfactant/albumin",
"    </span>",
"    ratio (TDx-FLM ll),",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    <span class=\"nowrap\">",
"     (L/S)",
"    </span>",
"    ratio, lamellar body count, and detection of phosphatidylglycerol (PG) are the tests that have, in the past, been most commonly used to assess fetal lung maturity (",
"    <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/8\">",
"     8",
"    </a>",
"    ]. The foam stability index and optical density at 650 nm are not widely used.",
"   </p>",
"   <p>",
"    The choice of test should be based upon availability, presence or absence of contaminants (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Blood, meconium'",
"    </a>",
"    below), and physician preference. Although randomized trials comparing all of these tests have not been performed, controlled studies found that none of the tests performed significantly better than the others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/7,9-12\">",
"     7,9-12",
"    </a>",
"    ]. All are better at predicting the absence, rather than the presence, of respiratory distress. All performed less well at earlier gestational ages, which should be taken into account when interpreting results.",
"   </p>",
"   <p>",
"    We recommend avoiding the performance of multiple different tests. Although these tests predict pulmonary maturity more accurately than immaturity, we would delay delivery with an immature test result to avoid medicolegal issues if the neonate developed respiratory problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93483124\">",
"    <span class=\"h2\">",
"     Lamellar body count",
"    </span>",
"    &nbsp;&mdash;&nbsp;This is probably the most common test currently in use for assessing fetal lung maturity in the United States. Lamellar body counts are a direct measurement of surfactant production by type II pneumocytes. A standard Coulter counter can be used for quantification because of the similarity in size of lamellar bodies and platelets. Values less than 15,000 per microliter are almost always associated with pulmonary immaturity; values &ge;50,000 per microliter strongly suggest pulmonary maturity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. However, there is no consensus on the optimal threshold for predicting pulmonary maturity; values greater than 30,000 to 40,000 per microliter, as well as higher levels, have been suggested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Therefore, some clinicians use the lamellar body count as an initial screening test and perform the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    <span class=\"nowrap\">",
"     (L/S)",
"    </span>",
"    ratio if the lamellar body count is neither clearly mature (&ge;50,000) nor immature (&lt;30,000).",
"   </p>",
"   <p>",
"    Compared to thin-layer chromatography techniques, the lamellar body count is faster, more objective, less labor intensive, less technique dependent, and less expensive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/9\">",
"     9",
"    </a>",
"    ]. A meta-analysis calculated receiver-operating characteristic curves based upon data from six studies and showed the lamellar body count (cut-off &lt;10,000, &lt;20,000 [2 studies], &lt;25,000, &lt;30,000, and &lt;46,000) performed slightly better than the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio (&lt;2 [4 studies], &lt;2.7, &lt;3) in predicting respiratory distress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/19\">",
"     19",
"    </a>",
"    ]. The lamellar body count was as accurate as TDx-FLM ll; both performed best when interpreted according to gestational age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood contamination can lead to false elevation of the lamellar body count because platelets are counted as lamellar body; the effect of meconium is minimal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lecithin/sphingomyelin ratio",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    <span class=\"nowrap\">",
"     (L/S)",
"    </span>",
"    ratio for assessment of fetal pulmonary maturity was first introduced by Gluck and colleagues in 1971 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/20\">",
"     20",
"    </a>",
"    ]. It is based upon the observation that there is outward flow of pulmonary secretions from the lungs into the amniotic fluid. This process changes the phospholipid composition of amniotic fluid, thereby enabling indirect assessment of fetal lung maturity through evaluation of this fluid.",
"   </p>",
"   <p>",
"    The concentrations of lecithin and sphingomyelin in amniotic fluid are approximately equal until 32 to 33 weeks of gestation, at which time, the concentration of lecithin begins to increase significantly while the sphingomyelin concentration remains about the same. The measurement of sphingomyelin serves as a constant comparison for control of the relative increases in lecithin because the volume of amniotic fluid cannot be accurately measured clinically. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/52/31558?source=see_link\">",
"     \"Assessment of amniotic fluid volume\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Determination of the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio involves thin-layer chromatography after organic solvent extraction. It is a technically difficult test to perform and interpret; care at each step of sample handling is critical for consistent results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/21\">",
"     21",
"    </a>",
"    ]. The sample should be kept on ice or refrigerated if transport to a laboratory is required. Improper storage conditions can change the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio since amniotic fluid contains enzymes that can be affected by temperature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/22\">",
"     22",
"    </a>",
"    ]. The amniotic fluid sample must be well mixed before testing. It takes several hours to perform the test, which is another disadvantage of this method.",
"   </p>",
"   <p>",
"    A threshold value for prediction of lung maturity should be calculated in individual centers by correlation with clinical outcome, as the variation within and between laboratories can be considerable. Empirically, the risk of respiratory distress is exceedingly low when the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio is greater than 2.0 (",
"    <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Phosphatidylglycerol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphatidylglycerol (PG) is a minor constituent of surfactant. It begins to increase appreciably in amniotic fluid after 35 weeks, several weeks after the rise in lecithin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/24\">",
"     24",
"    </a>",
"    ]. Because PG enhances the spread of phospholipids on the alveoli, its presence indicates an advanced state of fetal lung development and function.",
"   </p>",
"   <p>",
"    Phosphatidylglycerol testing can be performed by thin-layer chromatography, so it can be determined alone or in conjunction with testing for the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio. It may be reported qualitatively as positive or negative, where positive represents an exceedingly low risk of respiratory distress, or in a quantitative fashion, in which a value &ge;0.5 is associated with a minimal rate of respiratory distress (",
"    <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"     table 1",
"    </a>",
"    ). Because thin-layer chromatography is a complicated and time-consuming technique, a rapid semi-quantitative immunologic slide agglutination test (AmnioStat-FLM) and several enzymatic assays were developed and have been validated as acceptable alternative techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. The slide agglutination test is the most common method for testing for phosphatidylglycerol; however, it appears to be less sensitive for detecting fetal lung maturity than thin-layer chromatography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An advantage of this test is that usually it is not affected by the presence of blood or meconium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/7\">",
"     7",
"    </a>",
"    ]. A disadvantage is that the absence of phosphatidylglycerol, especially before 36 weeks of gestation, is less predictive of the occurrence of respiratory distress than immature results from other tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93483296\">",
"    <span class=\"h2\">",
"     Surfactant/albumin ratio",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     surfactant/albumin",
"    </span>",
"    ratio is based on the principle of fluorescence polarization and uses an automated analyzer to quantitate the competitive binding of a fluorescent probe to both surfactant and albumin in a sample of amniotic fluid; thus, it is a true direct measurement of surfactant concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/30\">",
"     30",
"    </a>",
"    ]. An elevated",
"    <span class=\"nowrap\">",
"     surfactant/albumin",
"    </span>",
"    ratio has been correlated with the presence of fetal lung maturity; the threshold for maturity is 55 mg of surfactant per gram albumin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/31\">",
"     31",
"    </a>",
"    ]. The performance of this test compares favorably with the well-established",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio and phosphatidylglycerol tests (",
"    <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"     table 1",
"    </a>",
"    ) and is gestational age-dependent (",
"    <a class=\"graphic graphic_table graphicRef72799 \" href=\"mobipreview.htm?33/45/34525\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/11,32,33\">",
"     11,32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advantages of this test are that it is a simple, automated, rapid test that varies minimally between laboratories, and requires only a small volume of amniotic fluid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A disadvantage to the TDx-FLM ll method is the large quantification scale. Values greater than 55 are regarded as mature and values less than 40 are considered immature, while values of 40 to 54 are considered \"indeterminate\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/7,32\">",
"     7,32",
"    </a>",
"    ]. Blood or meconium in the amniotic fluid also affects results.",
"   </p>",
"   <p>",
"    The manufacturer of the TDx-FLM II test has retired the analytical systems for TDx-FLM ll and ended production of the reagent required to perform it. Currently, there are no commercially available tests for measuring the",
"    <span class=\"nowrap\">",
"     surfactant/albumin",
"    </span>",
"    ratio; however, new methods are in development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1159561295\">",
"    <span class=\"h2\">",
"     Optical density at 650 nm",
"    </span>",
"    &nbsp;&mdash;&nbsp;An indirect measurement of lamellar bodies can be performed by measuring optical density of amniotic fluid at a wavelength of 650 nm. It is based upon the concept that increasing opalescence is due to increasing numbers of lamellar bodies. An optical density reading of &ge;0.15 is used as the indicator of pulmonary maturity (",
"    <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Foam stability index",
"    </span>",
"    &nbsp;&mdash;&nbsp;The foam stability index (FSI) is a rapid predictor of fetal lung maturity based upon the ability of surfactant to generate stable foam in the presence of ethanol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/34\">",
"     34",
"    </a>",
"    ]. Ethanol is added to a sample of amniotic fluid to eliminate the effects of nonsurfactant factors on foam formation. The mixture is then shaken and will demonstrate generation of a stable ring of foam if surfactant is present. The foam stability index (FSI) is calculated by utilizing serial dilutions of ethanol to quantitate the amount of surfactant present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Amniotic fluid samples should not be collected in silicone tubes when this test is planned, as the silicone will produce \"false foam.\" The discriminating value indicative of lung maturity is usually set at &ge;47. A positive result virtually excludes the risk of respiratory distress; however, a negative test often occurs in the presence of mature lungs (",
"    <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/36\">",
"     36",
"    </a>",
"    ]. The presence of blood or meconium interferes with results of the FSI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     FACTORS THAT MAY AFFECT INTERPRETATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Gestational age",
"    </span>",
"    &nbsp;&mdash;&nbsp;For each test, the ability to predict absence of respiratory distress is influenced by the prevalence of respiratory distress in the population tested; thus, the predictive value varies with gestational age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/12,37,38\">",
"     12,37,38",
"    </a>",
"    ]. As an example, in one analysis, the risk of respiratory distress after a TDx-FLM ll of 60",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    at 29 and 37 weeks of gestation was 16 and 1 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/37\">",
"     37",
"    </a>",
"    ]. Whether gestational age should be used in combination with laboratory test results to estimate the likelihood of respiratory distress is controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of fetal lung maturity is not necessarily indicative of readiness for neonatal life and absence of neonatal morbidity. This was illustrated in a retrospective cohort study of neonatal outcomes of infants with mature fetal pulmonary indices on prenatal testing who delivered at 34",
"    <sup>",
"     0",
"    </sup>",
"    to 36",
"    <sup>",
"     6",
"    </sup>",
"    weeks or 37",
"    <sup>",
"     0",
"    </sup>",
"    to 38",
"    <sup>",
"     6",
"    </sup>",
"    weeks versus those who delivered at &ge;39 weeks of gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/41\">",
"     41",
"    </a>",
"    ]. The rates of composite neonatal adverse outcome (defined as NICU admission, phototherapy, antibiotic treatment, intravenous fluids for hypoglycemia, or gavage feeding) for the three groups were significantly different at 21, 13, and 4 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Blood, meconium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphatidylglycerol determination generally is not affected by blood, meconium, or other contaminants; its ability to predict pulmonary maturity is the same whether or not contamination is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/4\">",
"     4",
"    </a>",
"    ]. This is an advantage for assessing fetal lung maturity status since these substances are commonly found in amniotic fluid.",
"   </p>",
"   <p>",
"    The",
"    <span class=\"nowrap\">",
"     surfactant/albumin",
"    </span>",
"    ratio is usually reliable if mature since contaminants tend to cause falsely immature findings, although the degree and direction of interference are not well defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/42-46\">",
"     42-46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of blood or meconium can interfere with interpretation of the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/47\">",
"     47",
"    </a>",
"    ]. Bloody samples give false information due to the presence of sphingomyelin in blood and decreased extraction of lecithin by cold acetone techniques in the presence of red blood cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/48\">",
"     48",
"    </a>",
"    ]. Therefore, if blood or other particulate matter is present in the amniotic fluid sample, a low speed, short centrifugation should be used to remove the cellular component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/21\">",
"     21",
"    </a>",
"    ]; however, this does not guarantee an accurate result, especially when there is a lot of blood or meconium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Oligohydramnios and polyhydramnios",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect of amniotic fluid volume (oligohydramnios, polyhydramnios) on test results has not been studied extensively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Theoretically, tests that are expressed as a ratio or proportion of two solutes released into the amniotic fluid should remain accurate independent of amniotic fluid volume, while tests that reflect the concentration of a substance in the amniotic fluid (eg, lamellar body count, phosphatidylglycerol) may be affected by amniotic fluid volume.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Vaginal pool samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with intact membranes, amniotic fluid is obtained by amniocentesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/11/16570?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnostic amniocentesis\", section on 'Third trimester amniocentesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In women with ruptured membranes, a syringe can be used to aspirate amniotic fluid pooled in the posterior vaginal fornix. The FLM-TDx ll test (which is no longer available) on a vaginal pool specimen appeared to be reliable if a mature result is obtained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In a study of 16 patients who underwent both amniocentesis and vaginal collection of amniotic fluid at a mean gestational age of 33 weeks, the vaginal pool TDx-FLM ll result was lower than the amniocentesis result in every patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/52\">",
"     52",
"    </a>",
"    ]. Additionally, collecting vaginal pool specimens using a sterile sponge is useful to assess lung maturity, especially when looking for PG.",
"   </p>",
"   <p>",
"    By comparison, the",
"    <span class=\"nowrap\">",
"     lecithin/sphingomyelin",
"    </span>",
"    ratio can be higher in the vaginal pool than in fluid from amniocentesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/53\">",
"     53",
"    </a>",
"    ] and false positive phosphatidylglycerol have been reported in vaginal pool samples due to bacterial contamination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antenatal corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard tests for predicting fetal lung maturity may be less reliable for predicting absence of fetal lung maturity in women who have received antenatal corticosteroids to enhance fetal lung maturation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/55/31610?source=see_link&amp;anchor=H26#H26\">",
"     \"Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery\", section on 'Amniocentesis after antenatal corticosteroid therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Maternal diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The current consensus is that the same threshold value for lung maturity can be used for both nondiabetic and diabetic patients (pregestational or gestational diabetes) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/56-60\">",
"     56-60",
"    </a>",
"    ]. As an example, in one series of 45 pregnant women with diabetes who gave birth within three days of a TDx-FLM ll, there were no cases of respiratory distress among the 40 fetuses with TDx-FLM ll &ge;55",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    and one case of respiratory distress among the 5 fetuses with TDx-FLM ll between 40 and 55",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42919/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Twin pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary maturation of twins, the upper and lower gestational ages when pulmonary maturity should be evaluated before delivery, and assessment of pulmonary maturity in one or both twins are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/11/5306?source=see_link&amp;anchor=H5#H5\">",
"     \"Twin pregnancy: Labor and delivery\", section on 'Assessment of pulmonary maturity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fetal pulmonary maturity testing may be useful in timing semi-elective medically indicated preterm birth. Testing is unnecessary for well documented gestational age &ge;39 weeks (because lung maturity is likely), pregnancies less than 32 weeks of gestation (because lung immaturity is likely), and when delaying delivery because of pulmonary immaturity will place the mother or fetus at significant risk. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'When is fetal pulmonary maturity testing performed?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fetal lung maturity can be assessed by testing for components of fetal lung secretions in amniotic fluid. No test performs significantly better than another and all are better at predicting the absence, rather than the presence, of respiratory distress. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of test should be based upon availability, presence or absence of contaminants, and physician preference. A summary of the different tests available and the assets and liabilities associated with each is shown in the table (",
"      <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"       table 1",
"      </a>",
"      ). We suggest use of the lamellar body count. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Fetal maturity tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We avoid performing more than one test (eg,",
"      <span class=\"nowrap\">",
"       lecithin/sphingomyelin",
"      </span>",
"      ratio and phosphatidylglycerol). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All tests perform less well at earlier gestational ages, which should be taken into account when interpreting results. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Gestational age'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of blood or meconium in amniotic fluid affects some test results (",
"      <a class=\"graphic graphic_table graphicRef64274 \" href=\"mobipreview.htm?14/34/14892\">",
"       table 1",
"      </a>",
"      ). Oligohydramnios, polyhydramnios, and source of amniotic fluid (vaginal pool versus amniocentesis) also may play a role. The same threshold value for lung maturity can be used for both nondiabetic and diabetic patients (pregestational or gestational diabetes). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Factors that may affect interpretation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/1\">",
"      Balchin I, Whittaker JC, Lamont RF, Steer PJ. Timing of planned cesarean delivery by racial group. Obstet Gynecol 2008; 111:659.",
"     </a>",
"    </li>",
"    <li>",
"     Preterm Birth, 1988-1998. National Center for Health Statistics. March of Dimes Perinatal Data Center, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/3\">",
"      Parilla BV, Dooley SL, Jansen RD, Socol ML. Iatrogenic respiratory distress syndrome following elective repeat cesarean delivery. Obstet Gynecol 1993; 81:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/4\">",
"      Dubin SB. The laboratory assessment of fetal lung maturity. Am J Clin Pathol 1992; 97:836.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists and American Academy of Pediatrics. Guidelines For Perinatal Care. 7th Ed, 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/6\">",
"      Bates E, Rouse DJ, Mann ML, et al. Neonatal outcomes after demonstrated fetal lung maturity before 39 weeks of gestation. Obstet Gynecol 2010; 116:1288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/7\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 97: Fetal lung maturity. Obstet Gynecol 2008; 112:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/8\">",
"      Grenache DG, Wilson AR, Gross GA, Gronowski AM. Clinical and laboratory trends in fetal lung maturity testing. Clin Chim Acta 2010; 411:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/9\">",
"      Neerhof MG, Haney EI, Silver RK, et al. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol 2001; 97:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/10\">",
"      Winn-McMillan T, Karon BS. Comparison of the TDx-FLM II and lecithin to sphingomyelin ratio assays in predicting fetal lung maturity. Am J Obstet Gynecol 2005; 193:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/11\">",
"      Haymond S, Luzzi VI, Parvin CA, Gronowski AM. A direct comparison between lamellar body counts and fluorescent polarization methods for predicting respiratory distress syndrome. Am J Clin Pathol 2006; 126:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/12\">",
"      Karcher R, Sykes E, Batton D, et al. Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid. Am J Obstet Gynecol 2005; 193:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/13\">",
"      Neerhof MG, Dohnal JC, Ashwood ER, et al. Lamellar body counts: a consensus on protocol. Obstet Gynecol 2001; 97:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/14\">",
"      Ventolini G, Neiger R, Hood DL, Belcastro MR. Changes in the threshold of fetal lung maturity testing and neonatal outcome of infants delivered electively before 39 weeks gestation: implications and cost-effectiveness. J Perinatol 2006; 26:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/15\">",
"      Khazardoost S, Yahyazadeh H, Borna S, et al. Amniotic fluid lamellar body count and its sensitivity and specificity in evaluating of fetal lung maturity. J Obstet Gynaecol 2005; 25:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/16\">",
"      Dalence CR, Bowie LJ, Dohnal JC, et al. Amniotic fluid lamellar body count: a rapid and reliable fetal lung maturity test. Obstet Gynecol 1995; 86:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/17\">",
"      Ghidini A, Poggi SH, Spong CY, et al. Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non-diabetic pregnant women. Arch Gynecol Obstet 2005; 271:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/18\">",
"      Janicki MB, Dries LM, Egan JF, Zelop CM. Determining a cutoff for fetal lung maturity with lamellar body count testing. J Matern Fetal Neonatal Med 2009; 22:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/19\">",
"      Wijnberger LD, Huisjes AJ, Voorbij HA, et al. The accuracy of lamellar body count and lecithin/sphingomyelin ratio in the prediction of neonatal respiratory distress syndrome: a meta-analysis. BJOG 2001; 108:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/20\">",
"      Gluck L, Kulovich MV, Borer RC Jr, et al. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 1971; 109:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/21\">",
"      Ashwood ER. Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem 1997; 43:211.",
"     </a>",
"    </li>",
"    <li>",
"     Whitsett, JA, Pryhuber, GS, Rice, WR, et al. Acute respiratory disorders. In: Neonatology pathophysiology and the management of the newborn, Avery, GB, Fletcher, MA, MacDonald, MG, (Eds), JB Lippincott, Philadelphia 1994. p. 429.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/23\">",
"      Gluck L, Kulovich MV, Borer RC Jr, Keidel WN. The interpretation and significance of the lecithin-sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/24\">",
"      Hallman M, Kulovich M, Kirkpatrick E, et al. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976; 125:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/25\">",
"      Coapman-Hankin RA, Kiechle FL, Epstein E, et al. Three methods compared for determining phosphatidylglycerol in amniotic fluid. Clin Chem 1985; 31:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/26\">",
"      Halvorsen PR, Gross TL. Laboratory and clinical evaluation of a rapid slide agglutination test for phosphatidylglycerol. Am J Obstet Gynecol 1985; 151:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/27\">",
"      Eisenbrey AB, Epstein E, Zak B, et al. Phosphatidylglycerol in amniotic fluid. Comparison of an \"ultrasensitive\" immunologic assay with TLC and enzymatic assay. Am J Clin Pathol 1989; 91:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/28\">",
"      Lockitch G, Wittmann BK, Mura SM, Hawkley LC. Evaluation of the Amniostat-FLM assay for assessment of fetal lung maturity. Clin Chem 1984; 30:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/29\">",
"      Knight JA, Miya T, Wu JT. Standard lecithin/sphingomyelin and phosphatidylglycerol techniques compared with immunologic slide test. Obstet Gynecol 1985; 65:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/30\">",
"      Bernstein LH, Stiller R, Menzies C, et al. Amniotic fluid polarization of fluorescence and lecithin/sphingomyelin ratio decision criteria assessed. Yale J Biol Med 1995; 68:101.",
"     </a>",
"    </li>",
"    <li>",
"     Standards of Laboratory Practice: Guidelines for the Evaluation and Management of the Newborn. National Acadamy of Clinical Biochemisry, 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/32\">",
"      Kesselman EJ, Figueroa R, Garry D, Maulik D. The usefulness of the TDx/TDxFLx fetal lung maturity II assay in the initial evaluation of fetal lung maturity. Am J Obstet Gynecol 2003; 188:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/33\">",
"      Hagen E, Link JC, Arias F. A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome. Obstet Gynecol 1993; 82:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/34\">",
"      Clements JA, Platzker AC, Tierney DF, et al. Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med 1972; 286:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/35\">",
"      Sher G, Statland BE, Freer DE, Kraybill EN. Assessing fetal lung maturation by the foam stability index test. Obstet Gynecol 1978; 52:673.",
"     </a>",
"    </li>",
"    <li>",
"     Jobe, AH. Fetal lung development, tests for maturation, induction of maturation and treatment. In: Maternal-Fetal Medicine, Creasy, RK, Resnik, R, (Eds), WB Saunders, Philadelphia 1999. p. 418.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/37\">",
"      Parvin CA, Kaplan LA, Chapman JF, et al. Predicting respiratory distress syndrome using gestational age and fetal lung maturity by fluorescent polarization. Am J Obstet Gynecol 2005; 192:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/38\">",
"      Kaplan LA, Chapman JF, Bock JL, et al. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay. Clin Chim Acta 2002; 326:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/39\">",
"      Tanasijevic MJ, Wybenga DR, Richardson D, et al. A predictive model for fetal lung maturity employing gestational age and test results. Am J Clin Pathol 1994; 102:788.",
"     </a>",
"    </li>",
"    <li>",
"     Gillen-Goldstein, J, Kaplan, LA, Chapman, JF, et al. Prediction of Respiratory Distress Syndrome from Amniotic Fluid Surfactant Measures: The NACB Fetal Lung Maturity Project. Journal of Society for Gynecologic Investigation 2001. Abstract 716. p. 257.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/41\">",
"      Kamath BD, Marcotte MP, DeFranco EA.. Neonatal morbidity after documented fetal lung maturty in late preterm and early term infants. Am J Obstet Gynecol 2011; 204:518.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/42\">",
"      Carlan SJ, Gearity D, O'Brien WF. The effect of maternal blood contamination on the TDx-FLM II assay. Am J Perinatol 1997; 14:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/43\">",
"      Albright TS, Colombo DF, Euscher E, Samuels P. Evaluation of the effect of meconium on assessment of fetal lung maturity status by TDxFLM II testing. Obstet Gynecol 2004; 104:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/44\">",
"      Wong SS, Schenkel O, Qutishat A. Strategic utilization of fetal lung maturity tests. Scand J Clin Lab Invest 1996; 56:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/45\">",
"      Srouji SS, Carr DB, Gardella CM, et al. The effect of common clinical contaminants on amniotic fluid fluorescence polarization results. Obstet Gynecol 2004; 104:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/46\">",
"      Grenache DG, Parvin CA, Gronowski AM. Preanalytical factors that influence the Abbott TDx Fetal Lung Maturity II assay. Clin Chem 2003; 49:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/47\">",
"      Spillman T, Cotton DB. Current perspectives in assessment of fetal pulmonary surfactant status with amniotic fluid. Crit Rev Clin Lab Sci 1989; 27:341.",
"     </a>",
"    </li>",
"    <li>",
"     Jobe, AH. Fetal lung development, tests for maturation, induction of maturation and treatment. In: Maternal-Fetal Medicine, Creasy, RK, Resnik, R (Eds), WB Saunders Philadelphia 1999. p. 417.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/49\">",
"      Piazze JJ, Maranghi L, Cosmi EV, Anceschi MM. The effect of polyhydramnios and oligohydramnios on fetal lung maturity indexes. Am J Perinatol 1998; 15:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/50\">",
"      Wijnberger LD, de Kleine M, Voorbij HA, et al. The effect of clinical characteristics on the lecithin/sphingomyelin ratio and lamellar body count: a cross-sectional study. J Matern Fetal Neonatal Med 2003; 14:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/51\">",
"      Edwards RK, Duff P, Ross KC. Amniotic fluid indices of fetal pulmonary maturity with preterm premature rupture of membranes. Obstet Gynecol 2000; 96:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/52\">",
"      Cleary-Goldman J, Connolly T, Chelmow D, Malone F. Accuracy of the TDx-FLM assay of amniotic fluid: a comparison of vaginal pool samples with amniocentesis. J Matern Fetal Neonatal Med 2002; 11:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/53\">",
"      Dombroski RA, MacKenna J, Brame RG. Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens. Am J Obstet Gynecol 1981; 140:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/54\">",
"      Lambers DS, Brady K, Leist PA, et al. Ability of normal vaginal flora to produce detectable phosphatidylglycerol in amniotic fluid in vitro. Obstet Gynecol 1995; 85:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/55\">",
"      Schumacher RE, Parisi VM, Steady HM, Tsao FH. Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid. Am J Obstet Gynecol 1985; 151:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/56\">",
"      Tanasijevic MJ, Winkelman JW, Wybenga DR, et al. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests. Am J Clin Pathol 1996; 105:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/57\">",
"      Livingston EG, Herbert WN, Hage ML, et al. Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. The Diabetes and Fetal Maturity Study Group. Obstet Gynecol 1995; 86:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/58\">",
"      Curet LB, Tsao FH, Zachman RD, et al. Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies. Int J Gynaecol Obstet 1989; 30:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/59\">",
"      Berkowitz K, Reyes C, Saadat P, Kjos SL. Fetal lung maturation. Comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med 1997; 42:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42919/abstract/60\">",
"      Melanson SE, Jarolim P, McElrath TF. Fetal lung maturity testing in diabetic mothers. Lab Med 2007; 38:553.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 405 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-558F5CFEDC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42919=[""].join("\n");
var outline_f41_58_42919=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      WHEN IS FETAL PULMONARY MATURITY TESTING PERFORMED?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96072826\">",
"      Term",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96073487\">",
"      Preterm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      FETAL MATURITY TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93483124\">",
"      Lamellar body count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lecithin/sphingomyelin ratio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Phosphatidylglycerol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93483296\">",
"      Surfactant/albumin ratio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1159561295\">",
"      Optical density at 650 nm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Foam stability index",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      FACTORS THAT MAY AFFECT INTERPRETATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Gestational age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Blood, meconium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Oligohydramnios and polyhydramnios",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Vaginal pool samples",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antenatal corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Maternal diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Twin pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/405\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/405|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/34/14892\" title=\"table 1\">",
"      Tests for lung maturity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/45/34525\" title=\"table 2\">",
"      Probability RDS by FLM and GA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/55/31610?source=related_link\">",
"      Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/52/31558?source=related_link\">",
"      Assessment of amniotic fluid volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/11/16570?source=related_link\">",
"      Diagnostic amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/12/19656?source=related_link\">",
"      Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/47/34553?source=related_link\">",
"      Prenatal assessment of gestational age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/34/43561?source=related_link\">",
"      Prevention and treatment of respiratory distress syndrome in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/11/5306?source=related_link\">",
"      Twin pregnancy: Labor and delivery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_58_42920="Inherited disorders of the complement system";
var content_f41_58_42920=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Inherited disorders of the complement system",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     M Kathryn Liszewski, BA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     John P Atkinson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42920/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/58/42920/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited deficiencies of complement components predispose patients to bacterial infections and autoimmune conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/1\">",
"     1",
"    </a>",
"    ]. They are associated with predictable defects in complement-dependent function, as the affected individual loses not only the activity of the deficient protein, but also the functions of the proteins that follow in the cascade. Complete deficiencies are rare.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with some forms of complement deficiency are susceptible to recurrent sinopulmonary infections, bacteremia,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      meningitis. The pathogens most commonly implicated are encapsulated bacteria such as Streptococcus pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=see_link\">",
"       \"Approach to the child with recurrent infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43433?source=see_link\">",
"       \"Approach to the adult with recurrent infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Autoimmunity develops in individuals deficient in the early components of the classical pathway (ie, C1q, C1r, C1s, C4, and C2). A deficiency of a complement inhibitor may also lead to excessive complement activation and tissue damage. The most common autoimmune disorder in patients with complement deficiencies is systemic lupus erythematosus (SLE) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/2-7\">",
"       2-7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10810?source=see_link\">",
"       \"Systemic lupus erythematosus in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/31/41464?source=see_link\">",
"       \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Inherited disorders of the complement system will be reviewed here. Acquired disorders and the general evaluation of the complement system are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29542?source=see_link\">",
"     \"Acquired disorders of the complement system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=see_link\">",
"     \"Overview and clinical assessment of the complement system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/59/11190?source=see_link\">",
"     \"Complement pathways\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSICAL PATHWAY DEFICIENCIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetics of deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most inherited disorders of the classical pathway components are transmitted as autosomal codominant (recessive) traits. Two abnormal alleles must be present to yield complete deficiency. Most heterozygous deficiencies of complement components are asymptomatic. One exception is partial C4 deficiency, which predisposes patients to SLE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/8\">",
"     8",
"    </a>",
"    ]. In contrast, homozygous deficiencies are often associated with disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications for screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for a classical complement pathway defect is indicated in patients with any of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recurrent, unexplained pyogenic infections in whom the white blood count and immunoglobulin levels are normal",
"     </li>",
"     <li>",
"      Recurrent Neisserial infections at any age",
"     </li>",
"     <li>",
"      Multiple family members who have suffered Neisserial infections",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, it is reasonable to check a CH50 in any patient with systemic lupus erythematosus (SLE). However, this is particularly relevant in those with familial lupus or subacute cutaneous lupus, in whom C2 deficiency should be excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Screening CH50 and interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The total hemolytic complement (THC or CH50) assay is a reliable screen for homozygous deficiencies in the classical pathway.",
"   </p>",
"   <p>",
"    Care must be taken in the handling of serum specimens, since complement activity is unstable and heat-labile, and is reduced after a few hours at room temperature. A common cause for low or zero complement activity in patients with SLE is cold activation by soluble immune complexes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cryoglobulins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=see_link\">",
"     \"Overview and clinical assessment of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CH50 measures the capacity of a patient's serum to lyse sheep erythrocytes coated with rabbit antibody. All nine components of the classical pathway (C1 through C9) are required for a normal CH50 value, which is 150 to 250",
"    <span class=\"nowrap\">",
"     units/mL",
"    </span>",
"    in a commonly used assay system. For example, a CH50 of 200",
"    <span class=\"nowrap\">",
"     units/mL",
"    </span>",
"    means that a serum sample diluted 1:200 lysed 50 percent of the antibody-coated sheep erythrocytes in the test mixture.",
"   </p>",
"   <p>",
"    Heterozygous deficient individuals will generally have a normal CH50, because the level of a component must be reduced by more than 50 percent before the CH50 is altered. Heterozygous C2 deficiency is one exception. C2 is the limiting component in a CH50 determination, and patients with heterozygous C2 deficiency tend to have low CH50 values. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'C2 deficiency'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A complete deficiency of any one component gives an undetectable CH50 value (often reported as less than some specified low value), with the exception of C9 deficiency. Homozygous C9 deficiency, which is most often reported in patients of Japanese descent, gives a low but detectable CH50 titer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'C5-C9 deficiency'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    If a patient is found to have a very low or undetectable CH50, then the next step in the evaluation is the measurement of specific complement proteins. The most common deficiency is C2, followed by C4 and C1q, and then a member of the membrane attack complex (C5-C9). The protein levels should be checked in this order.",
"   </p>",
"   <p>",
"    Another approach is to perform an alternative pathway (AH50) assay. This test, although not widely available, can be performed in referral laboratories. If it is also undetectable, then the deficiency is of C3, C5, C6, C7, C8, or C9.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Specific disorders",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     C1 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although any one of the three subcomponents (C1q, C1r, or C1s) of the C1 complex may be deficient, the most common deficiency is of C1q.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      More than 90 percent of C1q deficient individuals develop SLE and they may also have recurrent infections. Most of these patients have typical clinical and serologic findings of SLE. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10810?source=see_link\">",
"       \"Systemic lupus erythematosus in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/31/41464?source=see_link\">",
"       \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A deficiency of the serine protease C1r or C1s also results in the development of SLE, with prominent renal and cutaneous sequelae. C1r or C1s homozygous deficiency is exceptionally rare (ie, fewer than 10 cases reported). Some of these patients have deficiencies of both C1r and C1s, consistent with the close linkage of the genes for these two homologous proteins.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     C4 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;A borderline or low C4 (with normal C3) is observed in 1 to 3 percent of the Caucasian population. C4 is encoded as two highly polymorphic genes, C4A and C4B, which are located in the major histocompatibility complex on chromosome 6. The C4 gene is duplicated with ~65 percent of the population, who therefore carry two C4A and two C4B genes. In the remaining ~35 percent, at least one or more C4A",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    C4B gene(s) are deleted.",
"   </p>",
"   <p>",
"    The more null or nonfunctional C4 alleles an individual possesses, the greater the predisposition to SLE. Partial deficiency of C4 is common and predisposes to the development of SLE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/8\">",
"     8",
"    </a>",
"    ]. Total deficiency of C4 is rare and approximately 80 percent of patients present with SLE that is often severe and begins at an early age. Overall, about 10 percent of patients with SLE have C4A deficiency (produce no C4A or null with both C4A genes deleted). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/16/3338?source=see_link\">",
"     \"Diagnosis and differential diagnosis of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/31/41464?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Levels of C4 may be 0, 25, 50, or 75 percent of normal depending upon whether the patient inherits 4, 3, 2, or 1 nonfunctional allele(s), respectively. In these individuals, C4 is borderline low throughout life and, if SLE develops, C4 drops even lower. Even with successful treatment of the disease, these patients may continue to show low or low-normal total C4. Genetic testing to determine the number and type of C4 genes is required to identify this situation.",
"   </p>",
"   <p>",
"    The interpretation of a low C4 in a patient with SLE can be complicated. Reduced levels may be due to consumption as well as to deficiency of one or more alleles. Both causes may be present in a given patient. The underlying mechanisms can sometimes be distinguished by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consumption is associated with a reduction in multiple complement components. As an example, low C2 and C3 in this setting indicate consumption.",
"     </li>",
"     <li>",
"      Inherited complement deficiency is characterized by the fixed absence of a single complement component, whereas consumption fluctuates over time.",
"     </li>",
"     <li>",
"      If there is still uncertainty, then a blood sample should be sent to a commercial laboratory specializing in complement tests to determine the protein level. To determine the number of C4 alleles at the DNA level, the sample would need to be sent to a research laboratory. HLA typing can also be informative in this setting as C4A deletion is usually observed (ie, &gt;90 of cases) on the DR3B8 background. Two definitive reviews have been published on determining copy number of C4 genes in a large number of normal controls and SLE patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/8,11\">",
"       8,11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Deficiency of C4A or C4B has also been associated with the development of other disorders. These include scleroderma, IgA nephropathy, Henoch-Sch&ouml;nlein purpura (IgA vasculitis), childhood diabetes mellitus, chronic forms of hepatitis, membranous nephropathy, and subacute sclerosing panencephalitis. There is a report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/12\">",
"     12",
"    </a>",
"    ] that identifies a strikingly high frequency of capillary leak syndrome (CLS) in children undergoing cardiac surgery with cardiopulmonary bypass who are C4A null (ie, no C4A protein in their blood). If these patients were given C4A-rich blood, only 3 of 58 developed CLS. If they were given blood lacking C4A, 56 (97 percent) developed CLS. The authors are unaware of a confirmatory report.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     C2 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Homozygous, complete deficiency of C2 occurs in approximately 1 in 10,000 Caucasians. Ten to 30 percent of such individuals present with an SLE-like illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/5,13,14\">",
"     5,13,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/16/3338?source=see_link\">",
"     \"Diagnosis and differential diagnosis of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/31/41464?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another common presentation, especially in early childhood, is recurrent pyogenic infections with encapsulated bacteria, such as Streptococcus pneumoniae, Haemophilus influenza type b, and Neisseria meningitidis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C2 deficiency is also sometimes associated with IgG subclass deficiency. Other disease associations include discoid lupus erythematosus, polymyositis, glomerulonephritis, Hodgkin lymphoma, vasculitis, and Henoch-Sch&ouml;nlein purpura (IgA vasculitis). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=see_link\">",
"     \"Approach to the child with recurrent infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24326?source=see_link\">",
"     \"Primary humoral immune deficiencies: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tests for antinuclear antibodies may be positive in a low titer and often demonstrate a speckled pattern. Tests for antibodies to double-stranded DNA are usually negative. However, more than 50 percent of patients have antibodies to the Ro (SS-A) antigen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/23/8568?source=see_link\">",
"     \"The anti-Ro/SSA and anti-La/SSB antigen-antibody systems\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Partial C2 deficiency has no clinical importance in most individuals, and its frequency does not appear to be increased among patients with SLE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/5,6,15\">",
"     5,6,15",
"    </a>",
"    ]. It is sometimes detected because it can yield a low CH50, as previously discussed. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Screening CH50 and interpretation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients may also have a combination of multiple autoimmune phenomena, especially various cutaneous manifestations, and pyogenic infections. In a single case of the type illustrated in reference, the patient appeared to respond to treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     C3 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of C3, the major opsonin of the complement system, results in severe, recurrent infections with encapsulated bacteria that begin shortly after birth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/2\">",
"     2",
"    </a>",
"    ]. Patients with C3 deficiency are particularly prone to infections with the pneumococcus and H. influenza.",
"   </p>",
"   <p>",
"    Deficiencies of factors H or I give rise to a secondary C3 deficiency. Deficiencies in these regulator proteins should be considered in the evaluation of a child with presumed C3 deficiency. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Complement inhibitor proteins'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Children who survive these infections subsequently develop problems secondary to excess immune complex formation, especially glomerulonephritis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=see_link\">",
"     \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Partial C3 deficiency, which results in half the normal serum level of C3, appears to have no clinical significance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     C5-C9 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiencies of components of the membrane attack complex (MAC, C5-C9) are associated with infection by Neisseria species (primarily the meningococcus and gonococcus), which are sometimes of unusual serotypes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the United States, C5, C6, and C8 deficiencies are the most commonly seen deficiencies of the MAC components [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/16-21\">",
"       16-21",
"      </a>",
"      ]. C6 deficiency is usually reported in African Americans from South Africa [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      C7 deficiency has been reported worldwide [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/22-28\">",
"       22-28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      C9 deficiency is almost always observed in people of Japanese descent, in whom it is inherited as an autosomal recessive trait and is one of the most frequent genetic disorders in the Japanese population. It is associated with lower rates of mortality compared with complement-normal patients, so this variant may confer some evolutionary advantage to affected individuals [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/10\">",
"       10",
"      </a>",
"      ]. C9 deficiency is less severe of a defect because cells can still be lysed by C5b-8, albeit with less efficiency than if C9 is present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neisserial infections in these patients tend to be recurrent and clinically mild to moderate, with a low (approximately 2 percent) mortality rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/2,16-24\">",
"     2,16-24",
"    </a>",
"    ]. Patients are otherwise healthy in most cases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/52/37704?source=see_link\">",
"     \"Clinical manifestations of meningococcal infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/32/7688?source=see_link\">",
"     \"Microbiology and pathobiology of Neisseria meningitidis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27432?source=see_link\">",
"     \"Epidemiology of Neisseria meningitidis infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/34/39462?source=see_link\">",
"     \"Gonococcal infection in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As mentioned previously, a complete deficiency of any one component of the MAC gives an undetectable CH50 value. The exception is C9 deficiency, which gives a low but detectable CH50 titer. The CH50 should be the initial screening test. The usual clinical indication is recurrent Neisserial infections. If the CH50 is zero or very low, then the specific deficiency is diagnosed by measuring levels of C5, C6, C7, C8, and C9. C6 should be measured first in African Americans, while C5 and C8 should be checked initially in Caucasians and C9 in patients of Japanese descent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ALTERNATIVE PATHWAY DEFICIENCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited defects in components of the alternative pathway, including factor D and properdin, are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/29-33\">",
"     29-33",
"    </a>",
"    ]. Properdin deficiency is the only one of these disorders for which more than a few cases have been reported. An alternative pathway AH50 assay is a screen for such a deficiency. If very low or undetectable, individual components (factor D, properdin) can be assessed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=see_link\">",
"     \"Overview and clinical assessment of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Properdin-deficient individuals have no activity of the alternative pathway (",
"    <a class=\"graphic graphic_figure graphicRef61780 \" href=\"mobipreview.htm?33/54/34669\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/30\">",
"     30",
"    </a>",
"    ]. Properdin deficiency affects males within a family because the gene is on the X chromosome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/2,29,34\">",
"     2,29,34",
"    </a>",
"    ]. Neisseria meningitidis is most frequently implicated and is often of unusual subtypes. Thus, a male child with a family history of Neisserial meningitis should be evaluated for properdin deficiency. Recurrent otitis media and pneumonia have also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/34\">",
"     34",
"    </a>",
"    ]. The mortality rate for properdin deficiency is in the range of 34 to 63 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factor H and factor I are sometimes included in the discussions of the alternative pathway, although they are more accurately classified as regulatory proteins. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Factor H, factor I, or membrane cofactor protein'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LECTIN PATHWAY DEFICIENCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited defects in components of the lectin pathway include deficiencies of mannose-binding lectin (MBL), mannan-binding lectin-associated protease 2 (MASP-2), and ficolin-3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     MBL deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of mannose-binding lectin (MBL), also known as mannan-binding protein (MBP), is associated with an increased frequency of pyogenic infections, especially with encapsulated bacteria. Neonates and infants are particularly at risk. MBL deficiency is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/14/19690?source=see_link\">",
"     \"Mannose-binding lectin deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     MASP-2 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;A deficiency of mannan-binding lectin-associated protease 2 (MASP-2) has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/37\">",
"     37",
"    </a>",
"    ]. Severe pneumococcal pneumonia and immune disorders, including ulcerative colitis and erythema multiforme bullosum, were reported in one patient with this abnormality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Ficolin-3 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient homozygous for a frameshift mutation of the ficolin-3 gene (FCN3) resulting in the absence of serum ficolin-3 has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/38\">",
"     38",
"    </a>",
"    ]. This patient had recurrent severe pulmonary infections since early childhood that resulted in bronchiectasis, pulmonary fibrosis, and progressive obstructive lung disease. He also had recurrent warts on his fingers and brain abscesses beginning in early adulthood. He had normal activity of the three complement pathways, but lacked complement deposition on acetylated structures. His heterozygous parents and a sibling were healthy, which suggests an autosomal recessive pattern of inheritance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OTHER DEFICIENCIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Complement inhibitor proteins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically important deficiencies of complement inhibitor proteins include those of C1 inhibitor, factor H, factor I, and complement receptor 3. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10854?source=see_link\">",
"     \"Regulators and receptors of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     C1 inhibitor deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of C1 inhibitor gives rise to hereditary angioedema, which is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33864?source=see_link\">",
"     \"Hereditary angioedema: Pathogenesis and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19272?source=see_link\">",
"     \"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29658?source=see_link\">",
"     \"Hereditary angioedema: Prevention of attacks\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33657?source=see_link\">",
"     \"Hereditary angioedema: Treatment of acute attacks\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Factor H, factor I, or membrane cofactor protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma factors H and I regulate C3, and a complete deficiency of either factor allows the alternative pathway to fire to exhaustion and thereby consume C3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/39\">",
"     39",
"    </a>",
"    ]. As a result, afflicted individuals exhibit symptoms and findings similar to that of C3 deficient patients, ie, recurrent infections and glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. In homozygous factor H or factor I deficiency, factor B is also low, while it is normal in isolated C3 deficiency. Protein levels of factor H or factor I should be assessed.",
"   </p>",
"   <p>",
"    Purified factor H and factor I are not available for infusion. There are no long-term studies of supplying these regulatory proteins by plasma transfusions. Infusion of plasma, which contains factors H and I, temporarily alleviates clinical symptoms and normalize the C3 level.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Heterozygous mutations in the genes for factor H, factor I, as well as those for membrane cofactor protein (MCP or CD46) have been associated with atypical (non-diarrheal) hemolytic uremic syndrome (aHUS) (",
"      <a class=\"graphic graphic_table graphicRef72700 \" href=\"mobipreview.htm?27/6/27755\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/42,43\">",
"       42,43",
"      </a>",
"      ]. Approximately 50 percent of patients with aHUS have a defect in one of these three complement regulatory proteins. In addition, these patients may have autoantibodies to factor H. This is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/52/43849?source=see_link\">",
"       \"Atypical hemolytic uremic syndrome in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An association exists between a polymorphism in factor H and age-related macular degeneration (AMD). The 402H variant (the uncommon allele) is carried by about 30 percent of the population. This variant increases the risk of developing AMD by 1.5- to threefold if heterozygous, and up to 10-fold if homozygous. It accounts for approximately 50 percent of the attributable genetic risk for AMD. This association is most consistent with a decrease in functional activity of the variant in controlling alternative pathway activation in the retina. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6986?source=see_link&amp;anchor=H9#H9\">",
"       \"Age-related macular degeneration: Clinical presentation, etiology, and diagnosis\", section on 'Genetic factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Also described is an alteration in the promoter region of the gene encoding factor H, which results in higher serum levels of factor H, less complement activity, and increased susceptibility to meningococcal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27432?source=see_link\">",
"       \"Epidemiology of Neisseria meningitidis infection\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Complement receptor 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inherited deficiency of complement receptor 3 (CR3), an integrin that binds inactive iC3b as well as other noncomplement ligands, causes recurrent and severe bacterial (Staphylococcus aureus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Pseudomonas) infections. This condition, known as leukocyte adhesion deficiency syndrome-I",
"    <span class=\"nowrap\">",
"     (CD11/CD18",
"    </span>",
"    deficiency), may present shortly after birth with delayed separation of the umbilical cord and development of omphalitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/26/22953?source=see_link\">",
"     \"Leukocyte adhesion deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Decay accelerating factor and CD59 deficiency in paroxysmal nocturnal hemoglobinuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of proteins are tethered to cells by a glycophosphatidylinositol (GPI or \"greasy foot\") anchor. A mutation in bone marrow stem cells of an enzyme on the X chromosome required to produce this anchor causes a deficiency of the GPI-linked, complement regulatory proteins decay accelerating factor (DAF) and CD59 on blood cells. The normal function of these proteins is the inhibition of complement activation by disassociating C3 convertases (DAF) and by blocking binding of C8 and C9 to the assembling MAC (CD59). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10854?source=see_link\">",
"     \"Regulators and receptors of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Deficiency of DAF and CD59 predisposes cells to lysis, especially red blood cells. The disease process is known as paroxysmal nocturnal hemoglobinuria. Hemolytic anemia, mediated by the unchecked complement system, is the most prominent clinical manifestation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13593?source=see_link\">",
"     \"Pathogenesis of paroxysmal nocturnal hemoglobinuria: Missing cell proteins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CARE OF THE COMPLEMENT DEFICIENT PATIENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Vigilance for early signs of serious infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with complement deficiencies who have experienced one or more serious infections should wear a medical identification badge identifying their specific condition.",
"   </p>",
"   <p>",
"    Patients should be instructed to seek medical assistance for high fevers, stiff neck, severe headache, severe myalgias, or purpuric rash. Once they have had meningococcal disease, most patients are very cognizant of the symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with complement deficiency may receive all routine vaccines safely and are not at increased risk for adverse reactions to live viral vaccines. It is important to ensure that patients are vaccinated against those diseases for which they are at increased risk, especially the meningococcus and the pneumococcus.",
"   </p>",
"   <p>",
"    When vaccinating patients with complement deficiency, conjugate vaccines are preferred over pure polysaccharide vaccines.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vaccination against meningococcus is particularly critical for patients deficient in properdin and for those deficient in C5, C6, C7, C8, or C9 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/46\">",
"       46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23050?source=see_link\">",
"       \"Meningococcal vaccines\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The pneumococcal and Hib conjugated vaccines are also indicated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/47\">",
"       47",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=see_link\">",
"       \"Pneumococcal vaccination in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/31/42489?source=see_link&amp;anchor=H2#H2\">",
"       \"Prevention of Haemophilus influenzae infection\", section on 'Immunization'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Replacement therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;With rare exceptions, complement deficient patients are not treated with regular plasma infusions, because this is impractical, and over a lifetime would be associated with risk of blood-borne diseases. In addition, there is a risk of the development of antibody against the missing component.",
"   </p>",
"   <p>",
"    A patient with C1q deficiency was treated with fresh frozen plasma infusions over a 10 year period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/48\">",
"     48",
"    </a>",
"    ]. A small number of cases of C2 deficiency and refractory lupus have been successfully treated with plasma replacement therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42920/abstract/49\">",
"     49",
"    </a>",
"    ]. However, most patients with C2 deficiency SLE have mild to moderate disease and respond to standard therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Homozygous deficiencies in complement components are rare. The main clinical manifestations are autoimmune disorders, recurrent infections with encapsulated bacteria, or both.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Deficiencies in the early components of the classical complement pathway (ie, C1q, C1r, C1s, C4, and C2) predispose patients to autoimmune disorders, particularly systemic lupus erythematosus (SLE). Recurrent infections may also be seen in these deficiencies. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Specific disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Deficiencies in later components of the classical complement pathway predispose patients to recurrent infections, especially pneumococcus and H. influenzae (with C3 deficiency) and Neisserial infections (with C5-C9 deficiencies). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Specific disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The CH50 assay is an effective screening test for a complete deficiency of a component of the classical pathway. Complete deficiency generally yields a very low or undetectable CH50 value (with the exception of complete C9 deficiency). Individuals with heterozygous deficiencies (who are usually healthy) have normal CH50 values (with the exception of partial C2 deficiency). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Screening CH50 and interpretation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Properdin is the most common component of the alternative pathway to be deficient. Properdin deficiency is X-linked and presents in males as a familial predisposition to Neisserial infections, especially meningitis. The alternative pathway AH50 assay is a screen. Inherited defects in Factor D have only been described in a few case reports. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Alternative pathway deficiencies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Partial deficiencies in complement inhibitors (ie, factor H, factor I, or MCP) predispose to atypical HUS. A polymorphism in factor H is associated with increased risk for age-related macular degeneration. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Complement inhibitor proteins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of complement deficient patients involves education of the patient in vigilance for early signs of infection and vaccination against the organisms to which the patient is susceptible. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Care of the complement deficient patient'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/1\">",
"      Botto M, Kirschfink M, Macor P, et al. Complement in human diseases: Lessons from complement deficiencies. Mol Immunol 2009; 46:2774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/2\">",
"      Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/3\">",
"      O'Neil KM. Complement deficiency. Clin Rev Allergy Immunol 2000; 19:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/4\">",
"      Barilla-LaBarca ML, Gioffr&egrave; D, Zanichelli A, et al. Acquired C1 esterase inhibitor deficiency in two patients presenting with a lupus-like syndrome and anticardiolipin antibodies. Arthritis Rheum 2002; 47:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/5\">",
"      Pickering MC, Botto M, Taylor PR, et al. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000; 76:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/6\">",
"      Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 2004; 113:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/7\">",
"      Colten HR, Rosen FS. Complement deficiencies. Annu Rev Immunol 1992; 10:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/8\">",
"      Wu YL, Yang Y, Chung EK, et al. Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res 2008; 123:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/9\">",
"      Atkinson JP, Gorman JC, Curd J, et al. Cold dependent activation of complement in systemic lupus erythematosus. A unique cause for a discrepancy between clinical and laboratory parameters. Arthritis Rheum 1981; 24:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/10\">",
"      Khajoee V, Ihara K, Kira R, et al. Founder effect of the C9 R95X mutation in Orientals. Hum Genet 2003; 112:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/11\">",
"      Wouters D, van Schouwenburg P, van der Horst A, et al. High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's. Mol Immunol 2009; 46:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/12\">",
"      Zhang S, Wang S, Li Q, et al. Capillary leak syndrome in children with C4A-deficiency undergoing cardiac surgery with cardiopulmonary bypass: a double-blind, randomised controlled study. Lancet 2005; 366:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/13\">",
"      J&ouml;nsson G, Truedsson L, Sturfelt G, et al. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 2005; 84:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/14\">",
"      Hauck F, Lee-kirsch MA, Aust D, et al. Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab. Arthritis Care Res (Hoboken) 2011; 63:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/15\">",
"      Glass D, Raum D, Gibson D, et al. Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest 1976; 58:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/16\">",
"      L&oacute;pez-Lera A, Garrido S, de la Cruz RM, et al. Molecular characterization of three new mutations causing C5 deficiency in two non-related families. Mol Immunol 2009; 46:2340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/17\">",
"      Parham KL, Roberts A, Thomas A, et al. Prevalence of mutations leading to complete C6 deficiency (C6Q0) in the Western Cape, South Africa and detection of novel mutations leading to C6Q0 in an Irish family. Mol Immunol 2007; 44:2756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/18\">",
"      Zhu Z, Atkinson TP, Hovanky KT, et al. High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA. Clin Exp Immunol 2000; 119:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/19\">",
"      Pickering MC, Macor P, Fish J, et al. Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. Rheumatology (Oxford) 2008; 47:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/20\">",
"      Kojima T, Horiuchi T, Nishizaka H, et al. Genetic basis of human complement C8 alpha-gamma deficiency. J Immunol 1998; 161:3762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/21\">",
"      Tedesco F, Roncelli L, Petersen BH, et al. Two distinct abnormalities in patients with C8 alpha-gamma deficiency. Low level of C8 beta chain and presence of dysfunctional C8 alpha-gamma subunit. J Clin Invest 1990; 86:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/22\">",
"      Rameix-Welti MA, R&eacute;gnier CH, Bienaim&eacute; F, et al. Hereditary complement C7 deficiency in nine families: subtotal C7 deficiency revisited. Eur J Immunol 2007; 37:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/23\">",
"      Barroso S, Rieubland C, Jos&eacute; &aacute;lvarez A, et al. Molecular defects of the C7 gene in two patients with complement C7 deficiency. Immunology 2006; 118:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/24\">",
"      Chiang YC, Shyur SD, Huang LH, et al. Deficiency of the seventh component of complement in a Taiwanese boy. J Formos Med Assoc 2006; 105:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/25\">",
"      Nishizaka H, Horiuchi T, Zhu ZB, et al. Genetic bases of human complement C7 deficiency. J Immunol 1996; 157:4239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/26\">",
"      Thomas AD, Orren A, Connaughton J, et al. Characterization of a large genomic deletion in four Irish families with C7 deficiency. Mol Immunol 2012; 50:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/27\">",
"      Barroso S, L&oacute;pez-Trascasa M, Merino D, et al. C7 deficiency and meningococcal infection susceptibility in two spanish families. Scand J Immunol 2010; 72:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/28\">",
"      Kuijpers TW, Nguyen M, Hopman CT, et al. Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease. Mol Immunol 2010; 47:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/29\">",
"      Sp&auml;th PJ, Sj&ouml;holm AG, Fredrikson GN, et al. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol 1999; 118:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/30\">",
"      Sprong T, Roos D, Weemaes C, et al. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 2006; 107:4865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/31\">",
"      Bathum L, Hansen H, Teisner B, et al. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol Immunol 2006; 43:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/32\">",
"      Fijen CA, van den Bogaard R, Schipper M, et al. Properdin deficiency: molecular basis and disease association. Mol Immunol 1999; 36:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/33\">",
"      Fijen CA, Kuijper EJ, te Bulte MT, et al. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis 1999; 28:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/34\">",
"      Schejbel L, Rosenfeldt V, Marquart H, et al. Properdin deficiency associated with recurrent otitis media and pneumonia, and identification of male carrier with Klinefelter syndrome. Clin Immunol 2009; 131:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/35\">",
"      Sallenbach S, Thiel S, Aebi C, et al. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 2011; 22:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/36\">",
"      Endo Y, Matsushita M, Fujita T. The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol 2011; 43:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/37\">",
"      Stengaard-Pedersen K, Thiel S, Gadjeva M, et al. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N Engl J Med 2003; 349:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/38\">",
"      Munthe-Fog L, Hummelsh&oslash;j T, Honor&eacute; C, et al. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med 2009; 360:2637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/39\">",
"      Walport MJ, Lachmann PJ. Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum 1988; 31:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/40\">",
"      Fakhouri F, Fr&eacute;meaux-Bacchi V, No&euml;l LH, et al. C3 glomerulopathy: a new classification. Nat Rev Nephrol 2010; 6:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/41\">",
"      Lesher AM, Song WC. Review: Complement and its regulatory proteins in kidney diseases. Nephrology (Carlton) 2010; 15:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/42\">",
"      Richards A, Kavanagh D, Atkinson JP. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration. Adv Immunol 2007; 96:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/43\">",
"      Jokiranta TS, Zipfel PF, Fremeaux-Bacchi V, et al. Where next with atypical hemolytic uremic syndrome? Mol Immunol 2007; 44:3889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/44\">",
"      Warwicker P, Goodship TH, Goodship JA. Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics 1997; 46:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/45\">",
"      Haralambous E, Dolly SO, Hibberd ML, et al. Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis 2006; 38:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/46\">",
"      Platonov AE, Vershinina IV, Kuijper EJ, et al. Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine. Vaccine 2003; 21:4437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/47\">",
"      J&ouml;nsson G, Lood C, Gullstrand B, et al. Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation. Clin Immunol 2012; 144:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/48\">",
"      Mehta P, Norsworthy PJ, Hall AE, et al. SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience. Rheumatology (Oxford) 2010; 49:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42920/abstract/49\">",
"      Erlendsson K, Traustad&oacute;ttir K, Freysd&oacute;ttir J, et al. Reciprocal changes in complement activity and immune-complex levels during plasma infusion in a C2-deficient SLE patient. Lupus 1993; 2:161.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3962 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42920=[""].join("\n");
var outline_f41_58_42920=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSICAL PATHWAY DEFICIENCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetics of deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications for screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Screening CH50 and interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Specific disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - C1 deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - C4 deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - C2 deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - C3 deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - C5-C9 deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ALTERNATIVE PATHWAY DEFICIENCIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LECTIN PATHWAY DEFICIENCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      MBL deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MASP-2 deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Ficolin-3 deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OTHER DEFICIENCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Complement inhibitor proteins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - C1 inhibitor deficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Factor H, factor I, or membrane cofactor protein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Complement receptor 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Decay accelerating factor and CD59 deficiency in paroxysmal nocturnal hemoglobinuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CARE OF THE COMPLEMENT DEFICIENT PATIENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Vigilance for early signs of serious infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Replacement therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3962\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3962|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/54/34669\" title=\"figure 1\">",
"      Alternative complement pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3962|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/6/27755\" title=\"table 1\">",
"      Heterozyg comp def",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/54/29542?source=related_link\">",
"      Acquired disorders of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/52/6986?source=related_link\">",
"      Age-related macular degeneration: Clinical presentation, etiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43433?source=related_link\">",
"      Approach to the adult with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=related_link\">",
"      Approach to the child with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/52/43849?source=related_link\">",
"      Atypical hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/52/37704?source=related_link\">",
"      Clinical manifestations of meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/51/43833?source=related_link\">",
"      Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/59/11190?source=related_link\">",
"      Complement pathways",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/16/3338?source=related_link\">",
"      Diagnosis and differential diagnosis of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/50/27432?source=related_link\">",
"      Epidemiology of Neisseria meningitidis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/34/39462?source=related_link\">",
"      Gonococcal infection in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19272?source=related_link\">",
"      Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33864?source=related_link\">",
"      Hereditary angioedema: Pathogenesis and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29658?source=related_link\">",
"      Hereditary angioedema: Prevention of attacks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/55/33657?source=related_link\">",
"      Hereditary angioedema: Treatment of acute attacks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/26/22953?source=related_link\">",
"      Leukocyte adhesion deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/14/19690?source=related_link\">",
"      Mannose-binding lectin deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23050?source=related_link\">",
"      Meningococcal vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/32/7688?source=related_link\">",
"      Microbiology and pathobiology of Neisseria meningitidis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=related_link\">",
"      Overview and clinical assessment of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/31/41464?source=related_link\">",
"      Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/17/13593?source=related_link\">",
"      Pathogenesis of paroxysmal nocturnal hemoglobinuria: Missing cell proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/31/42489?source=related_link\">",
"      Prevention of Haemophilus influenzae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/38/10854?source=related_link\">",
"      Regulators and receptors of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/23/8568?source=related_link\">",
"      The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_58_42921="Acute bacterial rhinosinusitis in children: Microbiology and treatment";
var content_f41_58_42921=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute bacterial rhinosinusitis in children: Microbiology and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Ellen R Wald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/58/42921/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/58/42921/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rhinosinusitis is a disease that results from infection of one or more of the paranasal sinuses. A viral infection associated with the common cold is the most frequent etiology of acute rhinosinusitis, more properly called viral rhinosinusitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22281?source=see_link\">",
"     \"The common cold in children: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13146?source=see_link\">",
"     \"The common cold in children: Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uncomplicated viral rhinosinusitis usually resolves without treatment in 7 to 10 days. Although untreated acute bacterial rhinosinusitis (ABRS) also may resolve without treatment, treatment with antibiotics hastens recovery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It is important to distinguish between uncomplicated viral rhinosinusitis and ABRS to prevent unnecessary use of antibiotics (",
"    <a class=\"graphic graphic_table graphicRef83921 \" href=\"mobipreview.htm?39/48/40715\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The microbiology and treatment of ABRS in children will be discussed here. The clinical features and diagnosis of ABRS in children and acute sinusitis and rhinosinusitis in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H496645221\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of acute bacterial rhinosinusitis in children is characterized by [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent symptoms (nasal discharge or cough or both) for &gt;10 days without improvement, or",
"     </li>",
"     <li>",
"      Severe symptoms (onset with temperature of &ge;39&ordm;C [102.2&ordm;F] and purulent nasal discharge for &ge;3 consecutive days), or",
"     </li>",
"     <li>",
"      Worsening symptoms (respiratory symptoms that worsen after initial improvement) or onset of new fever or severe headache",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H9#H9\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Acute bacterial rhinosinusitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704286561\">",
"    <span class=\"h2\">",
"     Common pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     Streptococcus pneumoniae",
"    </em>",
"    ,",
"    <em>",
"     Haemophilus influenzae",
"    </em>",
"    (nontypeable), and",
"    <em>",
"     Moraxella catarrhalis",
"    </em>",
"    are the predominant causes of acute bacterial rhinosinusitis (ABRS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Culture of material aspirated from the sinus yielding at least 10",
"    <sup>",
"     4",
"    </sup>",
"    colony-forming",
"    <span class=\"nowrap\">",
"     units/mL",
"    </span>",
"    of bacteria is the gold standard for determining the etiology of ABRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/12\">",
"     12",
"    </a>",
"    ]. However, sinus aspiration is an invasive procedure that is not routinely performed in children with uncomplicated ABRS. Studies of the microbiology of ABRS in which sinus aspirates were obtained from children with uncomplicated ABRS were performed before the widespread development of antibiotic resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/5\">",
"     5",
"    </a>",
"    ]. However, because acute otitis media (AOM) and ABRS have similar pathogenesis and microbiology, data generated from cultures of middle-ear fluid obtained by tympanocentesis from children with AOM can be used as a surrogate for cultures of the paranasal sinuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Before the availability of pneumococcal conjugate vaccines (2000), the relative proportion of middle ear isolates in cases of AOM was 55:35:10 for",
"    <em>",
"     S. pneumoniae, H. influenzae",
"    </em>",
"    and",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    , respectively. Studies of the microbiology of pediatric AOM after the pneumococcal conjugate vaccine was introduced into the childhood immunization schedule indicate that",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    is isolated in approximately 45 percent of episodes in which an organism is cultured,",
"    <em>",
"     H. influenzae",
"    </em>",
"    (predominantly nontypeable",
"    <em>",
"     H. influenzae",
"    </em>",
"    ) in about the same, and",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    in the remainder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. There was a brief resurgence in the recovery of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    when penicillin-resistant serotype 19A emerged. However, this has resolved since initiation of immunization with the 13-valent pneumococcal conjugate vaccine (in 2010), which includes serotype 19A. A study in which tympanocentesis was performed in children with AOM during 2010 and 2011 indicates that nontypeable",
"    <em>",
"     H. influenzae",
"    </em>",
"    is currently the most frequent isolate in cases of AOM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29642?source=see_link&amp;anchor=H16#H16\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies have reported isolation of",
"    <em>",
"     S. aureus",
"    </em>",
"    from sinus aspirates (obtained endoscopically) or from cultures of the middle meatus in children (most of whom had chronic sinusitis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. However, these studies must be interpreted with caution because of methodologic limitations (eg, unknown indication for obtaining culture, lack of quantification, and possibility of contamination from the nasal cavity) and because cultures of the middle meatus have not been established as a reliable surrogate for maxillary sinus aspirates in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704286587\">",
"    <span class=\"h2\">",
"     Antimicrobial susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proportion of isolates of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    that are nonsusceptible to penicillin varies from community to community. Isolates obtained from surveillance centers nationwide indicate that 10 to 15 percent of upper respiratory tract isolates of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    are nonsusceptible to penicillin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. However, values as high as 50 to 60 percent have been reported in some areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Of the organisms that are resistant, approximately one-half are highly resistant to penicillin and the remaining one-half are intermediate in resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/22,23,25-28\">",
"     22,23,25-28",
"    </a>",
"    ]. Between 10 and 42 percent of",
"    <em>",
"     H. influenzae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/25-28\">",
"     25-28",
"    </a>",
"    ] and close to 100 percent of",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    are likely to be beta-lactamase positive and nonsusceptible to",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    . A study of middle ear isolates obtained from children with AOM during 2010-2011 found a decreasing recovery of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    (including penicillin-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    ) and increasing recovery of beta-lactamase producing",
"    <em>",
"     H. influenzae",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/81?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risks for resistant pathogens include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4,29-32\">",
"     4,29-32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Living in an area with high endemic rates of invasive penicillin non-susceptible",
"      <em>",
"       S. pneumoniae",
"      </em>",
"     </li>",
"     <li>",
"      Age &lt;2 years",
"     </li>",
"     <li>",
"      Daycare attendance",
"     </li>",
"     <li>",
"      Antibiotic therapy within the past month",
"     </li>",
"     <li>",
"      Hospitalization within the past five days",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H742622640\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with uncomplicated acute bacterial rhinosinusitis (ABRS) can usually be managed by their primary care provider. Consultation with a specialist (eg, infectious disease, otolaryngology, immunology) may be warranted in the following circumstances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4,33,34\">",
"     4,33,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracranial or orbital complications (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H13#H13\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Complications'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Need for sinus aspiration (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H495182753#H495182753\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Microbiologic studies'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Isolation of resistant or rare pathogens from sinus aspirate",
"     </li>",
"     <li>",
"      Diagnosed or suspected immunodeficiency",
"     </li>",
"     <li>",
"      Recurrent ABRS, particularly if it exacerbates underlying pulmonary conditions (eg, asthma)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EMPIRIC ANTIBIOTIC THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656460459\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that children with a clinical presentation that is compatible with acute bacterial rhinosinusitis (ABRS) be treated with antimicrobial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3,4\">",
"     3,4",
"    </a>",
"    ] (see",
"    <a class=\"local\" href=\"#H496645221\">",
"     'Clinical presentations'",
"    </a>",
"    above). Empiric antibiotic therapy should be initiated as soon as possible. Prompt initiation of therapy may shorten the duration of illness. Whether treatment of ABRS prevents serious complications has not been adequately studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unfortunately, there have been no randomized, placebo-controlled trials of antibiotic treatment for ABRS that have used pre- and post-treatment quantitative sinus aspirate culture as the standard for diagnosis and cure. Studies that use clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiologic criteria for diagnosis and outcome may underestimate the benefit of antibiotic therapy because they are likely to include at least some patients with self-limited uncomplicated viral upper respiratory tract infection.",
"   </p>",
"   <p>",
"    Randomized trials evaluating antibiotics versus placebo for the treatment of ABRS in children have conflicting results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/1,2,35\">",
"     1,2,35",
"    </a>",
"    ]. In a meta-analysis of three trials including a total of 310 children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/1,2,35\">",
"     1,2,35",
"    </a>",
"    ], the rate of improvement or cure was greater among children treated with antibiotics than placebo (78.5 versus 59.7 percent, odds ratio 2.52, 95% CI 1.52-4.18) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ]. In the only study that was performed after the development of widespread antibiotic-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    , treatment with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    was associated with increased rates of cure (50 versus 14 percent) and decreased rates of treatment failure (14 versus 68 percent) compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/2\">",
"     2",
"    </a>",
"    ]. Adverse events, predominantly self-limited diarrhea, were more common in the treatment group (44 versus 14 percent), but only three patients in the treatment group discontinued therapy because of adverse effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Outpatient therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with ABRS can be treated as outpatients. Those who are toxic-appearing (eg, lethargic, poorly perfused, with cardiorespiratory compromise) or have complications or suspected complications should be admitted for parenteral therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H742621521\">",
"     'Inpatient therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Antibiotics that are used to treat ABRS must provide antibacterial coverage for",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    ,",
"    <em>",
"     H. influenzae",
"    </em>",
"    , and",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Microbiology'",
"    </a>",
"    above). Additional factors in the choice of therapy include the severity of illness, risk of complications, likelihood of infection with a resistant organism, antimicrobial spectrum, acceptability, dosing convenience, and adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4,11\">",
"     4,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    as the first-line agent for the treatment of ABRS in children because of its spectrum of activity, effectiveness, and safety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/2,4,36\">",
"     2,4,36",
"    </a>",
"    ]. Less comprehensive alternatives include third-generation cephalosporins (eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"     cefpodoxime",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"     cefdinir",
"    </a>",
"    ).",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"     Levofloxacin",
"    </a>",
"    may be used when there is no other safe and effective alternative (eg, in patients who have anaphylaxis with or are intolerant of beta-lactams) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/37\">",
"     37",
"    </a>",
"    ]. Levofloxacin typically remains active against multi-drug resistant pneumococci with high level resistance to penicillin or third-generation cephalosporins and is an option for treatment when patients have failed first-line therapy. (See",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23768?source=see_link\">",
"     \"Levofloxacin (systemic): Pediatric drug information\"",
"    </a>",
"    .)",
"    <span class=\"nowrap\">",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656458098\">",
"    <span class=\"h3\">",
"     Mild/moderate disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild/moderate",
"    ABRS is characterized by temperature &lt;39&deg;C (102.2&deg;F) and lack of systemic signs or a clinical severity score &lt;8 (",
"    <a class=\"graphic graphic_table graphicRef83453 \" href=\"mobipreview.htm?13/30/13804\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For children with uncomplicated",
"    <span class=\"nowrap\">",
"     mild/moderate",
"    </span>",
"    ABRS who have no risks for antibiotic resistance, we suggest empiric antimicrobial therapy with standard dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    rather than other oral antibiotics (eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    , fluoroquinolones, macrolides,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/54/12136?source=see_link\">",
"     doxycycline",
"    </a>",
"    , or second- or third-generation cephalosporins) (",
"    <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"     table 3",
"    </a>",
"    ) (see",
"    <a class=\"local\" href=\"#H704286587\">",
"     'Antimicrobial susceptibility'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      45",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component orally in 2 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For children with uncomplicated",
"    <span class=\"nowrap\">",
"     mild/moderate",
"    </span>",
"    ABRS who have one or more risks for antibiotic resistance, we suggest treatment with high-dose rather than standard-dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (",
"    <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"     table 3",
"    </a>",
"    ) (see",
"    <a class=\"local\" href=\"#H704286587\">",
"     'Antimicrobial susceptibility'",
"    </a>",
"    above)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      90",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component orally in two divided doses (maximum daily dose 4 g)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    rather than",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    because the addition of clavulanate improves coverage for",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    -resistant",
"    <em>",
"     H. influenzae",
"    </em>",
"    and",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    . Beta-lactamase producing nontypeable",
"    <em>",
"     H. influenzae",
"    </em>",
"    is an increasingly important cause of respiratory tract infection, particularly in children with acute otitis media (the microbiology of which is similar to ABRS since introduction of immunization the 13-valent pneumococcal conjugate vaccine) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4,15,24,26,38,39\">",
"     4,15,24,26,38,39",
"    </a>",
"    ]. However, some experts continue to recommend high-dose amoxicillin (90",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day orally divided in two doses) as initial therapy for mild disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H704286587\">",
"     'Antimicrobial susceptibility'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    High-dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    provides better coverage for penicillin nonsusceptible",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    -resistant non-beta-lactamase producing",
"    <em>",
"     H. influenzae",
"    </em>",
"    than standard dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    -clavulanate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/24\">",
"     24",
"    </a>",
"    ]. However, because of the increased cost and potentially increased side effects, we suggest that high-dose amoxicillin-clavulanate be reserved for children with severe disease or increased risk of antibiotic resistance (particularly penicillin-nonsusceptible",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H704286587\">",
"     'Antimicrobial susceptibility'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In a meta-analysis of randomized trials, fluoroquinolones provided no advantage over beta-lactam antibiotics in the treatment of ABRS in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/41\">",
"     41",
"    </a>",
"    ]. Although fluoroquinolones have a wider spectrum of activity, they are associated with more severe side effects than",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    . In vitro studies have demonstrated high rates of resistance among the most common ABRS pathogens to macrolides,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and variable rates of resistance to second- and third-generation cephalosporins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/24,38,39,42-44\">",
"     24,38,39,42-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656458106\">",
"    <span class=\"h3\">",
"     Severe disease or risk for severe disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe disease is characterized by temperature &ge;39&deg;C (102.2&deg;F) and other systemic signs or a clinical severity score &ge;8 (",
"    <a class=\"graphic graphic_table graphicRef83453 \" href=\"mobipreview.htm?13/30/13804\">",
"     table 2",
"    </a>",
"    ). Children with immune compromising conditions (eg, human immunodeficiency virus) are at increased risk for severe disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For children with severe ABRS or risk for severe ABRS, we suggest treatment with high-dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (",
"    <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      90",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component orally in two divided doses (maximum daily dose 4 g)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest high-dose rather than standard-dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    for children with severe ABRS to provide coverage for penicillin-nonsusceptible",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    in addition to",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    -resistant",
"    <em>",
"     H. influenzae",
"    </em>",
"    and",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Microbiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Less comprehensive alternative regimens include a third-generation cephalosporin such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"     cefpodoxime",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"     cefdinir",
"    </a>",
"    . The advanced generation cephalosporins have been considered less comprehensive because they fall short in covering penicillin-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    . However, if penicillin-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    are diminishing as causes of acute otitis media and acute bacterial sinusitis (since the introduction of immunization with the 13-valent pneumococcal conjugate vaccine) this may be less of an issue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/17\">",
"     17",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"     Levofloxacin",
"    </a>",
"    , which has a comprehensive spectrum, should be reserved for cases in which there are no alternative choices (see",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23768?source=see_link\">",
"     \"Levofloxacin (systemic): Pediatric drug information\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"       Cefpodoxime",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 hours",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"       Cefdinir",
"      </a>",
"      14",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 or 24 hours,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"       Levofloxacin",
"      </a>",
"      10 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 to 24 hours; levofloxacin should be reserved for cases in which there is no other safe and effective alternative [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H689793379\">",
"    <span class=\"h3\">",
"     Penicillin allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternatives to",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    for children with an allergy to penicillin depend upon the type of allergy (",
"    <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef80466 \" href=\"mobipreview.htm?13/11/13500\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=see_link\">",
"     \"Allergy to penicillins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/19/15672?source=see_link\">",
"     \"Penicillin-allergic patients: Use of cephalosporins, carbapenems, and monobactams\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For children with uncomplicated ABRS who have a type I allergy (",
"      <a class=\"graphic graphic_table graphicRef80466 \" href=\"mobipreview.htm?13/11/13500\">",
"       table 4",
"      </a>",
"      ) to penicillin, we suggest",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"       levofloxacin",
"      </a>",
"      10 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 or 24 hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4,37\">",
"       4,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For children with uncomplicated ABRS who have a non-type I allergy to penicillin, we suggest therapy with a third-generation cephalosporin (eg,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"       cefpodoxime",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"       cefdinir",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"       Cefpodoxime",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 hours,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"       Cefdinir",
"      </a>",
"      14",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 or 24 hours",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H689793371\">",
"    <span class=\"h3\">",
"     Vomiting",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single dose of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (maximum dose 2",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    intravenously or intramuscularly can be used in children with uncomplicated ABRS and vomiting that precludes administration of oral antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Therapy with an oral antibiotic should be initiated 24 hours later, provided the vomiting has resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H742621521\">",
"    <span class=\"h2\">",
"     Inpatient therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for hospitalization and parenteral antibiotics include toxic-appearance (eg, lethargic, poorly perfused, cardiorespiratory compromise) complications or suspected complications, and treatment failure with outpatient therapy (ie, high-dose",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    , third-generation cephalosporin, or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H13#H13\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H656460010\">",
"     'Treatment failure'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Sinus imaging should be performed before initiation of intravenous therapy to confirm the diagnosis (for patients who were not previously imaged). Sinus imaging with contrast-enhanced computed tomography should be performed in patients with symptoms or signs of intracranial or orbital complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H13#H13\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sinus aspiration (performed by a specialist) for Gram stain, aerobic and anaerobic culture, and antimicrobial susceptibility testing should be obtained in hospitalized children with complications or outpatient failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4,45\">",
"     4,45",
"    </a>",
"    ]. Isolation of a pathogen and antimicrobial susceptibilities enable better targeting of antimicrobial therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H495182753#H495182753\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Microbiologic studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Empiric therapy for children hospitalized with ABRS should provide coverage for highly resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    -resistant",
"    <em>",
"     H. influenzae",
"    </em>",
"    and",
"    <em>",
"     M. catarrhalis",
"    </em>",
"    .",
"    <em>",
"    </em>",
"    The regimen should be adjusted based upon clinical response and culture results.",
"   </p>",
"   <p>",
"    For children hospitalized with ABRS, we suggest empiric antibiotic therapy with one of the following regimens (",
"    <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?29/3/29750?source=see_link\">",
"       Ampicillin-sulbactam",
"      </a>",
"      200 to 400",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day intravenously (IV) divided every six hours (maximum 8 g",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      component per day),",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/23/40310?source=see_link\">",
"       Cefotaxime",
"      </a>",
"      100 to 200",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every six hours (maximum 8 g per day),",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/19/312?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every 12 hours (maximum 2 g per day),",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"       Levofloxacin",
"      </a>",
"      10 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every 12 to 24 hours (maximum 500 mg per day); levofloxacin should be reserved for cases in which there is no other safe and effective alternative [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/37\">",
"       37",
"      </a>",
"      ]. (See",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23768?source=see_link\">",
"       \"Levofloxacin (systemic): Pediatric drug information\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These suggestions are based on in vitro susceptibilities. There are no studies comparing intravenous antibiotic regimens for the treatment of ABRS in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H496645662\">",
"    <span class=\"h1\">",
"     RESPONSE TO THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656460002\">",
"    <span class=\"h2\">",
"     Improvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with acute bacterial rhinosinusitis (ABRS) who are treated with an appropriate antimicrobial agent respond within 48 to 72 hours with improvement of symptoms and general well-being [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. We generally continue antimicrobial therapy for total of 10 days in children whose symptoms improve within three to five days of initial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9804910\">",
"     'Duration'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656460010\">",
"    <span class=\"h2\">",
"     Treatment failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment failure is defined by worsening within three days or failure to improve after three to five days of antimicrobial therapy. Causes of treatment failure may include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Resistant pathogen (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Complication (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H13#H13\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Complications'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Noninfectious etiology (eg, foreign body, structural abnormality) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H21#H21\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Differential diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Initial presentation of immune deficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/47\">",
"       47",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=see_link\">",
"       \"Approach to the child with recurrent infections\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1034758001\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF TREATMENT FAILURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656459852\">",
"    <span class=\"h2\">",
"     In outpatients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children with uncomplicated acute bacterial rhinosinusitis (ABRS) who are initially treated as outpatients and whose symptoms worsen after two to three days or fail to improve after three to five days of initial antimicrobial treatment, we suggest broadening antimicrobial coverage or switching to a different class of antibiotic. Potential regimens depend on what was used initially and might include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       Amoxicillin-clavulanate",
"      </a>",
"      90",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component orally in two divided doses (maximum daily dose 4 g) (for patients initially treated with low-dose amoxicillin or amoxicillin-clavulanate)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/19/312?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      50",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day intramuscularly for one to three days, followed by",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      90",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of the",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"       amoxicillin",
"      </a>",
"      component to complete 10 to 14 days,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"       Cefpodoxime",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 hours",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"       Cefdinir",
"      </a>",
"      14",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 or 24 hours,",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"       Levofloxacin",
"      </a>",
"      10 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day orally divided every 12 or 24 hours; levofloxacin should be reserved for cases in which there is no other safe and effective alternative [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/37\">",
"       37",
"      </a>",
"      ]. (See",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23768?source=see_link\">",
"       \"Levofloxacin (systemic): Pediatric drug information\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Imaging",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sinus aspiration may be indicated to confirm the diagnosis, evaluate complications, and tailor therapy, particularly for children whose symptoms have not improved or have worsened after three to five days of initial antibiotics and another three to five days of broadened coverage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H493278515#H493278515\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Complicated ABRS'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link&amp;anchor=H495182753#H495182753\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Microbiologic studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hospital admission for a trial of intravenous therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    consultation with a specialist (eg, infectious disease, otolaryngology) may be warranted for children with ABRS who fail to improve after second-line therapy. (See",
"    <a class=\"local\" href=\"#H742621521\">",
"     'Inpatient therapy'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H742622640\">",
"     'Indications for referral'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H704286720\">",
"    <span class=\"h2\">",
"     In hospitalized patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to improve or worsening in hospitalized children who are receiving empiric antibiotic therapy warrants additional evaluation, including [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Contrast-enhanced computed tomography imaging (or magnetic resonance imaging) to exclude orbital and intracranial complications (if not performed previously).",
"     </li>",
"     <li>",
"      Quantitative sinus aspirate cultures if they were not obtained at the time of admission.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Antimicrobial therapy should be modified according to results of sinus aspirate cultures as soon as the results are available.",
"   </p>",
"   <p>",
"    If sinus aspirate cultures are unavailable or if no pathogens are isolated in an ill child who has not improved despite therapy with a third-generation cephalosporin,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?29/3/29750?source=see_link\">",
"     ampicillin-sulbactam",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/11/33968?source=see_link\">",
"     levofloxacin",
"    </a>",
"    , the addition of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    (to cover highly resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    and",
"    <em>",
"     S. aureus",
"    </em>",
"    ) with or without",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/59/21425?source=see_link\">",
"     metronidazole",
"    </a>",
"    (to cover anaerobes) may be warranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every six hours (maximum 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/59/21425?source=see_link\">",
"       Metronidazole",
"      </a>",
"      30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV divided every six hours (maximum 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consultation with an infectious disease specialist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    otolaryngologist is suggested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9804910\">",
"    <span class=\"h1\">",
"     DURATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal duration of therapy for patients with acute bacterial rhinosinusitis (ABRS) has not been studied systematically. We consider 10 days adequate for children whose symptoms improve within three to five days of initial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/46\">",
"     46",
"    </a>",
"    ]. For those who improve more slowly or who have required escalation of therapy, we continue antibiotic therapy for seven days after the patient becomes free of symptoms (ie, a minimum of 10 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3,49\">",
"     3,49",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H496645662\">",
"     'Response to therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Guidelines from the Infectious Diseases Society of America suggest a 10- to 14-day course for the treatment of ABRS in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SYMPTOMATIC TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Theoretic therapies to improve sinus drainage in patients with acute bacterial rhinosinusitis (ABRS), include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3,50,51\">",
"     3,50,51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Saline nasal irrigation",
"     </li>",
"     <li>",
"      Decongestants (topical or systemic)",
"     </li>",
"     <li>",
"      Antihistamines",
"     </li>",
"     <li>",
"      Intranasal corticosteroids",
"     </li>",
"     <li>",
"      Sinus aspiration",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are limited data regarding the efficacy of these therapies in children with ABRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/51-53\">",
"     51-53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Topical saline",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest topical saline as an adjunctive therapy for children with ABRS. Saline nose drops, saline nasal sprays,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    saline nasal irrigation may help in preventing crust formation and liquefying sinus secretions. In a small randomized trial, nasal saline irrigation improved symptoms, quality of life scores, and peak expiratory flow rates in children with acute sinusitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/54\">",
"     54",
"    </a>",
"    ]. Although the potential benefits for children are not well established by this single trial, topical saline is inexpensive and unlikely to be harmful or impede recovery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Decongestants and antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest the use of decongestants or antihistamines in children with ABRS who do not have an underlying allergic component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3,50\">",
"     3,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although decongestants may reduce tissue edema, improve ostial drainage, and provide symptomatic relief [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/50\">",
"     50",
"    </a>",
"    ], these benefits may be offset by increased viscosity of secretions, decreased blood flow to the nasal mucosa (potentially impeding delivery of antibiotics to the sinuses), and increased irritability in children. Antihistamines also can dry secretions and impair sinus drainage. In a randomized trial in which children with presumed ABRS were treated with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    and a combination decongestant-antihistamine or amoxicillin and placebo, symptoms improved in all children within three days of initiation of antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Intranasal corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest the use of intranasal corticosteroids in children with ABRS who do not have an underlying allergic component. Although nasal corticosteroids theoretically may decrease inflammation of the mucous membranes, which contributes to obstruction of the ostia and impaired mucociliary clearance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/56\">",
"     56",
"    </a>",
"    ], the benefits in randomized trials have been marginal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H656460061\">",
"    <span class=\"h2\">",
"     Sinus aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus aspiration may be warranted for relief of intense headache or facial pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/58/42921/abstract/45\">",
"     45",
"    </a>",
"    ]. Sinus aspiration should be performed by a specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical presentations compatible with a diagnosis of acute bacterial rhinosinusitis (ABRS) include (see",
"      <a class=\"local\" href=\"#H496645221\">",
"       'Clinical presentations'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Persistent symptoms (nasal discharge or cough or both) for &gt;10 days without improvement, or",
"     </li>",
"     <li>",
"      Severe symptoms (onset with temperature of &ge;39&ordm;C [102.2&ordm;F] and purulent nasal discharge for &ge;3 consecutive days), or",
"     </li>",
"     <li>",
"      Worsening symptoms (respiratory symptoms that worsen or onset of fever or severe headache after initial improvement)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       Streptococcus pneumoniae",
"      </em>",
"      ,",
"      <em>",
"       Haemophilus influenzae",
"      </em>",
"      (nontypeable), and",
"      <em>",
"       Moraxella catarrhalis",
"      </em>",
"      are the predominant causes of uncomplicated ABRS in otherwise healthy children. The proportion of",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      isolates nonsusceptible to penicillin varies from community to community. Approximately 10 to 42 percent of",
"      <em>",
"       H. influenzae",
"      </em>",
"      and more than 90 percent of",
"      <em>",
"       M. catarrhalis",
"      </em>",
"      respiratory tract isolates are beta-lactamase producing (ie, resistant to",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that children with a clinical presentation compatible with ABRS be treated with antimicrobial therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Empiric antibiotic therapy should be initiated as soon as possible. (See",
"      <a class=\"local\" href=\"#H656460459\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most children with ABRS can be treated as outpatients. Those who are toxic-appearing (eg, lethargic, poorly perfused, with cardiorespiratory compromise) or have complications or suspected complications should be admitted for parenteral therapy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Outpatient therapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H742621521\">",
"       'Inpatient therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of antibiotic is based upon the degree of severity of illness, recent exposure to antibiotics, and the likelihood of infection with resistant bacteria (",
"      <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"       table 3",
"      </a>",
"      ). We suggest",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      rather than other oral antibiotics as the initial treatment for uncomplicated ABRS in children (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Outpatient therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment failure is defined by worsening after two to three days or failure to improve after three to five days of antimicrobial therapy. Causes of treatment failure may include a resistant pathogen, complication, noninfectious etiology (eg, foreign body), or immune deficiency. (See",
"      <a class=\"local\" href=\"#H656460010\">",
"       'Treatment failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children with uncomplicated ABRS who are initially treated as outpatients and whose symptoms worsen after two to three days or fail to improve after three to five days, we broaden antimicrobial coverage or switch to a different class of antibiotic (",
"      <a class=\"graphic graphic_table graphicRef83454 \" href=\"mobipreview.htm?31/10/31917\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H656459852\">",
"       'In outpatients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We continue antibiotics for 10 days in children whose symptoms improve within three to five days of initial therapy. For children who respond more slowly, we continue antibiotics for seven days after symptoms resolve (a minimum of 10 days). (See",
"      <a class=\"local\" href=\"#H9804910\">",
"       'Duration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest saline nose drops",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      saline nasal sprays for children with ABRS (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest not using decongestants, antihistamines, or nasal corticosteroids (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Symptomatic treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/1\">",
"      Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children: a double-blind, placebo-controlled trial. Pediatrics 1986; 77:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/2\">",
"      Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009; 124:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/3\">",
"      American Academy of Pediatrics. Subcommittee on Management of Sinusitis and Committee on Quality Improvement. Clinical practice guideline: management of sinusitis. Pediatrics 2001; 108:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/4\">",
"      Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54:e72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/5\">",
"      Wald ER, Milmoe GJ, Bowen A, et al. Acute maxillary sinusitis in children. N Engl J Med 1981; 304:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/6\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/7\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg 2006; 135:S31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/8\">",
"      Thomas M, Yawn BP, Price D, et al. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. Prim Care Respir J 2008; 17:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/9\">",
"      Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/10\">",
"      Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 1998; 316:13.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Shapiro NL. Sinusitis. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.201.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/12\">",
"      Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/13\">",
"      Parsons DS, Wald ER. Otitis media and sinusitis: similar diseases. Otolaryngol Clin North Am 1996; 29:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/14\">",
"      Marchisio P, Ghisalberti E, Fusi M, et al. Paranasal sinuses and middle ear infections: what do they have in common? Pediatr Allergy Immunol 2007; 18 Suppl 18:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/15\">",
"      Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010; 29:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/16\">",
"      Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23:829.",
"     </a>",
"    </li>",
"    <li>",
"     Pichichero M, Casey J, Center K, et al.  Efficacy of PCV13 in prevention of AOM and NP colonization in children: First year of data from the US. In: 8th International Symposium of Pneumococci and Pneumococcal Diseases. Iguacu Falls, Brazil 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/18\">",
"      Whitby CR, Kaplan SL, Mason EO Jr, et al. Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol 2011; 75:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/19\">",
"      Huang WH, Hung PK. Methicillin-resistant Staphylococcus aureus infections in acute rhinosinusitis. Laryngoscope 2006; 116:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/20\">",
"      Payne SC, Benninger MS. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. Clin Infect Dis 2007; 45:e121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/21\">",
"      Wald ER. Staphylococcus aureus: is it a pathogen of acute bacterial sinusitis in children and adults? Clin Infect Dis 2012; 54:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/22\">",
"      Centers for Disease Control and Prevention (CDC). Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007. MMWR Morb Mortal Wkly Rep 2008; 57:1353.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Active Bacterial Core Surveillance. 2011. Available at: www.cdc.gov/abcs/reports-findings/survreports/spneu09.html (Accessed on April 23, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/24\">",
"      Harrison CJ, Woods C, Stout G, et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother 2009; 63:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/25\">",
"      Garbutt J, St Geme JW 3rd, May A, et al. Developing community-specific recommendations for first-line treatment of acute otitis media: is high-dose amoxicillin necessary? Pediatrics 2004; 114:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/26\">",
"      Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/27\">",
"      Critchley IA, Jacobs MR, Brown SD, et al. Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem. Antimicrob Agents Chemother 2008; 52:2639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/28\">",
"      Jacobs MR, Good CE, Windau AR, et al. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 2010; 54:2716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/29\">",
"      Wald ER, Mason EO Jr, Bradley JS, et al. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J 2001; 20:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/30\">",
"      Kellner JD, Ford-Jones EL. Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Toronto Child Care Centre Study Group. Arch Pediatr Adolesc Med 1999; 153:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/31\">",
"      Chung A, Perera R, Brueggemann AB, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ 2007; 335:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/32\">",
"      Wald ER, Dashefsky B, Byers C, et al. Frequency and severity of infections in day care. J Pediatr 1988; 112:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/33\">",
"      Blomgren K, Alho OP, Ertama L, et al. Acute sinusitis: Finnish clinical practice guidelines. Scand J Infect Dis 2005; 37:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/34\">",
"      Manning SC. Pediatric sinusitis. Otolaryngol Clin North Am 1993; 26:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/35\">",
"      Garbutt JM, Goldstein M, Gellman E, et al. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001; 107:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/36\">",
"      Ip S, Fu L, Balk E, et al. Update on acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ) 2005; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/37\">",
"      Bradley JS, Jackson MA, Committee on Infectious Diseases, American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics 2011; 128:e1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/38\">",
"      Critchley IA, Brown SD, Traczewski MM, et al. National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. Antimicrob Agents Chemother 2007; 51:4382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/39\">",
"      Sahm DF, Brown NP, Draghi DC, et al. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005. Postgrad Med 2008; 120:8.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Principles of appropriate use for upper respiratory tract infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.802.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/41\">",
"      Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, et al. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ 2008; 178:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/42\">",
"      Fenoll A, Gim&eacute;nez MJ, Robledo O, et al. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. J Chemother 2008; 20:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/43\">",
"      Sader HS, Jacobs MR, Fritsche TR. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis 2007; 57:5S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/44\">",
"      Jansen WT, Verel A, Beitsma M, et al. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Curr Med Res Opin 2008; 24:2853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/45\">",
"      Wald ER, Reilly JS, Casselbrant M, et al. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J Pediatr 1984; 104:297.",
"     </a>",
"    </li>",
"    <li>",
"     Wald ER. Sinusitis. In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG.  (Eds), Elsevier Saunders, Edinburgh 2012. p.227.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/47\">",
"      Shapiro GG, Virant FS, Furukawa CT, et al. Immunologic defects in patients with refractory sinusitis. Pediatrics 1991; 87:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/48\">",
"      Wald ER. Microbiology of acute and chronic sinusitis in children. J Allergy Clin Immunol 1992; 90:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/49\">",
"      Wald ER. Sinusitis. Pediatr Ann 1998; 27:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/50\">",
"      Leung AK, Kellner JD. Acute sinusitis in children: diagnosis and management. J Pediatr Health Care 2004; 18:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/51\">",
"      Ioannidis JP, Lau J. Technical report: evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic overview. Pediatrics 2001; 108:E57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/52\">",
"      Novembre E, Mori F, Pucci N, et al. Systemic treatment of rhinosinusitis in children. Pediatr Allergy Immunol 2007; 18 Suppl 18:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/53\">",
"      Shaikh N, Wald ER, Pi M. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev 2012; 9:CD007909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/54\">",
"      Wang YH, Yang CP, Ku MS, et al. Efficacy of nasal irrigation in the treatment of acute sinusitis in children. Int J Pediatr Otorhinolaryngol 2009; 73:1696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/55\">",
"      McCormick DP, John SD, Swischuk LE, Uchida T. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996; 35:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/56\">",
"      Patow CA, Kaliner M. Corticosteroid treatment of rhinologic diseases. Ear Nose Throat J 1983; 62:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/57\">",
"      Barlan IB, Erkan E, Bakir M, et al. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997; 78:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/58/42921/abstract/58\">",
"      Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993; 92:812.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5999 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-4C9EBFD82E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42921=[""].join("\n");
var outline_f41_58_42921=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H496645221\">",
"      CLINICAL PRESENTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704286561\">",
"      Common pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704286587\">",
"      Antimicrobial susceptibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H742622640\">",
"      INDICATIONS FOR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EMPIRIC ANTIBIOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H656460459\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Outpatient therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H656458098\">",
"      - Mild/moderate disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H656458106\">",
"      - Severe disease or risk for severe disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H689793379\">",
"      - Penicillin allergy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H689793371\">",
"      - Vomiting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H742621521\">",
"      Inpatient therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H496645662\">",
"      RESPONSE TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H656460002\">",
"      Improvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H656460010\">",
"      Treatment failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1034758001\">",
"      MANAGEMENT OF TREATMENT FAILURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H656459852\">",
"      In outpatients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H704286720\">",
"      In hospitalized patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9804910\">",
"      DURATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SYMPTOMATIC TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Topical saline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Decongestants and antihistamines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Intranasal corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H656460061\">",
"      Sinus aspiration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5999\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5999|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/48/40715\" title=\"table 1\">",
"      Viral versus bacterial sinusitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/30/13804\" title=\"table 2\">",
"      Sinusitis clinical severity score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?31/10/31917\" title=\"table 3\">",
"      Antimicrobial regimens sinusitis children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/11/13500\" title=\"table 4\">",
"      Types allergic reactions SS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/46/23274?source=related_link\">",
"      Allergy to penicillins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=related_link\">",
"      Approach to the child with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23768?source=related_link\">",
"      Levofloxacin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/19/15672?source=related_link\">",
"      Penicillin-allergic patients: Use of cephalosporins, carbapenems, and monobactams",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/81?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to beta-lactam antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22281?source=related_link\">",
"      The common cold in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/53/13146?source=related_link\">",
"      The common cold in children: Treatment and prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_58_42922="LVH tutorial";
var content_f41_58_42922=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1268px;\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Left ventricular hypertrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The electrocardiogram demonstrates a number of features of left ventricular hypertrophy (LVH). The QRS complex is slightly widened (about 0.11 sec), the frontal plane axis is leftward, tall R waves are present in multiple leads, and ST-T changes (formerly called a &ldquo;strain&rdquo; pattern) are present. The somewhat prominent P waves also raise consideration of left atrial abnormality. Slow R wave progression (V1-V3) is non-specific and may be seen with LVH, or with multiple other factors. Underlying anteroseptal MI is not excluded.",
"    <br>",
"     <br>",
"      <br>",
"       <br>",
"        <br>",
"         <div class=\"footnotes\">",
"         </div>",
"         <div class=\"reference\">",
"         </div>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42922=[""].join("\n");
var outline_f41_58_42922=null;
var title_f41_58_42923="Types of airway stents";
var content_f41_58_42923=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58596&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Advantages and disadvantages of different airway stents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Advantages",
"       </td>",
"       <td class=\"subtitle1\">",
"        Disadvantages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Silicone stents",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Easily inserted",
"        </p>",
"        <p>",
"         Repositioning and removal are easily accomplished",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Rigid bronchoscopy and general anesthesia required",
"        </p>",
"        <p>",
"         Stent migration is common",
"        </p>",
"        <p>",
"         Granulation tissue may obstruct proximal or distal ends of stent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Metal stents",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         May be introduced with fiberoptic scope without general anesthesia",
"        </p>",
"        <p>",
"         Self-expanding; resist extrinsic compression",
"        </p>",
"        <p>",
"         Minimal migration after placement",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Cannot be easily removed or repositioned",
"        </p>",
"        <p>",
"         Granulation tissue or tumor easily grows through spaces between metal struts",
"        </p>",
"        <p>",
"         Expansile force may rupture airways and vascular structures",
"        </p>",
"        <p>",
"         More expensive than silicone stents",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        Hybrid stents",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Resist extrinsic compression",
"        </p>",
"        <p>",
"         Silicone membrane resists ingrowth of tumor or granulation tissue",
"        </p>",
"       </td>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        <p>",
"         Cannot be easily removed or repositioned",
"        </p>",
"        <p>",
"         Most expensive",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42923=[""].join("\n");
var outline_f41_58_42923=null;
var title_f41_58_42924="Anticoagulation bleeding AF";
var content_f41_58_42924=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61232&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major bleeding during antithrombotic therapy in atrial fibrillation trials*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"3\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\" rowspan=\"1\">",
"        Rate, percent/year",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"2\" rowspan=\"1\">",
"        Warfarin",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"1\" rowspan=\"2\">",
"        Aspirin",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"1\" rowspan=\"2\">",
"        Placebo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        All&bull;",
"       </td>",
"       <td class=\"subtitle3\">",
"        Intracranial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial Fibrillation, Aspirin, and Anticoagulation",
"(AFASAK 1)",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Boston Area Anticoagulation Trial for Atrial",
"Fibrillation (BAATAF)",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        1.6&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke Prevention in Atrial Fibrillation (SPAF I)",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"       <td>",
"        1.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Canadian Atrial Fibrillation Anticoagulation",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke Prevention in Nonrheumatic Atrial Fibrillation",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        -",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        European Atrial Fibrillation Trial",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0.9",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"5\" rowspan=\"1\">",
"        SPAF II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &le;75",
"y",
"       </td>",
"       <td class=\"sublist_other\">",
"        1.6&nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.5&nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.9&nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &gt;75 y",
"       </td>",
"       <td class=\"sublist_other\">",
"        4.2",
"       </td>",
"       <td class=\"sublist_other\">",
"        1.8",
"       </td>",
"       <td class=\"sublist_other\">",
"        1.6",
"       </td>",
"       <td class=\"sublist_other\">",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        SPAF III",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td colspan=\"1\">",
"        2.4&loz;",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AFASAK 2",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"       <td>",
"        -",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Major bleeding was defined as bleeding requiring transfusion of blood or leading to permanent disability or to death. The rate was calculated as number of events per year of treatment.",
"     <br>",
"      &bull;&nbsp;Includes intracranial bleeding events.",
"      <br>",
"       &Delta;&nbsp;Aspirin voluntary.",
"       <br>",
"        &loz;&nbsp;Aspirin plus warfarin international normalized ratio of the prothrombin time ratio, 1.2-1.5.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Gullov, AL, Koefoed, BG, Peterson, P, Arch Intern Med 1999; 159:1322.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42924=[""].join("\n");
var outline_f41_58_42924=null;
var title_f41_58_42925="Hyperkalemia rapid overview";
var content_f41_58_42925=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F74169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F74169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hyperkalemia management rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Clinical features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Signs and symptoms are uncommon and tend to occur only when the serum potassium exceeds 7.0 meq/L; symptoms can include muscle weakness and ventricular arrhythmias",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       There are two major mechanisms of hyperkalemia:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Increased potassium release from cells (eg, severe hyperglycemia, rhabdomyolysis, succinylcholine)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Reduced potassium excretion in urine, most often due to hypoaldosteronism or renal failure",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pseudohyperkalemia, which is most often due to hemolysis of the blood specimen, is the most common cause of a reported elevation in serum potassium and must be excluded. It does not reflect true hyperkalemia and does not produce ECG changes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Electrocardiogram manifestations",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Large interpatient variability",
"       </strong>",
"       exists in the relationship between the serum potassium and ECG changes; at a given serum potassium, ECG changes are more common with acute elevations and less common with chronic elevations (eg, chronic kidney disease)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Careful cardiac monitoring and serial ECGs are essential",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       ECG findings commonly progress as follows:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Peaked T waves",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Prolonged PR and QRS intervals, and small P waves",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Loss of P wave, further prolongation of QRS interval (\"sine wave\" pattern), and conduction delay that can manifest as bundle branch or AV nodal block",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ventricular fibrillation or asystole can result",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Management",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Confirm the patient is truly hyperkalemic",
"       </strong>",
"       (ie, exclude pseudohyperkalemia)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Obtain electrocardiogram",
"       </strong>",
"       and, if signs of hyperkalemia are seen, place patient on cardiac monitor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       The specific therapies that follow are listed according to their rapidity of action; the choice among them varies according to the severity of ECG changes and muscle weakness",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       <strong>",
"        Stabilize cardiac membranes with calcium:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Give",
"       <strong>",
"        only",
"       </strong>",
"       for hyperkalemia with significant ECG findings (eg, widening of the QRS complex or loss of P waves, but",
"       <strong>",
"        not",
"       </strong>",
"       peaked T waves alone) or severe arrhythmias thought to be caused by hyperkalemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Give adults",
"       <strong>",
"        calcium chloride",
"       </strong>",
"       500 to 1000 mg (5 to 10 mL of 10 percent solution) by IV infusion slowly over 2 to 3 minutes, preferably via a central line; or give",
"       <strong>",
"        calcium gluconate",
"       </strong>",
"       1000 mg (10 mL of 10 percent solution) also infused slowly; may be given peripherally in large vein; time to onset is immediate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Calcium treatment may be repeated after 5 minutes if ECG changes persist; patient must be on cardiac monitor when receiving calcium; calcium can exacerbate digoxin toxicity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Give children",
"       <strong>",
"        calcium gluconate",
"       </strong>",
"       (10 percent solution) 0.5 mL/kg",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Since the effect of calcium is transient, patients with hyperkalemia also require treatments to shift potassium into cells and to remove potassium",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       <strong>",
"        Shift potassium into cells:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Give insulin and glucose to hyperkalemic patients with ECG changes OR serum potassium &ge;6.5 to 7 meq/L",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Insulin and glucose:",
"       </strong>",
"       Give IV bolus of regular insulin 10 units with 50 mL of a 50 percent glucose solution; give children regular insulin 0.2 units per gram of glucose, give glucose 1 g/kg; time to onset is 10 to 20 minutes; after insulin and glucose bolus therapy, start dextrose infusion; monitor fingerstick glucose closely",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Beta 2 agonist:",
"       </strong>",
"       May give albuterol 10 to 20 mg in 4 mL saline nebulized over 10 minutes (may use metered dose inhaler); pediatric dose 0.1 to 0.3 mg/kg; time to onset is 20 to 30 minutes; IV albuterol or epinephrine are alternatives",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Sodium bicarbonate:",
"       </strong>",
"       Provides minimal effect on shifting potassium intracellularly, even in acidemic patients; may give 150 meq in one liter of 5 percent dextrose in water at 250 mL/hour; do not give in same IV as calcium",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Since the effect of shifting potassium into the cells is transient, treatments to remove potassium are also required",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       <strong>",
"        Remove potassium",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Cation exchange resin (sodium polystyrene sulfonate):",
"       </strong>",
"       Give 15 to 30 grams of sodium polystyrene sulfonate (without sorbitol) orally; pediatric dose is 1 g/kg; although less preferable, sodium polystyrene sulfonate may be given as a retention enema (dose is 50 g) without sorbitol; time to onset is approximately 1 to 2 hours; may repeat dose after 4 to 6 hours based upon repeat serum potassium; Sorbitol can cause intestinal necrosis and should be avoided; Do not give sodium polystyrene sulfonate or sorbitol to post-operative or renal transplant patients",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Loop or thiazide diuretic:",
"       </strong>",
"       Provides only limited short-term effect; May give furosemide 20 to 40 mg IV; pediatric dose is 1 to 2 mg/kg IV; higher dose may be required with renal insufficiency; fluid losses must be replaced unless the patient is volume expanded",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       <strong>",
"        Hemodialysis:",
"       </strong>",
"       Can be used if the conservative measures listed above fail, if hyperkalemia is severe, if the patient has renal failure, or if the patient has marked tissue breakdown and is releasing large amounts of potassium from injured cells",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42925=[""].join("\n");
var outline_f41_58_42925=null;
var title_f41_58_42926="Contents: Pediatric dermatology";
var content_f41_58_42926=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric dermatology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric dermatology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acne",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/35/44599\">",
"           Hormonal therapy for women with acne vulgaris",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/54/33639\">",
"           Light-based, adjunctive, and other therapies for acne vulgaris",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/42/22184\">",
"           Oral isotretinoin therapy for acne vulgaris",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/20/6474\">",
"           Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/9/44183\">",
"           Postadolescent acne in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/28/39370\">",
"           Treatment of acne vulgaris",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cutaneous eruptions in newborns and infants",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/13/22745\">",
"           Benign skin and scalp lesions in the newborn and young infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/29/1495\">",
"           Juvenile xanthogranuloma (JXG)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/43/6840\">",
"           Skin nodules in newborns and infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/31/15864\">",
"           Vesiculobullous and pustular lesions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dermatitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/31/26104\">",
"           Contact dermatitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/14/2278\">",
"           Cradle cap and seborrheic dermatitis in infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/40/42631\">",
"           Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/26/44457\">",
"           Management of severe refractory atopic dermatitis (eczema)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/33/37401\">",
"           Overview of diaper dermatitis in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/59/26551\">",
"           Role of allergy in atopic dermatitis (eczema)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/37/10842\">",
"           Treatment of atopic dermatitis (eczema)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/0/24586\">",
"           The genodermatoses",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hair disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/46/1768\">",
"           Clinical manifestations and diagnosis of alopecia areata",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/14/4330\">",
"           Management of alopecia areata",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/33/13846\">",
"           Nonscarring hair loss",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hemangiomas and vascular malformations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/10/2217\">",
"           Capillary malformations (port wine stains): Clinical features, diagnosis, and associated syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/39/44665\">",
"           Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/23/5495\">",
"           Evaluation and diagnosis of infantile hemangiomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/39/4727\">",
"           Sturge-Weber syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/21/30038\">",
"           Vascular lesions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/7/8312\">",
"           Condylomata acuminata (anogenital warts) in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/40/26249\">",
"           Cutaneous warts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/58/7082\">",
"           Dermatophyte (tinea) infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/35/23097\">",
"           Gianotti-Crosti syndrome (papular acrodermatitis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/21/21846\">",
"           Impetigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/43/6842\">",
"           Molluscum contagiosum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/8/5258\">",
"           Onychomycosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/47/31481\">",
"           Overview of Candida infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/15/3320\">",
"           Tinea versicolor",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infestations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/15/25849\">",
"           Pediculosis capitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/30/1511\">",
"           Pediculosis pubis and pediculosis ciliaris",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/2/28712\">",
"           Scabies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nevi and other pigmented lesions",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/1/44056\">",
"           Acquired melanocytic nevi (moles)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/17/43287\">",
"           Benign pigmented skin lesions other than melanocytic nevi (moles)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/17/7447\">",
"           Congenital melanocytic nevi and speckled lentiginous nevi",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/29/18906\">",
"           Spitzoid melanocytic neoplasms (Spitz nevus and atypical Spitz tumors)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/36/14922\">",
"           Linear IgA bullous dermatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/35/18999\">",
"           Pityriasis rosea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/29/26072\">",
"           Vulvovaginal complaints in the prepubertal child",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Patient evaluation and treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/45/35541\">",
"           Approach to dermatologic diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/28/37318\">",
"           Approach to the patient with a scalp eruption",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/8/29831\">",
"           Approach to the patient with macular skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/48/28423\">",
"           Approach to the patient with pustular skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/29/9690\">",
"           Evaluation and diagnosis of hair loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/6/27752\">",
"           General principles of dermatologic therapy and topical corticosteroid use",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Systemic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/38/33383\">",
"           Approach to evaluating childhood vasculitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/49/40729\">",
"           Clinical manifestations and diagnosis of Henoch-Sch������nlein purpura (IgA vasculitis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/22/31079\">",
"           Diagnosis of juvenile dermatomyositis and polymyositis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/13/26841\">",
"           Evaluation of purpura in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/32/39433\">",
"           Juvenile systemic sclerosis (scleroderma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/1/40985\">",
"           Localized scleroderma in childhood",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/62/28646\">",
"           Management of Henoch-Sch������nlein purpura (IgA vasculitis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/43/29368\">",
"           Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/5/2138\">",
"           Treatment and prognosis of juvenile dermatomyositis and polymyositis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vascular malformations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/60/25546\">",
"           Management of infantile hemangiomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/5/29785\">",
"           Pyogenic granuloma (Lobular capillary hemangioma)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-B7D03E8B80-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f41_58_42926=[""].join("\n");
var outline_f41_58_42926=null;
var title_f41_58_42927="Saber shins";
var content_f41_58_42927=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital syphilis: Saber shins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sweet RL, Gibbs RS. Atlas of Infectious Diseases of the Female Genital Tract. Lippincott Williams &amp; Wilkins, Philadelphia 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_58_42927=[""].join("\n");
var outline_f41_58_42927=null;
